Upcoming Issue Highlights

Monograph: Folate


Based on a systemic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration.

Folate and folic acid are forms of a water-soluble B vitamin. Folate occurs naturally in food, and folic acid is the synthetic form of this vitamin. Folic acid is well-tolerated in amounts found in fortified foods and supplements. Sources include cereals, baked goods, leafy vegetables (spinach, broccoli, lettuce), okra, asparagus, fruits (bananas, melons, lemons), legumes, yeast, mushrooms, organ meat (beef liver, kidney), orange juice and tomato juice. Folic acid is frequently used in combination with other B vitamins in vitamin B complex formulations.

Folic acid supplements are effective for increasing folate levels in blood and decreasing symptoms associated with low folate levels.Folic acid supplementation, with and without other B vitamins, reduce levels of homocysteine in blood (a cardiovascular risk factor).

Folic acid supplements are suggested for use in women of childbearing age in order to prevent neural tube defects. Neural tube defect risk appears to have decreased in many countries since folic acid fortification of flour and cereals.

Folic acid is also of interest with respect to cognitive enhancement, cancer, psychiatric illnesses and cardiovascular conditions, although conclusions may not be drawn for many of these uses at this time. Some concern exists with respect to increased folic acid intake masking symptoms of vitamin B12 deficiency, especially in the elderly population.


AIDS, anemia (associated with inflammatory bowel disease), anti-aging, appetite stimulation, autism, canker sores, celiac disease, critical illness, Crohn’s disease, dental conditions, fistula (abnormal connection between organs), fractures (risk reduction), gastritis (stomach inflammation), genetic damage (X-ray induced chromosomal damage), infertility, inflammatory bowel disease, insomnia, ischemic heart disease (decreased blood supply to the heart), lichen planus (itchy mouth rash), liver disease, macular degeneration (eye disease), mood, myofascial pain (chronic muscle pain), osteoporosis, peripheral neuropathy (damage of peripheral nerves such as toes and fingertips), restless leg syndrome, retinal vein occlusion (blockage of veins in the eye), schizophrenia, sickle Cell anemia, spinal cord injury, ulcerative colitis, weight loss.


Adults (18 years and older) 

The daily suggested intake levels of folic acid are as follows: males over 13 years, 400 micrograms; females over 13 years, 400-600 micrograms; pregnancy all ages, 400-600 micrograms; breastfeeding females of all ages, 500 micrograms. The maximum daily intake level of folic acid for people 19 years and older (including pregnant or breastfeeding women), 1,000 micrograms.

For anemia caused by folate deficiency, 1-5 milligrams has been taken by mouth daily until recovery.

For antiseizure drug-induced folate deficiency, 15 milligrams has been taken by mouth daily under the supervision of a qualified healthcare provider.

For bipolar disorder, 200 international units of folic acid has been taken by mouth daily for 52 weeks in patients stabilized on lithium. Three milligrams of folic acid have been taken by mouth daily for three weeks in patients starting valproic acid therapy.

For cancer (general), 0.2-40 milligrams of folate or folic acid (either taken alone or in combination with aspirin, vitamins B6 or B12) has been taken by mouth daily for three to eight years, with mixed results.

For cognitive effects, 0.75-15 milligrams of folic acid has been taken by mouth daily for 1-36 months.

For colorectal cancer, 0.5-5 milligrams of folic acid has been taken by mouth daily for three to eight years with mixed results.

For chronic kidney disease, 2-15 milligrams of folic acid has been taken by mouth daily, every other day or three times weekly, for a follow- up duration of 1-3.6 years.

For depression, 0.5-3 milligrams or 200 international units of folic acid or 15-50 milligrams of methylenetetrahydrofolate have been taken by mouth daily for three to 52 weeks.

For diabetes, 5 milligrams of folic acid has been taken by mouth daily for one to six months.

For folate deficiency, 250-1,000 micrograms has been taken by mouth daily. In addition, for severe folate deficiency, 1-5 milligrams has been taken by mouth daily until blood levels are corrected and documented by a qualified healthcare professional.

For fragile X syndrome, 10-250 milligrams of folic acid has been taken by mouth daily for two to eight months with a lack of effect on symptoms.

For heart disease, 0.8-40 milligrams of folic acid have been taken by mouth daily for three to 88 months.

For high homocysteine levels, 0.2-5 milligrams of folic acid has been taken by mouth For 21-168 days.

For high blood pressure, 5-10 milligrams of folic acid has been taken by mouth for two to six weeks.

For methotrexate toxicity, 1-27.5 milligrams of folic acid or 1-20 milligrams of folinic acid has been taken by mouth daily or weekly for up to 12 weeks.

For the prevention of birth defects, wheat flour fortified with folic acid has been taken by mouth before pregnancy and during the first two months of pregnancy. Doses of 0.36-5 milligrams have been taken by mouth daily.

For the prevention of pregnancy complications (other), 0.25-5 milligrams of folic acid have been taken by mouth daily for 12-24 weeks.

For stroke, 0.5-40 milligrams of folic acid have been taken by mouth daily for 6-88 months. For vein clots, 5 milligrams of folic acid has been taken by mouth once daily during pregnancy.

For vitiligo, 5 milligrams has been taken by mouth twice daily.

For gum overgrowth caused by phenytoin, folic acid has been applied to the gum. For pregnancy-related gum disease, folic acid has been applied to the gum.

Children (under 18 years old) 

The daily suggested intake levels of folic acid are as follows: babies 0-6 months, 65 micrograms; 7 to 12 months, 80 micrograms; children 1-3 years, 150 micrograms; 4-8 years, 200 micrograms; males 9-13 years, 300 micrograms; males over 13 years, 400 micrograms; and females 9-13 years, 300 micrograms.

The maximum daily intakes are as follows: for children 1-3 years-old, 300 micrograms; for children 4-8 years-old, 400 micrograms; for children 9-13 years-old, 600 micrograms; and for adolescents 14-18 years-old, 800 micrograms. Folic acid injection contains benzyl alcohol (1.5 percent), and extreme care should be used when given to newborns.Folic acid injections should be given by a health care provider.

For fragile X syndrome, 10-250 milligrams has been taken by mouth daily for 2-8 months with a lack of effect on symptoms.

For general health maintenance, 0.005-15 milligrams has been taken by mouth daily for two weeks to 18 months, with mixed results.


Allergies Avoid in people with known allergy or sensitivity to product ingredients in folic acid-containing supplements.

Side Effects & Warnings 

Folate is likely safe when added to foods in the following amounts: in breakfast cereals, below 400 micrograms per serving; in infant formula, 4 micrograms per 100 kilocalories of Infant formula; in corn grits, 1 milligram per pound; in meal-replacement products, 200-400 micrograms per serving, with the amount depending on whether the food is used once or more than once daily.

Use cautiously if taken above the suggested or maximum daily intake levels.

Folate may cause bitter taste, bloating, blood flow problems (caused by narrowed vessels), breathing difficulty, changes in urine color, confusion, cramps, diarrhea, dizziness, fatigue, gas, hair loss, headache, impaired judgment, increased asthma risk (in children of women taking folic acid during late pregnancy), increased cancer risk, increased seizure frequency, inflammation (such as in the mouth), lung muscle spasms, mood swings (excitability or irritability), nausea, overactivity, psychotic behavior, skin symptoms (flushing, hives, itching, rash, and redness), sleep problems, vivid dreaming, and weight changes.

Folate may cause low blood pressure. Caution is advised in people taking drugs or herbs and supplements that lower blood pressure.

Folate may lower blood sugar levels. Caution is advised in people with diabetes or low blood sugar, and in those taking drugs, herbs, or supplements that affect blood sugar. Blood sugar levels may need to be monitored by a qualified healthcare professional, including a pharmacist, and medication adjustments may be necessary.

Use cautiously in combination with aspirin or in supplemental doses above the maximum daily intake without the care of a medical professional. Injections of folic acid containing benzyl alcohol should only be used under the care of a doctor.

Use cautiously in people who have or are at risk of anemia, cancer, lung disorders, malaria, nervous system disorders, seizure disorders, skin conditions and stomach problems.

Avoid using with a combination of B vitamins after heart surgery or in people taking anticancer agents or folic acid antagonists (blockers), unless prescribed by a health care professional.

Avoid in people with known allergy or sensitivity to product ingredients in folic acidcontaining supplements.

Pregnancy & Breast 

Feeding The U.S. Preventive Services Task Force and other groups suggests that all women planning to be pregnant take a daily supplement containing 0. 4-0.8 milligrams (400-800 micrograms) of folic acid. It is suggested that all women capable of becoming pregnant consume folate in order to reduce the risk of the fetus developing birth defects.

Folic acid is likely safe to use during breastfeeding under the supervision of a qualified health care provider.


Interactions with Drugs 

Folate may lower blood sugar levels. Caution is advised when using medications that may also lower blood sugar. People taking drugs for diabetes by mouth or insulin should be monitored closely by a qualified healthcare professional, including a pharmacist. Medication adjustments may be necessary.

Folate may cause low blood pressure. Caution is advised in people taking drugs that lower blood pressure.

Folate may also interact with agents that promote urination, alcohol, Alzheimer’s agents, aminosalicylic acid, antacids, antibiotics, anticancer agents, antidepressants, anti-malaria agents, anti-seizure agents, aspirin, birth control, cholestyramine, colestipol, conjugated estrogens, cycloserine, folic acid antagonists, H2 blockers, heart agents, homocysteine-lowering agents, iron, methotrexate, methylprednisolone sodium succinate (Solu-Medrol®), nervous system agents, nitroglycerin, nonsteroidal anti-inflammatories (NSAIDs), omega-3 fatty acids, pancreatic extracts, pemetrexed disodium, pentamidine, phenytoin, proton pump inhibitors, sulfasalazine Sulfonamides, tobacco, trimethoprim, vitamin A, vitamin B12, warfarin and zinc.

Interactions with Herbs & Dietary Supplements 

Folate may lower blood sugar levels. Caution is advised when using herbs or supplements that may also lower blood sugar. Blood glucose levels may require monitoring, and doses may need adjustment.

Folate may cause low blood pressure. Caution is advised in people taking herbs or supplements that lower blood pressure.

Folate may also interact with aged garlic extract, alcohol, Alzheimer’s herbs and supplements, antacids, antibacterials, anticancer herbs and supplements, antidepressants, anti-inflammatories, anti-malaria herbs and supplements, antioxidants, anti-seizure herbs and supplements, B vitamins, birth control, green tea, heart herbs and supplements, herbs and supplements that promote urination, homocysteine-lowering herbs and supplements, iron, leaf concentrate, multiple micronutrients, nervous system herbs and supplements, omega-3 fatty acids, pancreatic extracts, phytoestrogens, probiotics, salicylates, vitamin A, vitamin B12 and zinc.


  1. King, J. C. Zinc: an essential but elusive nutrient. Am.J.Clin Nutr. 2011;94(2):679S-684S. View Abstract
  2. Pincus, T., Furer, V., and Sokka, T. Underestimation of the efficacy, effectiveness, tolerability, and safety of weekly low-dose methotrexate in information presented to physicians and patients. Clin Exp.Rheumatol 2010;28(5 Suppl 61):S68-S79. View Abstract
  3. Stone, J., Doube, A., Dudson, D., and Wallace, J. Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: results of a dietary survey. Semin.Arthritis Rheum. 1997;27(3):180-185. View Abstract
  4. Alazzam, M., Tidy, J., Hancock, B. W., Osborne, R., and Lawrie, T. A. First-line chemotherapy in low-risk gestational trophoblastic neoplasia. Cochrane.Database.Syst.Rev. 2012;7:CD007102. View Abstract
  5. Montaudie, H., Sbidian, E., Paul, C., Maza, A., Gallini, A., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B., Joly, P., Jullien, D., Le, Maitre M., Misery, L., Richard, M. A., and Ortonne, J. P. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur.Acad.Dermatol.Venereol. 2011;25 Suppl 2:12-18. View Abstract
  6. Paul, C., Gallini, A., Maza, A., Montaudie, H., Sbidian, E., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B., Joly, P., Jullien, D., Le, Maitre M., Misery, L., Richard, M. A., and Ortonne, J. P. Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J.Eur.Acad.Dermatol.Venereol. 2011;25 Suppl 2:2-11. View Abstract
  7. Deng, L., Zhang, J., Wu, T., and Lawrie, T. A. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour. Cochrane.Database.Syst.Rev. 2013;1:CD005196. View Abstract
  8. Chladek, J., Simkova, M., Vaneckova, J., Hroch, M., Chladkova, J., Martinkova, J., Vavrova, J., and Beranek, M. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis. Eur J Clin Pharmacol. 2008;64(4):347-355. View Abstract
  9. Ebbing, M., Bonaa, K. H., Nygard, O., Arnesen, E., Ueland, P. M., Nordrehaug, J. E., Rasmussen, K., Njolstad, I., Refsum, H., Nilsen, D. W., Tverdal, A., Meyer, K., and Vollset, S. E. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 11-18-2009;302(19):2119-2126. View Abstract
  10. Collin, S. M., Metcalfe, C., Refsum, H., Lewis, S. J., Zuccolo, L., Smith, G. D., Chen, L., Harris, R., Davis, M., Marsden, G., Johnston, C., Lane, J. A., Ebbing, M., Bonaa, K. H., Nygard, O., Ueland, P. M., Grau, M. V., Baron, J. A., Donovan, J. L., Neal, D. E., Hamdy, F. C., Smith, A. D., and Martin, R. M. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol.Biomarkers Prev. 2010;19(6):1632-1642. View Abstract
  11. Fife, J., Raniga, S., Hider, P. N., and Frizelle, F. A. Folic acid supplementation and colorectal cancer risk: a meta-analysis. Colorectal Dis. 2011;13(2):132-137. View Abstract
  12. Charles, D., Ness, A. R., Campbell, D., Davey, Smith G., and Hall, M. H. Taking folate in pregnancy and risk of maternal breast cancer. BMJ 12-11-2004;329(7479):1375-1376. View Abstract
  13. Hirsch, S., Sanchez, H., Albala, C., de la Maza, M. P., Barrera, G., Leiva, L., and Bunout, D. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol. 2009;21(4):436-439. View Abstract
  14. Marik, P. E. and Flemmer, M. Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence? JPEN J.Parenter.Enteral Nutr. 2012;36(2):159-168. View Abstract
  15. O’Connor, O. A., Pro, B., Pinter-Brown, L., Bartlett, N., Popplewell, L., Coiffier, B., Lechowicz, M. J., Savage, K. J., Shustov, A. R., Gisselbrecht, C., Jacobsen, E., Zinzani, P. L., Furman, R., Goy, A., Haioun, C., Crump, M., Zain, J. M., Hsi, E., Boyd, A., and Horwitz, S. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J.Clin Oncol. 3-20-2011;29(9):1182-1189. View Abstract
  16. Giannini, S. and Martes, C. Anemia in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2006;52(3):275-291. View Abstract
  17. Kulnigg, S. and Gasche, C. Systematic review: managing anaemia in Crohn’s disease. Aliment.Pharmacol.Ther 2006;24(11-12):1507-1523. View Abstract
  18. Hatamizadeh, N., Eftekhar, H., Shafaghi, B., and Mohammad, K. Effects of folic acid on preschool children’s appetite: randomized triple-blind clinical trial. Pediatr Int 2007;49(5):558-563. View Abstract
  19. Main, P. A., Angley, M. T., Thomas, P., O’Doherty, C. E., and Fenech, M. Folate and methionine metabolism in autism: a systematic review. Am J Clin Nutr 2010;91(6):1598-1620. View Abstract
  20. Esaki, M., Morita, M., Akhter, R., Akino, K., and Honda, O. Relationship between folic acid intake and gingival health in non-smoking adults in Japan. Oral Dis. 2010;16(1):96-101. View Abstract
  21. Tai, H. C., Yang, W. C., Chen, T. W., and Lin, C. C. Are homocysteine and MTHFR genotype polymorphism associated with arteriovenous fistula patency? Am J Kidney Dis. 2005;46(5):993-994. View Abstract
  22. Zintzaras, E. Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies. Biomarkers 2010;15(1):69-79. View Abstract
  23. M’Koma, A. E., Wise, P. E., Schwartz, D. A., Muldoon, R. L., and Herline, A. J. Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. Dis.Colon Rectum 2009;52(4):726-739. View Abstract
  24. Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., and Scott, J. M. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 4-27-1998;158(8):862-867. View Abstract
  25. Sahebjamee M, Beitollahi JM, Mansourian A, Shahsavari N, and Shabestari SB. Assessment of serum vitamin B12 and folic acid in patients with oral lichen planus: a case control study. J DENT SHIRAZ UNIV MED SCI 2010;10(Suppl):36-39.
  26. Williams, E., Stewart-Knox, B., Bradbury, I., Rowland, I., Pentieva, K., Helander, A., and McNulty, H. Effect of folic acid supplementation on mood and serotonin response in healthy males. Br J Nutr 2005;94(4):602-608. View Abstract
  27. Okumus, M., Ceceli, E., Tuncay, F., Kocaoglu, S., Palulu, N., and Yorgancioglu, Z. R. The relationship between serum trace elements, vitamin B12, folic acid and clinical parameters in patients with myofascial pain syndrome. J Back.Musculoskelet.Rehabil 2010;23(4):187-191. View Abstract
  28. Herrmann, M., Peter, Schmidt J., Umanskaya, N., Wagner, A., Taban-Shomal, O., Widmann, T., Colaianni, G., Wildemann, B., and Herrmann, W. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin.Chem.Lab Med 2007;45(12):1621-1632. View Abstract
  29. Cahill, M. T., Stinnett, S. S., and Fekrat, S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136(6):1136-1150. View Abstract
  30. Firth, Y., Murtaugh, M. A., and Tangney, C. C. Estimation of individual intakes of folate in women of childbearing age with and without simulation of folic acid fortification. J Am Diet Assoc 1998;98(9):985-988. View Abstract
  31. Martinez, O. B. Folic acid, iron and ascorbic acid in young schoolchildren: a biochemical and dietary assessment. Can.J Public Health 1982;73(2):109-118. View Abstract
  32. Fakhrzadeh H, Ghotbi S, Pour-Ebrahim R, Nouri M, Heshmat R, Shafaee A, and Larijani B. Evaluation of total plasma homocysteine, folic acid and vitamin B12 in 25-64 aged inhabitants of Tehran University of Medical Sciences Population Lab region. IRANIAN J DIABETES LIPID DISORD 2004;2:E13.
  33. Ortiz-Andrellucchi, A., Doreste-Alonso, J., Henriquez-Sanchez, P., Cetin, I., and Serra-Majem, L. Dietary assessment methods for micronutrient intake in pregnant women: a systematic review. Br J Nutr 2009;102 Suppl 1:S64-S86. View Abstract
  34. Henriquez-Sanchez, P., Sanchez-Villegas, A., Doreste-Alonso, J., Ortiz-Andrellucchi, A., Pfrimer, K., and Serra-Majem, L. Dietary assessment methods for micronutrient intake: a systematic review on vitamins. Br J Nutr 2009;102 Suppl 1:S10-S37. View Abstract
  35. Roman-Vinas, B., Ribas, Barba L., Ngo, J., Martinez-Gonzalez, M. A., Wijnhoven, T. M., and Serra-Majem, L. Validity of dietary patterns to assess nutrient intake adequacy. Br.J.Nutr. 2009;101 Suppl 2:S12-S20. View Abstract
  36. Johansson, I., Van, Guelpen B., Hultdin, J., Johansson, M., Hallmans, G., and Stattin, P. Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortification. Eur J Clin Nutr 2010;64(8):905-913. View Abstract
  37. Mikkelsen, T. B., Osler, M., and Olsen, S. F. Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr 2006;9(6):771-778. View Abstract
  38. Burton, A., Wilson, S., and Gillies, A. J. Folic acid: Is self reported use of supplements accurate? J Epidemiol.Community Health 2001;55(11):841-842. View Abstract
  39. Serra-Majem, L., Ribas, L., Ngo, J., Aranceta, J., Garaulet, M., Carazo, E., Mataix, J., Perez-Rodrigo, C., Quemada, M., Tojo, R., and Vazquez, C. Risk of inadequate intakes of vitamins A, B1, B6, C, E, folate, iron and calcium in the Spanish population aged 4 to 18. Int J Vitam.Nutr Res 2001;71(6):325-331. View Abstract
  40. Gjengedal, H., Dahl, L., Lavik, A., Trovik, T. A., Berg, E., Boe, O. E., and Malde, M. K. Randomized clinical trial comparing dietary intake in patients with implant-retained overdentures and conventionally relined denture. Int.J.Prosthodont. 2012;25(4):340-347. View Abstract
  41. Yang, Q. and Erickson, J. D. Influence of reporting error on the relation between blood folate concentrations and reported folic acid-containing dietary supplement use among reproductive-aged women in the United States. Am J Clin Nutr 2003;77(1):196-203. View Abstract
  42. Stockley, L. and Lund, V. Use of folic acid supplements, particularly by low-income and young women: a series of systematic reviews to inform public health policy in the UK. Public Health Nutr 2008;11(8):807-821. View Abstract
  43. Booth, C. K., Clark, T., and Fenn, A. Folic acid, riboflavin, thiamine, and vitamin B-6 status of a group of first-time blood donors. Am J Clin Nutr 1998;68(5):1075-1080. View Abstract
  44. Haidar, J. Prevalence of anaemia, deficiencies of iron and folic acid and their determinants in Ethiopian women. J Health Popul.Nutr 2010;28(4):359-368. View Abstract
  45. Oner, N., Vatansever, U., Karasalihoglu, S., Ekuklu, G., Celtik, C., and Biner, B. The prevalence of folic acid deficiency among adolescent girls living in Edirne, Turkey. J Adolesc.Health 2006;38(5):599-606. View Abstract
  46. Mazeh, D., Cholostoy, A., Zemishlani, C., and Barak, Y. Elderly psychiatric patients at risk of folic acid deficiency: a case controlled study. Arch Gerontol.Geriatr 2005;41(3):297-302. View Abstract
  47. Wahlin, A., Backman, L., Hultdin, J., Adolfsson, R., and Nilsson, L. G. Reference values for serum levels of vitamin B12 and folic acid in a population-based sample of adults between 35 and 80 years of age. Public Health Nutr 2002;5(3):505-511. View Abstract
  48. Johansson M, Jagerstad M, and Frolich W. Folates in lettuce: a pilot study. SCAND J FOOD NUTR 2007;51(1):22-30.
  49. Law, M. R. and Morris, J. K. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr 1998;52(8):549-556. View Abstract
  50. Zhao, G., Ford, E. S., Li, C., and Mokdad, A. H. The prevalence and correlates of taking folic acid and vitamin supplements among adults aged >/= 45 years with CVD. Public Health Nutr 2010;13(11):1810-1817. View Abstract
  51. Serra-Majem, L., Ortega, R., Aranceta, J., Entrala, A., and Gil, A. Fortified foods. Criteria for vitamin supplementation in Spain. Public Health Nutr 2001;4(6A):1331-1334. View Abstract
  52. Machado, J., Moncada, J. C., and Pineda, R. [Profile of use of anti tumor necrosis factor in Colombian patients]. Biomedica. 2011;31(2):250-257. View Abstract
  53. Clippe, C., Freyer, G., Milano, G., and Trillet-Lenoir, V. Lethal toxicity of capecitabine due to abusive folic acid prescription? Clin Oncol.(R.Coll.Radiol.) 2003;15(5):299-300. View Abstract
  54. Green-Raleigh, K., Carter, H., Mulinare, J., Prue, C., and Petrini, J. Trends in folic Acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995-2005. Matern.Child Health J 2006;10(5 Suppl):S177-S182. View Abstract
  55. Fauzi NAM, McKenna D, Yusoff A, and Rahman NA. Awareness and use of folic acid among Malaysian women of childbearing age. INT MED J 2009;16(3):201-209.
  56. Canfield, M. A., Przybyla, S. M., Case, A. P., Ramadhani, T., Suarez, L., and Dyer, J. Folic acid awareness and supplementation among Texas women of childbearing age. Prev.Med 2006;43(1):27-30. View Abstract
  57. Kannan, S., Menotti, E., Scherer, H. K., Dickinson, J., and Larson, K. Folic acid and the prevention of neural tube defects: A survey of awareness among Latina women of childbearing age residing in southeast Michigan. Health Promot.Pract. 2007;8(1):60-68. View Abstract
  58. Wilton, D. C. and Foureur, M. J. A survey of folic acid use in primigravid women. Women Birth 2010;23(2):67-73. View Abstract
  59. Victora, C. G., Barros, F. C., Assuncao, M. C., Restrepo-Mendez, M. C., Matijasevich, A., and Martorell, R. Scaling up maternal nutrition programs to improve birth outcomes: a review of implementation issues. Food Nutr.Bull. 2012;33(2 Suppl):S6-26. View Abstract
  60. Conde-Agudelo, A., Rosas-Bermudez, A., Castano, F., and Norton, M. H. Effects of birth spacing on maternal, perinatal, infant, and child health: a systematic review of causal mechanisms. Stud.Fam.Plann. 2012;43(2):93-114. View Abstract
  61. Williams, L. J., Mai, C. T., Edmonds, L. D., Shaw, G. M., Kirby, R. S., Hobbs, C. A., Sever, L. E., Miller, L. A., Meaney, F. J., and Levitt, M. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66(1):33-39. View Abstract
  62. Canfield, M. A., Anderson, J. L., Waller, D. K., Palmer, S. E., and Kaye, C. I. Folic acid awareness and use among women with a history of a neural tube defect pregnancy–Texas, 2000-2001. MMWR Recomm.Rep 9-13-2002;51(RR-13):16-19. View Abstract
  63. Chivu, C. M., Tulchinsky, T. H., Soares-Weiser, K., Braunstein, R., and Brezis, M. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy. Am J Health Promot. 2008;22(4):237-245. View Abstract
  64. Walfisch, A. and Koren, G. Preconception counseling: rational, practice and challenges. Minerva Ginecol. 2011;63(5):411-419. View Abstract
  65. Prevalence of neural tube defects and folic acid knowledge and consumption–Puerto Rico, 1996-2006. MMWR Morb.Mortal.Wkly.Rep 1-11-2008;57(1):10-13. View Abstract
  66. Dunlop, A. L., Kramer, M. R., Hogue, C. J., Menon, R., and Ramakrishan, U. Racial disparities in preterm birth: an overview of the potential role of nutrient deficiencies. Acta Obstet.Gynecol.Scand. 2011;90(12):1332-1341. View Abstract
  67. Prue, C. E., Flores, A. L., Panissidi, P., and Lira, A. But I’ve already had a healthy baby: folic acid formative research with Latina mothers. J Womens Health (Larchmt.) 2008;17(8):1257-1269. View Abstract
  68. Flores, A. L., Prue, C. E., and Daniel, K. L. Broadcasting behavior change: a comparison of the effectiveness of paid and unpaid media to increase folic acid awareness, knowledge, and consumption among Hispanic women of childbearing age. Health Promot.Pract. 2007;8(2):145-153. View Abstract
  69. Quinn, G. P., Thomas, K. B., Hauser, K., Rodriguez, N. Y., and Rodriguez-Snapp, N. Evaluation of educational materials from a social marketing campaign to promote folic acid use among Hispanic women: insight from Cuban and Puerto Rican ethnic subgroups. J Immigr.Minor.Health 2009;11(5):406-414. View Abstract
  70. Thomas KB, Hauser K, Rodriguez NY, and Quinn GP. Folic acid promotion for Hispanic women in Florida: A vitamin diary study. HEALTH EDUC J 2010;69(3):344-352.
  71. Flores, A. L., Prue, C. E., Panissidi, P., and Lira, A. Preparing for a healthy future today: Folic acid formative research with young Latina adults. Fam.Community Health 2010;33(4):301-317. View Abstract
  72. Mackert, M., Kahlor, L., Silva, K., and Padilla, Y. Promoting folic acid to Spanish-speaking Hispanic women: evaluating existing campaigns to guide new development. Women Health 2010;50(4):376-395. View Abstract
  73. Quinn, G. P., Hauser, K., Bell-Ellison, B. A., Rodriguez, N. Y., and Frias, J. L. Promoting pre-conceptional use of folic acid to Hispanic women: a social marketing approach. Matern.Child Health J 2006;10(5):403-412. View Abstract
  74. de Walle, H. E., van der Pal, K. M., de Jong-van den Berg LT, Jeeninga, W., Schouten, J. S., de Rover, C. M., Buitendijk, S. E., and Cornel, M. C. Effect of mass media campaign to reduce socioeconomic differences in women’s awareness and behaviour concerning use of folic acid: cross sectional study. BMJ 7-31-1999;319(7205):291-292. View Abstract
  75. Milan, J. E. and White, A. A. Impact of a stage-tailored, web-based intervention on folic acid-containing multivitamin use by college women. Am J Health Promot. 2010;24(6):388-395. View Abstract
  76. Kondo, A., Kamihira, O., Gotoh, M., Ozawa, H., Lee, T. Y., Lin, A. T., Kim, S. R., and Lin, H. H. Folic acid prevents neural tube defects: international comparison of awareness among obstetricians/gynecologists and urologists. J Obstet Gynaecol Res 2007;33(1):63-67. View Abstract
  77. Williams, J. L., Abelman, S. M., Fassett, E. M., Stone, C. E., Petrini, J. R., Damus, K., and Mulinare, J. Health care provider knowledge and practices regarding folic acid, United States, 2002-2003. Matern.Child Health J 2006;10(5 Suppl):S67-S72. View Abstract
  78. Prue, C. E., Hamner, H. C., and Flores, A. L. Effects of folic acid awareness on knowledge and consumption for the prevention of birth defects among Hispanic women in several U.S. Communities. J Womens Health (Larchmt.) 2010;19(4):689-698. View Abstract
  79. Little KT. Implications for nursing practice: delivering the folic acid message. University of Nevada, Las Vegas. 2009;
  80. Lefebvre, L. G., Ordean, A., Midmer, D., Kahan, M., and Tolomiczenko, G. Physicians’ knowledge of alcohol, tobacco and folic acid in pregnancy. Subst.Abus. 2007;28(1):3-9. View Abstract
  81. Power, M. L., Holzman, G. B., and Schulkin, J. Knowledge and clinical practice regarding folic acid among obstetrician-gynecologists. Obstet Gynecol. 2000;95(6 Pt 1):895-898. View Abstract
  82. Helinski, D. T., Trauth, J. M., Jernigan, J. C., and Kerr, M. J. Describing a folic acid intervention for health care providers: implications for professional practice and continuing education. Health Promot.Pract. 2004;5(3):326-333. View Abstract
  83. Edwards L and Wyles D. The folic acid message — can training make a difference? J Hum Nutr Diet 1999;12(4):317-326.
  84. Morgan, C., Klein, D. A., and Selbst, M. Using CD-ROM technology to increase folic acid knowledge among physician assistant students. J Allied Health 2004;33(3):194-199. View Abstract
  85. Elavenil, P., Murugavel, C., Kannadasan, K., Krishnakumar Raja, V. B., Gnanam, A., Kanimozhi, G., and Davis, D. Folic acid in cleft lip, alveolus and palate prevention: awareness among dental professionals. Indian J Dent.Res 2010;21(3):360-363. View Abstract
  86. Soni, M. G., Thurmond, T. S., Miller, E. R., III, Spriggs, T., Bendich, A., and Omaye, S. T. Safety of vitamins and minerals: controversies and perspective. Toxicol.Sci 2010;118(2):348-355. View Abstract
  87. Herrmann, W. and Obeid, R. The mandatory fortification of staple foods with folic acid: a current controversy in Germany. Dtsch.Arztebl.Int. 2011;108(15):249-254. View Abstract
  88. Dixon, S. and Shackley, P. The use of willingness to pay to assess public preferences towards the fortification of foodstuffs with folic acid. Health Expect. 2003;6(2):140-148. View Abstract
  89. Samaniego Vaesken, M. L., Alonso-Aperte, E., and Varela-Moreiras, G. [Folic acid fortified foods available in Spain: types of products, level of fortification and target population groups]. Nutr Hosp. 2009;24(4):459-466. View Abstract
  90. Bailey, R. L., McDowell, M. A., Dodd, K. W., Gahche, J. J., Dwyer, J. T., and Picciano, M. F. Total folate and folic acid intakes from foods and dietary supplements of US children aged 1-13 y. Am J Clin Nutr 2010;92(2):353-358. View Abstract
  91. Shakur, Y. A., Garriguet, D., Corey, P., and O’Connor, D. L. Folic acid fortification above mandated levels results in a low prevalence of folate inadequacy among Canadians. Am J Clin Nutr 2010;92(4):818-825. View Abstract
  92. Hennessy-Priest, K., Mustard, J., Keller, H., Rysdale, L., Beyers, J., Goy, R., and Randall, Simpson J. Folic acid food fortification prevents inadequate folate intake among preschoolers from Ontario. Public Health Nutr 2009;12(9):1548-1555. View Abstract
  93. Tighe, P., Ward, M., McNulty, H., Finnegan, O., Dunne, A., Strain, J., Molloy, A. M., Duffy, M., Pentieva, K., and Scott, J. M. A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am J Clin Nutr 2011;93(1):11-18. View Abstract
  94. Kelly, P., McPartlin, J., Goggins, M., Weir, D. G., and Scott, J. M. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997;65(6):1790-1795. View Abstract
  95. Macdonald, L. E., Brett, J., Kelton, D., Majowicz, S. E., Snedeker, K., and Sargeant, J. M. A systematic review and meta-analysis of the effects of pasteurization on milk vitamins, and evidence for raw milk consumption and other health-related outcomes. J.Food Prot. 2011;74(11):1814-1832. View Abstract
  96. Sweeney, M. R., McPartlin, J., Weir, D. G., Daly, L., and Scott, J. M. Postprandial serum folic acid response to multiple doses of folic acid in fortified bread. Br J Nutr 2006;95(1):145-151. View Abstract
  97. Vahteristo, L., Kariluoto, S., Barlund, S., Karkkainen, M., Lamberg-Allardt, C., Salovaara, H., and Piironen, V. Functionality of endogenous folates from rye and orange juice using human in vivo model. Eur J Nutr 2002;41(6):271-278. View Abstract
  98. Ekert, H. Mandatory fortification of flour with folic acid: an overdue public health opportunity. Med J Aust. 2-20-2006;184(4):199. View Abstract
  99. Bentley, T. G., Weinstein, M. C., Willett, W. C., and Kuntz, K. M. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr 2009;12(4):455-467. View Abstract
  100. Grosse, S. D., Waitzman, N. J., Romano, P. S., and Mulinare, J. Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Am J Public Health 2005;95(11):1917-1922. View Abstract
  101. Llanos, A., Hertrampf, E., Cortes, F., Pardo, A., Grosse, S. D., and Uauy, R. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 2007;83(2-3):295-303. View Abstract
  102. Hertrampf, E. and Cortes, F. National food-fortification program with folic acid in Chile. Food Nutr Bull. 2008;29(2 Suppl):S231-S237. View Abstract
  103. Jentink, J., van de Vrie-Hoekstra NW, de Jong-van den Berg LT, and Postma, M. J. Economic evaluation of folic acid food fortification in The Netherlands. Eur J Public Health 2008;18(3):270-274. View Abstract
  104. de, Weerd S., Polder, J. J., Cohen-Overbeek, T. E., Zimmermann, L. J., and Steegers, E. A. Preconception care: preliminary estimates of costs and effects of smoking cessation and folic acid supplementation. J Reprod.Med 2004;49(5):338-344. View Abstract
  105. Yi, Y., Lindemann, M., Colligs, A., and Snowball, C. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur.J.Pediatr. 2011;170(11):1391-1400. View Abstract
  106. Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Stoltzfus, R. J., Dutta, A., Dhingra, U., Kabole, I., Deb, S., Othman, M. K., and Kabole, F. M. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 1-14-2006;367(9505):133-143. View Abstract
  107. Baggott, J. E., Oster, R. A., and Tamura, T. Meta-analysis of cancer risk in folic acid supplementation trials. Cancer Epidemiol. 2012;36(1):78-81. View Abstract
  108. McRae, M. P. High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials. J Chiropr.Med 2009;8(1):15-24. View Abstract
  109. Papandreou, D., Malindretos, P., Arvanitidou, M., Makedou, A., and Rousso, I. Homocysteine lowering with folic acid supplements in children: effects on blood pressure. Int J Food Sci Nutr 2010;61(1):11-17. View Abstract
  110. Sharifi F, Fakhrzadeh H, Mirarefin M, Pourebrahim R, Nouri M, Forouzanfar M, Ghotbi S, Ghaderpanahi M, and Larijani B. The effects of high-dose folic acid on blood pressure of hypertensive adults with hyperhomocysteinemia: a randomized double-blind placebo controlled clinical trial (Tehran Homocysteine Survey). IRANIAN J DIABETES LIPID DISORD 2010;9
  111. Lohner, S., Fekete, K., Berti, C., Hermoso, M., Cetin, I., Koletzko, B., and Decsi, T. Effect of folate supplementation on folate status and health outcomes in infants, children and adolescents: a systematic review. Int.J.Food Sci.Nutr. 2012;63(8):1014-1020. View Abstract
  112. Ho, G. Y., Xue, X., Cushman, M., McKeown-Eyssen, G., Sandler, R. S., Ahnen, D. J., Barry, E. L., Saibil, F., Bresalier, R. S., Rohan, T. E., and Baron, J. A. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst. 12-2-2009;101(23):1650-1654. View Abstract
  113. Schneider, J. A., Tangney, C. C., and Morris, M. C. Folic acid and cognition in older persons. Expert.Opin.Drug Saf 2006;5(4):511-522. View Abstract
  114. Whitrow, M. J., Moore, V. M., Rumbold, A. R., and Davies, M. J. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol. 12-15-2009;170(12):1486-1493. View Abstract
  115. Haberg, S. E., London, S. J., Stigum, H., Nafstad, P., and Nystad, W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis.Child 2009;94(3):180-184. View Abstract
  116. Mao, G., Hong, X., Xing, H., Liu, P., Liu, H., Yu, Y., Zhang, S., Jiang, S., Wang, X., and Xu, X. Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: a multicenter, randomized, double-blind, parallel-controlled, clinical trial. Nutrition 2008;24(11-12):1088-1096. View Abstract
  117. Fairweather-Tait, S. J. Contribution made by biomarkers of status to an FP6 Network of Excellence, EURopean micronutrient RECommendations Aligned (EURRECA). Am.J.Clin Nutr. 2011;94(2):651S-654S. View Abstract
  118. Sarris, J., Mischoulon, D., and Schweitzer, I. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar.Disord. 2011;13(5-6):454-465. View Abstract
  119. Clarke, R., Halsey, J., Lewington, S., Lonn, E., Armitage, J., Manson, J. E., Bonaa, K. H., Spence, J. D., Nygard, O., Jamison, R., Gaziano, J. M., Guarino, P., Bennett, D., Mir, F., Peto, R., and Collins, R. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch.Intern.Med 10-11-2010;170(18):1622-1631. View Abstract
  120. Clarke, R., Halsey, J., Bennett, D., and Lewington, S. Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J.Inherit.Metab Dis. 2011;34(1):83-91. View Abstract
  121. Castillo, L., Tur, J. A., and Uauy, R. [Folate and breast cancer risk: a systematic review]. Rev.Med.Chil. 2012;140(2):251-260. View Abstract
  122. Yang, H. T., Lee, M., Hong, K. S., Ovbiagele, B., and Saver, J. L. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur.J.Intern.Med. 2012;23(8):745-754. View Abstract
  123. Qin, X., Xu, M., Zhang, Y., Li, J., Xu, X., Wang, X., Xu, X., and Huo, Y. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. Atherosclerosis 2012;222(2):307-313. View Abstract
  124. Zhou, Y. H., Tang, J. Y., Wu, M. J., Lu, J., Wei, X., Qin, Y. Y., Wang, C., Xu, J. F., and He, J. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS.One. 2011;6(9):e25142. View Abstract
  125. Ford, A. H. and Almeida, O. P. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J.Alzheimers.Dis. 2012;29(1):133-149. View Abstract
  126. Castillo, Lancellotti C., Tur Mari, J. A., and Uauy, Dagach R. [Effect of folate and related nutrients on cognitive function in older people; systematic review]. Nutr.Hosp. 2012;27(1):90-102. View Abstract
  127. Castillo-Lancellotti, C., Tur Mari, J. A., and Uauy, Dagach R. [Folic acid supplementation and colorrectal adenoma recurrence: systematic review]. Nutr.Hosp. 2012;27(1):13-21. View Abstract
  128. Jardine, M. J., Kang, A., Zoungas, S., Navaneethan, S. D., Ninomiya, T., Nigwekar, S. U., Gallagher, M. P., Cass, A., Strippoli, G., and Perkovic, V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ 2012;344:e3533. View Abstract
  129. Pan, Y., Guo, L. L., Cai, L. L., Zhu, X. J., Shu, J. L., Liu, X. L., and Jin, H. M. Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials. Br.J.Nutr. 2012;108(3):400-407. View Abstract
  130. Wu, C. C., Zheng, C. M., Lin, Y. F., Lo, L., Liao, M. T., and Lu, K. C. Role of homocysteine in end-stage renal disease. Clin Biochem. 2012;45(16-17):1286-1294. View Abstract
  131. Dierkes, J., Domrose, U., Ambrosch, A., Bosselmann, H. P., Neumann, K. H., and Luley, C. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol. 1999;51(2):108-115. View Abstract
  132. Taylor, M. J., Carney, S. M., Goodwin, G. M., and Geddes, J. R. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004;18(2):251-256. View Abstract
  133. Taylor, M. J., Carney, S., Geddes, J., and Goodwin, G. Folate for depressive disorders. Cochrane.Database.Syst.Rev. 2003;(2):CD003390. View Abstract
  134. Sudchada, P., Saokaew, S., Sridetch, S., Incampa, S., Jaiyen, S., and Khaithong, W. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012;98(1):151-158. View Abstract
  135. Rueda, J. R., Ballesteros, J., Guillen, V., Tejada, M. I., and Sola, I. Folic acid for fragile X syndrome. Cochrane.Database.Syst.Rev. 2011;(5):CD008476. View Abstract
  136. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am.J Clin.Nutr 2005;82(4):806-812. View Abstract
  137. Clarke, R. and Armitage, J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin.Thromb.Hemost. 2000;26(3):341-348. View Abstract
  138. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials. Indian Heart J 2000;52(7 Suppl):S59-S64. View Abstract
  139. Clarke, R. and Collins, R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc.Risk 1998;5(4):249-255. View Abstract
  140. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration. BMJ 3-21-1998;316(7135):894-898. View Abstract
  141. Boushey, C. J., Beresford, S. A., Omenn, G. S., and Motulsky, A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 10-4-1995;274(13):1049-1057. View Abstract
  142. Ortiz, Z., Shea, B., Suarez-Almazor, M. E., Moher, D., Wells, G. A., and Tugwell, P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 1998;25(1):36-43. View Abstract
  143. Ortiz, Z., Shea, B., Suarez, Almazor M., Moher, D., Wells, G., and Tugwell, P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane.Database.Syst.Rev. 2000;(2):CD000951. View Abstract
  144. Prey, S. and Paul, C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br J Dermatol. 2009;160(3):622-628. View Abstract
  145. Bhutta, Z. A., Yakoob, M. Y., Lawn, J. E., Rizvi, A., Friberg, I. K., Weissman, E., Buchmann, E., and Goldenberg, R. L. Stillbirths: what difference can we make and at what cost? Lancet 4-30-2011;377(9776):1523-1538. View Abstract
  146. Imdad, A., Yakoob, M. Y., and Bhutta, Z. A. The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. BMC.Public Health 2011;11 Suppl 3:S4. View Abstract
  147. Blencowe, H., Cousens, S., Modell, B., and Lawn, J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol. 2010;39 Suppl 1:i110-i121. View Abstract
  148. Blom, H. J. Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol.Teratol. 2009;85(4):295-302. View Abstract
  149. De-Regil, L. M., Fernandez-Gaxiola, A. C., Dowswell, T., and Pena-Rosas, J. P. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane.Database.Syst.Rev 2010;(10):CD007950. View Abstract
  150. Ramakrishnan, U., Grant, F., Goldenberg, T., Zongrone, A., and Martorell, R. Effect of women’s nutrition before and during early pregnancy on maternal and infant outcomes: a systematic review. Paediatr.Perinat.Epidemiol. 2012;26 Suppl 1:285-301. View Abstract
  151. Fekete, K., Berti, C., Trovato, M., Lohner, S., Dullemeijer, C., Souverein, O. W., Cetin, I., and Decsi, T. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr.J. 2012;11:75. View Abstract
  152. Wang, X., Qin, X., Demirtas, H., Li, J., Mao, G., Huo, Y., Sun, N., Liu, L., and Xu, X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 6-2-2007;369(9576):1876-1882. View Abstract
  153. Huo, Y., Qin, X., Wang, J., Sun, N., Zeng, Q., Xu, X., Liu, L., Xu, X., and Wang, X. Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis. Int.J.Clin Pract. 2012;66(6):544-551. View Abstract
  154. Zhou, K., Zhao, R., Geng, Z., Jiang, L., Cao, Y., Xu, D., Liu, Y., Huang, L., and Zhou, J. Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies. J.Thromb.Thrombolysis. 2012;34(4):459-467. View Abstract
  155. Szczurko, O. and Boon, H. S. A systematic review of natural health product treatment for vitiligo. BMC.Dermatol. 2008;8:2. View Abstract
  156. Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., Snover, D. C., Church, T. R., Allen, J. I., Robertson, D. J., Beck, G. J., Bond, J. H., Byers, T., Mandel, J. S., Mott, L. A., Pearson, L. H., Barry, E. L., Rees, J. R., Marcon, N., Saibil, F., Ueland, P. M., and Greenberg, E. R. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 6-6-2007;297(21):2351-2359. View Abstract
  157. Logan, R. F., Grainge, M. J., Shepherd, V. C., Armitage, N. C., and Muir, K. R. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008;134(1):29-38. View Abstract
  158. Lonn, E., Yusuf, S., Arnold, M. J., Sheridan, P., Pogue, J., Micks, M., McQueen, M. J., Probstfield, J., Fodor, G., Held, C., and Genest, J., Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N.Engl.J Med 4-13-2006;354(15):1567-1577. View Abstract
  159. Beaudet, A. L. and Goin-Kochel, R. P. Some, but not complete, reassurance on the safety of folic acid fortification. Am J Clin Nutr 2010;92(6):1287-1288. View Abstract
  160. Kakar, F. and Henderson, M. M. Potential toxic side effects of folic acid. J.Natl.Cancer Inst. 1985;74(1):263. View Abstract
  161. Lucock, M. and Yates, Z. Folic acid fortification: a double-edged sword. Curr Opin.Clin Nutr Metab Care 2009;12(6):555-564. View Abstract
  162. Tucker, K. L., Mahnken, B., Wilson, P. W., Jacques, P., and Selhub, J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA 12-18-1996;276(23):1879-1885. View Abstract
  163. Worthington, H. V., Clarkson, J. E., and Eden, O. B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane.Database.Syst.Rev. 2006;(2):CD000978. View Abstract
  164. Eros, E., Geher, P., Gomor, B., and Czeizel, A. E. Epileptogenic activity of folic acid after drug induces SLE (folic acid and epilepsy). Eur.J.Obstet.Gynecol.Reprod Biol 1998;80(1):75-78. View Abstract
  165. Ray, J. G., Wyatt, P. R., Vermeulen, M. J., Meier, C., and Cole, D. E. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol. 2005;105(2):261-265. View Abstract
  166. Bailey, R. L., Mills, J. L., Yetley, E. A., Gahche, J. J., Pfeiffer, C. M., Dwyer, J. T., Dodd, K. W., Sempos, C. T., Betz, J. M., and Picciano, M. F. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. Am J Clin Nutr 2010;92(2):383-389. View Abstract
  167. Kennedy, D. A., Stern, S. J., Moretti, M., Matok, I., Sarkar, M., Nickel, C., and Koren, G. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011;35(1):2-10. View Abstract
  168. Kim, D. H., Smith-Warner, S. A., Spiegelman, D., Yaun, S. S., Colditz, G. A., Freudenheim, J. L., Giovannucci, E., Goldbohm, R. A., Graham, S., Harnack, L., Jacobs, E. J., Leitzmann, M., Mannisto, S., Miller, A. B., Potter, J. D., Rohan, T. E., Schatzkin, A., Speizer, F. E., Stevens, V. L., Stolzenberg-Solomon, R., Terry, P., Toniolo, P., Weijenberg, M. P., Willett, W. C., Wolk, A., Zeleniuch-Jacquotte, A., and Hunter, D. J. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010;21(11):1919-1930. View Abstract
  169. Sanjoaquin, M. A., Allen, N., Couto, E., Roddam, A. W., and Key, T. J. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2-20-2005;113(5):825-828. View Abstract
  170. Garcia-Closas, R., Castellsague, X., Bosch, X., and Gonzalez, C. A. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int.J.Cancer 11-20-2005;117(4):629-637. View Abstract
  171. Larsson, S. C., Giovannucci, E., and Wolk, A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006;131(4):1271-1283. View Abstract
  172. Oaks, B. M., Dodd, K. W., Meinhold, C. L., Jiao, L., Church, T. R., and Stolzenberg-Solomon, R. Z. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2010;91(2):449-455. View Abstract
  173. Larsson, S. C., Giovannucci, E., and Wolk, A. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 1-3-2007;99(1):64-76. View Abstract
  174. Lewis, S. J., Harbord, R. M., Harris, R., and Smith, G. D. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst. 11-15-2006;98(22):1607-1622. View Abstract
  175. Thorand, B., Kohlmeier, L., Simonsen, N., Croghan, C., and Thamm, M. Intake of fruits, vegetables, folic acid and related nutrients and risk of breast cancer in postmenopausal women. Public Health Nutr 1998;1(3):147-156. View Abstract
  176. Diculescu, M., Ciocirlan, M., Ciocirlan, M., Pitigoi, D., Becheanu, G., Croitoru, A., and Spanache, S. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence. Rom.J Gastroenterol 2003;12(4):283-286. View Abstract
  177. Figueredo, A., Charette, M. L., Maroun, J., Brouwers, M. C., and Zuraw, L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol. 8-15-2004;22(16):3395-3407. View Abstract
  178. Lo, Bello L., Pistone, G., Restuccia, S., Vinci, E., Mazzoleni, G., and Malaguarnera, M. 5-fluorouracil alone versus 5-fluorouracil plus folinic acid in the treatment of colorectal carcinoma: meta-analysis. Int J Clin Pharmacol.Ther 2000;38(12):553-562. View Abstract
  179. Thirion, P., Wolmark, N., Haddad, E., Buyse, M., and Piedbois, P. Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer. Ann.Oncol. 1999;10(11):1317-1320. View Abstract
  180. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol. 1999;17(5):1356-1363. View Abstract
  181. Seitz, J. E., Rougier, P., and Giovannini, M. Recent advances in systemic chemotherapy of metastatic colorectal cancer. Ann.Ital.Chir 1996;67(6):805-812. View Abstract
  182. Piedbois, P. and Buyse, M. What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin? Advanced Colorectal Meta-analysis Project. Ann.Oncol. 1993;4 Suppl 2:15-19. View Abstract
  183. Becouarn, Y., Guillo, S., Artru, P., Assenat, E., Bosset, J. F., Conroy, T., Francois, E., Taieb, J., and Touboul, E. [Systematic review: value of perioperative chemotherapy in the management of resectable rectal adenocarcinoma (brief report)]. Bull.Cancer 2008;95(7):717-734. View Abstract
  184. Liang, X. B., Hou, S. H., Li, Y. P., Wang, L. C., Zhang, X., and Yang, J. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis. Chin Med J (Engl.) 2010;123(22):3314-3318. View Abstract
  185. Li, S. and Chi, P. Optimizing the efficacy of first-line chemotherapy plus bevacizumab in metastatic colorectal cancer: analysis of multiple methods. BioDrugs. 2-1-2011;25(1):43-50. View Abstract
  186. Garcia-Foncillas, J. and Diaz-Rubio, E. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome. Clin Transl.Oncol. 2010;12(8):533-542. View Abstract
  187. Ramanathan, R. K., Rothenberg, M. L., de, Gramont A., Tournigand, C., Goldberg, R. M., Gupta, S., and Andre, T. Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. Ann.Oncol. 2010;21(4):754-758. View Abstract
  188. Bachet, J. B., Rougier, P., de, Gramont A., and Andre, T. [Rectal cancer and adjuvant chemotherapy: which conclusions?]. Bull.Cancer 2010;97(1):107-122. View Abstract
  189. Hamada, C. The role of meta-analysis in cancer clinical trials. Int J Clin Oncol. 2009;14(2):90-94. View Abstract
  190. Chen, M. L., Fang, C. H., Liang, L. S., Dai, L. H., and Wang, X. K. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer. Surg Oncol. 2010;19(1):38-45. View Abstract
  191. Goekkurt, E., Al-Batran, S. E., Hartmann, J. T., Mogck, U., Schuch, G., Kramer, M., Jaeger, E., Bokemeyer, C., Ehninger, G., and Stoehlmacher, J. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. J Clin Oncol. 6-10-2009;27(17):2863-2873. View Abstract
  192. Davies, J. M. and Goldberg, R. M. First-line therapeutic strategies in metastatic colorectal cancer. Oncology (Williston.Park) 11-30-2008;22(13):1470-1479. View Abstract
  193. Neoptolemos, J. P., Stocken, D. D., Tudur, Smith C., Bassi, C., Ghaneh, P., Owen, E., Moore, M., Padbury, R., Doi, R., Smith, D., and Buchler, M. W. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 1-27-2009;100(2):246-250. View Abstract
  194. Arkenau, H. T., Arnold, D., Cassidy, J., Diaz-Rubio, E., Douillard, J. Y., Hochster, H., Martoni, A., Grothey, A., Hinke, A., Schmiegel, W., Schmoll, H. J., and Porschen, R. Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. J Clin Oncol. 12-20-2008;26(36):5910-5917. View Abstract
  195. Vente, M. A., Wondergem, M., van, der Tweel, I, van den Bosch, M. A., Zonnenberg, B. A., Lam, M. G., van Het Schip, A. D., and Nijsen, J. F. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol. 2009;19(4):951-959. View Abstract
  196. Folprecht, G., Seymour, M. T., Saltz, L., Douillard, J. Y., Hecker, H., Stephens, R. J., Maughan, T. S., Van, Cutsem E., Rougier, P., Mitry, E., Schubert, U., and Kohne, C. H. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials. J Clin Oncol. 3-20-2008;26(9):1443-1451. View Abstract
  197. Omura, K. Advances in chemotherapy against advanced or metastatic colorectal cancer. Digestion 2008;77 Suppl 1:13-22. View Abstract
  198. Mocellin, S., Pilati, P., Lise, M., and Nitti, D. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol. 12-10-2007;25(35):5649-5654. View Abstract
  199. Murdoch, D. and Sager, J. Will targeted therapy hold its promise? An evidence-based review. Curr Opin.Oncol. 2008;20(1):104-111. View Abstract
  200. Ghaneh, P., Smith, R., Tudor-Smith, C., Raraty, M., and Neoptolemos, J. P. Neoadjuvant and adjuvant strategies for pancreatic cancer. Eur J Surg Oncol. 2008;34(3):297-305. View Abstract
  201. Tappenden, P., Jones, R., Paisley, S., and Carroll, C. The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales. Eur J Cancer 2007;43(17):2487-2494. View Abstract
  202. Golfinopoulos, V., Salanti, G., Pavlidis, N., and Ioannidis, J. P. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol. 2007;8(10):898-911. View Abstract
  203. Diez-Fernandez, R., Salinas, Hernandez P., and Giron-Duch, C. [A review of chemotherapy for metastatic colon cancer]. Farm.Hosp. 2006;30(6):359-369. View Abstract
  204. Pandor, A., Eggington, S., Paisley, S., Tappenden, P., and Sutcliffe, P. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health Technol Assess. 2006;10(41):iii-xiv, 1. View Abstract
  205. Eggington, S., Tappenden, P., Pandor, A., Paisley, S., Saunders, M., Seymour, M., Sutcliffe, P., and Chilcott, J. Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. Br J Cancer 11-6-2006;95(9):1195-1201. View Abstract
  206. Goldberg, R. M., Tabah-Fisch, I., Bleiberg, H., de, Gramont A., Tournigand, C., Andre, T., Rothenberg, M. L., Green, E., and Sargent, D. J. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol. 9-1-2006;24(25):4085-4091. View Abstract
  207. Ward, S. E., Kaltenthaler, E., Cowan, J., Marples, M., Orr, B., and Seymour, M. T. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. Br J Cancer 7-3-2006;95(1):27-34. View Abstract
  208. Akasu, T. [Adjuvant chemotherapy for colorectal cancer]. Gan To Kagaku Ryoho 2006;33(3):307-312. View Abstract
  209. Carrato, A., Gallego-Plazas, J., and Guillen-Ponce, C. Adjuvant therapy of resected gastric cancer is necessary. Semin.Oncol. 2005;32(6 Suppl 9):S105-S108. View Abstract
  210. Taguchi, T. and Tsukuda, M. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck]. Gan To Kagaku Ryoho 2005;32(13):2030-2034. View Abstract
  211. Ishiguro, A., Shitara, K., Munakata, M., Saitoh, S., and Sakata, Y. [Recent progress of chemotherapy for colorectal cancer]. Gan To Kagaku Ryoho 2005;32(13):2017-2023. View Abstract
  212. Nitti, D., Wils, J., Dos Santos, J. G., Fountzilas, G., Conte, P. F., Sava, C., Tres, A., Coombes, R. C., Crivellari, D., Marchet, A., Sanchez, E., Bliss, J. M., Homewood, J., Couvreur, M. L., Hall, E., Baron, B., Woods, E., Emson, M., Van, Cutsem E., and Lise, M. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann.Oncol. 2006;17(2):262-269. View Abstract
  213. Ackland, S. P., Jones, M., Tu, D., Simes, J., Yuen, J., Sargeant, A. M., Dhillon, H., Goldberg, R. M., Abdi, E., Shepherd, L., and Moore, M. J. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer 11-28-2005;93(11):1236-1243. View Abstract
  214. De, Placido S., Lopez, M., Carlomagno, C., Paoletti, G., Palazzo, S., Manzione, L., Iannace, C., Ianniello, G. P., De, Vita F., Ficorella, C., Farris, A., Pistillucci, G., Gemini, M., Cortesi, E., Adamo, V., Gebbia, N., Palmeri, S., Gallo, C., Perrone, F., Persico, G., and Bianco, A. R. Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. Br J Cancer 10-17-2005;93(8):896-904. View Abstract
  215. Bin, Q., Li, J., Liao, C., Cao, Y., and Gao, F. Oral uracil-tegafur Plus Leucovorin versus Fluorouracil Bolus Plus Leucovorin For Advanced Colorectal Cancer: A Meta-analysis of Five Randomized Controlled Trials. Colorectal Dis. 12-28-2009; View Abstract
  216. Thirion, P., Michiels, S., Pignon, J. P., Buyse, M., Braud, A. C., Carlson, R. W., O’Connell, M., Sargent, P., and Piedbois, P. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol. 9-15-2004;22(18):3766-3775. View Abstract
  217. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol. 1992;10(6):896-903. View Abstract
  218. Roberts, J. D., Poplin, E. A., Tombes, M. B., Kyle, B., Spicer, D. V., Grant, S., Synold, T., and Moran, R. Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation. Cancer Chemother.Pharmacol. 2000;45(2):103-110. View Abstract
  219. Muggia, F. M., Synold, T. W., Newman, E. M., Jeffers, S., Leichman, L. P., Doroshow, J. H., Johnson, K., and Groshen, S. Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexol. J Natl Cancer Inst. 10-16-1996;88(20):1495-1496. View Abstract
  220. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann.Intern Med 5-5-2009;150(9):626-631. View Abstract
  221. Koletzko, B., Bauer, C. P., Bung, P., Cremer, M., Flothkotter, M., Hellmers, C., Kersting, M., Krawinkel, M., Przyrembel, H., Rasenack, R., Schafer, T., Vetter, K., Wahn, U., Weissenborn, A., and Wockel, A. [Nutrition in pregnancy – Practice recommendations of the Network “Healthy Start – Young Family Network”]. Dtsch.Med.Wochenschr. 2012;137(24):1309-1314. View Abstract
  222. Harden, C. L., Pennell, P. B., Koppel, B. S., Hovinga, C. A., Gidal, B., Meador, K. J., Hopp, J., Ting, T. Y., Hauser, W. A., Thurman, D., Kaplan, P. W., Robinson, J. N., French, J. A., Wiebe, S., Wilner, A. N., Vazquez, B., Holmes, L., Krumholz, A., Finnell, R., Shafer, P. O., and Le, Guen C. Practice parameter update: management issues for women with epilepsy–focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 7-14-2009;73(2):142-149. View Abstract
  223. Vinter, C. A., Tanvig, M. H., Damm, P., Naver, K. V., Andreasen, K. R., Andersen, L. L., Liest, S., Lunde, S., Jensen, D. M., and Renault, K. M. [Obese pregnant women and complications in relation to pregnancy and birth]. Ugeskr.Laeger 4-16-2012;174(16):1079-1082. View Abstract
  224. Gentile, S. Lithium in pregnancy: the need to treat, the duty to ensure safety. Expert.Opin.Drug Saf 2012;11(3):425-437. View Abstract
  225. Wender-Ozegowska, E., Bomba-Opon, D., Brazert, J., Celewicz, Z., Czajkowski, K., Karowicz-Bilinska, A., Malinowska-Polubiec, A., Meczekalski, B., and Zawiejska, A. [Recommendations of Polish Gynecological Society concerning perinatal care in obese pregnant women]. Ginekol.Pol. 2012;83(10):795-799. View Abstract
  226. Honein, M. A., Paulozzi, L. J., Mathews, T. J., Erickson, J. D., and Wong, L. Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 6-20-2001;285(23):2981-2986. View Abstract
  227. Felkner, M., Suarez, L., Hendricks, K., and Larsen, R. Implementation and outcomes of recommended folic acid supplementation in Mexican-American women with prior neural tube defect-affected pregnancies. Prev.Med 2005;40(6):867-871. View Abstract
  228. Bol, K. A., Collins, J. S., and Kirby, R. S. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 2006;117(3):803-813. View Abstract
  229. Wilcox, A. J., Lie, R. T., Solvoll, K., Taylor, J., McConnaughey, D. R., Abyholm, F., Vindenes, H., Vollset, S. E., and Drevon, C. A. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 3-3-2007;334(7591):464. View Abstract
  230. Shaw, G. M., Lammer, E. J., Wasserman, C. R., O’Malley, C. D., and Tolarova, M. M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 8-12-1995;346(8972):393-396. View Abstract
  231. Hovdenak, N. and Haram, K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet.Gynecol.Reprod.Biol. 2012;164(2):127-132. View Abstract
  232. Wen, S. W., Chen, X. K., Rodger, M., White, R. R., Yang, Q., Smith, G. N., Sigal, R. J., Perkins, S. L., and Walker, M. C. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008;198(1):45-47. View Abstract
  233. Evans, M. I., Llurba, E., Landsberger, E. J., O’Brien, J. E., and Harrison, H. H. Impact of folic acid fortification in the United States: markedly diminished high maternal serum alpha-fetoprotein values. Obstet Gynecol. 2004;103(3):474-479. View Abstract
  234. Nilsen, R. M., Vollset, S. E., Rasmussen, S. A., Ueland, P. M., and Daltveit, A. K. Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study. Am J Epidemiol. 4-1-2008;167(7):867-874. View Abstract
  235. Godwin, K. A., Sibbald, B., Bedard, T., Kuzeljevic, B., Lowry, R. B., and Arbour, L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can.J Public Health 2008;99(4):271-275. View Abstract
  236. Gindler, J., Li, Z., Berry, R. J., Zheng, J., Correa, A., Sun, X., Wong, L., Cheng, L., Erickson, J. D., Wang, Y., and Tong, Q. Folic acid supplements during pregnancy and risk of miscarriage. Lancet 9-8-2001;358(9284):796-800. View Abstract
  237. Roza, S. J., van Batenburg-Eddes, T., Steegers, E. A., Jaddoe, V. W., Mackenbach, J. P., Hofman, A., Verhulst, F. C., and Tiemeier, H. Maternal folic acid supplement use in early pregnancy and child behavioural problems: The Generation R Study. Br J Nutr 2010;103(3):445-452. View Abstract
  238. Timmermans, S., Jaddoe, V. W., Hofman, A., Steegers-Theunissen, R. P., and Steegers, E. A. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br J Nutr 2009;102(5):777-785. View Abstract
  239. Wehby, G. L. and Murray, J. C. The effects of prenatal use of folic acid and other dietary supplements on early child development. Matern.Child Health J 2008;12(2):180-187. View Abstract
  240. Takamura, N., Kondoh, T., Ohgi, S., Arisawa, K., Mine, M., Yamashita, S., and Aoyagi, K. Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan. Eur J Nutr 2004;43(5):285-287. View Abstract
  241. Bower, C., de, Klerk N., Hickling, S., Ambrosini, G., Flicker, L., Geelhoed, E., and Milne, E. Assessment of the potential effect of incremental increases in folic acid intake on neural tube defects in Australia and New Zealand. Aust.N.Z J Public Health 2006;30(4):369-374. View Abstract
  242. Folic Acid for the prevention of neural tube defects: recommendation statement. Am Fam.Physician 12-15-2010;82(12):1526-1527. View Abstract
  243. Lee, J. I., Lee, J. A., and Lim, H. S. Effect of time of initiation and dose of prenatal iron and folic acid supplementation on iron and folate nutriture of Korean women during pregnancy. Am J Clin Nutr 2005;82(4):843-849. View Abstract
  244. Koren, G. Folic acid and colorectal cancer: unwarranted fears. Can.Fam.Physician 2011;57(8):889-890. View Abstract
  245. Kim, M. H., Han, J. Y., Cho, Y. J., Ahn, H. K., Kim, J. O., Ryu, H. M., Kim, M. Y., Yang, J. H., and Nava-Ocampo, A. A. Factors associated with a positive intake of folic acid in the periconceptional period among Korean women. Public Health Nutr 2009;12(4):468-471. View Abstract
  246. Burak, L. J. and Costello, P. College women’s reported behaviors and beliefs regarding fish and folic acid and their roles in birth defects. Health Care Women Int 2006;27(9):793-806. View Abstract
  247. Timmermans, S., Jaddoe, V. W., Mackenbach, J. P., Hofman, A., Steegers-Theunissen, R. P., and Steegers, E. A. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in The Netherlands: the Generation R study. Prev.Med 2008;47(4):427-432. View Abstract
  248. Quinn LA. olic acid use in women of childbearing age. Kent State University. 2007;
  249. Hassan, A. S. and Al-Kharusi, B. M. Knowledge and use of folic acid among pregnant Arabian women residing in Qatar and Oman. Int J Food Sci Nutr 2008;59(1):70-79. View Abstract
  250. deRosset L, Mullenix A, and Zhang L. Multivitamins, folic acid and birth defects: knowledge, beliefs and behaviors of Hispanic women in North Carolina. AM J HEALTH EDUC 2009;40(3):155-64.
  251. Nilsen, R. M., Vollset, S. E., Gjessing, H. K., Magnus, P., Meltzer, H. M., Haugen, M., and Ueland, P. M. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr 2006;84(5):1134-1141. View Abstract
  252. Dobson, I., Devenish, C., Skeaff, C. M., and Green, T. J. Periconceptional folic acid use among women giving birth at Queen Mary Maternity Hospital in Dunedin. Aust.N.Z J Obstet Gynaecol 2006;46(6):534-537. View Abstract
  253. Li, Z., Ren, A., Zhang, L., Liu, J., and Li, Z. Periconceptional use of folic acid in Shanxi Province of northern China. Public Health Nutr 2007;10(5):471-476. View Abstract
  254. Tamim, H., Harrison, G., Atoui, M., Mumtaz, G., El-Kak, F., Seoud, M., and Yunis, K. Preconceptional folic acid supplement use in Lebanon. Public Health Nutr 2009;12(5):687-692. View Abstract
  255. Rosenberg, K. D., Gelow, J. M., and Sandoval, A. P. Pregnancy intendedness and the use of periconceptional folic acid. Pediatrics 2003;111(5 Part 2):1142-1145. View Abstract
  256. Forster, D. A., Wills, G., Denning, A., and Bolger, M. The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia. Midwifery 2009;25(2):134-146. View Abstract
  257. Carmichael, S. L., Shaw, G. M., Yang, W., Laurent, C., Herring, A., Royle, M. H., and Canfield, M. Correlates of intake of folic acid-containing supplements among pregnant women. Am J Obstet Gynecol. 2006;194(1):203-210. View Abstract
  258. Lawrence, J. M., Watkins, M. L., Chiu, V., Erickson, J. D., and Petitti, D. B. Do racial and ethnic differences in serum folate values exist after food fortification with folic acid? Am J Obstet Gynecol. 2006;194(2):520-526. View Abstract
  259. Mathews, F., Yudkin, P., and Neil, A. Folates in the periconceptional period: are women getting enough? Br J Obstet Gynaecol 1998;105(9):954-959. View Abstract
  260. Stepanuk, K. M., Tolosa, J. E., Lewis, D., Myers, V., Royds, C., Sabogal, J. C., and Librizzi, R. Folic acid supplementation use among women who contact a teratology information service. Am J Obstet Gynecol. 2002;187(4):964-967. View Abstract
  261. Cleves, M. A., Hobbs, C. A., Collins, H. B., Andrews, N., Smith, L. N., and Robbins, J. M. Folic acid use by women receiving routine gynecologic care. Obstet Gynecol. 2004;103(4):746-753. View Abstract
  262. Amitai, Y., Fisher, N., Haringman, M., Meiraz, H., Baram, N., and Leventhal, A. Increased awareness, knowledge and utilization of preconceptional folic acid in Israel following a national campaign. Prev.Med 2004;39(4):731-737. View Abstract
  263. Morin, P., De, Wals P., Noiseux, M., Niyonsenga, T., St-Cyr-Tribble, D., and Tremblay, C. Pregnancy planning and folic acid supplement use: results from a survey in Quebec. Prev.Med 2002;35(2):143-149. View Abstract
  264. Morin, P., De, Wals P., St-Cyr-Tribble, D., Niyonsenga, T., and Payette, H. Pregnancy planning: a determinant of folic acid supplements use for the primary prevention of neural tube defects. Can.J Public Health 2002;93(4):259-263. View Abstract
  265. Gross, S. M., Caufield, L. A., Kinsman, S. L., and Ireys, H. T. Inadequate folic acid intakes are prevalent among young women with neural tube defects. J Am Diet Assoc 2001;101(3):342-345. View Abstract
  266. Stark, K. D., Pawlosky, R. J., Beblo, S., Murthy, M., Flanagan, V. P., Janisse, J., Buda-Abela, M., Rockett, H., Whitty, J. E., Sokol, R. J., Hannigan, J. H., and Salem, N., Jr. Status of plasma folate after folic acid fortification of the food supply in pregnant African American women and the influences of diet, smoking, and alcohol consumption. Am J Clin Nutr 2005;81(3):669-677. View Abstract
  267. Garcia-Fragoso, L., Garcia-Garcia, I., and Rivera, C. E. The use of folic acid for the prevention of birth defects in Puerto Rico. Ethn.Dis. 2008;18(2 Suppl 2):S2-71. View Abstract
  268. Langley-Evans, S. C. and Langley-Evans, A. J. Use of folic acid supplements in the first trimester of pregnancy. J R.Soc Promot.Health 2002;122(3):181-186. View Abstract
  269. Watson, L. F., Brown, S. J., and Davey, M. A. Use of periconceptional folic acid supplements in Victoria and New South Wales, Australia. Aust.N.Z J Public Health 2006;30(1):42-49. View Abstract
  270. Zeng, Z. and Zhu, J. Low folic acid supplement intake rate among women in northern China with a high-prevalence of neural tube defects, 2008. Prev.Med 2010;51(3-4):338-339. View Abstract
  271. Brough, L., Rees, G. A., Crawford, M. A., and Dorman, E. K. Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status. J Hum Nutr Diet 2009;22(2):100-107. View Abstract
  272. Mytton, J., Harrison, V., McLoughlin, A., Thompson, R., and Overton, T. An evaluation of the recording of folic acid use in the South West Congenital Anomaly Register. Prenat.Diagn. 2008;28(8):722-726. View Abstract
  273. Sharp, G. F., Naylor, L. A., Cai, J., Hyder, M. L., Chandra, P., and Guillory, V. J. Assessing awareness, knowledge and use of folic acid in Kansas women between the ages of 18 and 44 years. Matern.Child Health J 2009;13(6):814-821. View Abstract
  274. Robbins, J. M., Hopkins, S. E., Mosley, B. S., Casey, P. H., Cleves, M. A., and Hobbs, C. A. Awareness and use of folic acid among women in the lower Mississippi Delta. J Rural.Health 2006;22(3):196-203. View Abstract
  275. Tinker, S. C., Cogswell, M. E., Devine, O., and Berry, R. J. Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev.Med 2010;38(5):534-542. View Abstract
  276. Yang, Q., Cogswell, M. E., Hamner, H. C., Carriquiry, A., Bailey, L. B., Pfeiffer, C. M., and Berry, R. J. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr 2010;91(1):64-72. View Abstract
  277. Case, A. P., Ramadhani, T. A., Canfield, M. A., Beverly, L., and Wood, R. Folic acid supplementation among diabetic, overweight, or obese women of childbearing age. J Obstet Gynecol.Neonatal Nurs. 2007;36(4):335-341. View Abstract
  278. Tedstone, A., Browne, M., Harrop, L., Vernon, C., Page, V., Swindells, J., Hayward, W., Croft, J., Harris, F., and Stockley, L. Fortification of selected foodstuffs with folic acid in the UK: consumer research carried out to inform policy recommendations. J Public Health (Oxf) 2008;30(1):23-29. View Abstract
  279. Milla, G. R., Flores, A. L., Umana, E., Mayes, I., and Rosenthal, J. Postpartum women in the Honduran health system: folic acid knowledge, attitudes, and practices. Rev Panam.Salud Publica 2007;22(5):340-347. View Abstract
  280. Amitai, Y., Fisher, N., Meiraz, H., Baram, N., Tounis, M., and Leventhal, A. Preconceptional folic acid utilization in Israel: five years after the guidelines. Prev.Med 2008;46(2):166-169. View Abstract
  281. Yang, Q. H., Carter, H. K., Mulinare, J., Berry, R. J., Friedman, J. M., and Erickson, J. D. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 2007;85(5):1409-1416. View Abstract
  282. Hilton JJ. A comparison of folic acid awareness and intake in young women. Duquesne University School of Nursing. 2003;
  283. Hilton, J. J. Folic acid intake of young women. J Obstet Gynecol.Neonatal Nurs. 2002;31(2):172-177. View Abstract
  284. Relton, C. L., Hammal, D. M., Rankin, J., and Parker, L. Folic acid supplementation and social deprivation. Public Health Nutr 2005;8(3):338-340. View Abstract
  285. Dawson, L. E., Pham, B., and Hunter, A. G. Low rate of adequate folic acid supplementation in well-educated women of high socioeconomic status attending a genetics clinic. CMAJ. 4-17-2001;164(8):1149-1150. View Abstract
  286. Bognar, M., Ponyi, A., Hauser, P., Muller, J., Constantin, T., Jakab, Z., Schuler, D., and Garami, M. Improper supplementation habits of folic acid intake by Hungarian pregnant women: improper recommendations. J Am Coll Nutr 2008;27(4):499-504. View Abstract
  287. Conlin, M. L., MacLennan, A. H., and Broadbent, J. L. Inadequate compliance with periconceptional folic acid supplementation in South Australia. Aust.N.Z J Obstet Gynaecol 2006;46(6):528-533. View Abstract
  288. Parrott, R., Volkman, J. E., Hillemeier, M. M., Weisman, C. S., Chase, G. A., and Dyer, A. M. Pregnancy intentions and folic acid supplementation exemplars: findings from the Central Pennsylvania Women’s Health Study. J Health Commun 2009;14(4):366-383. View Abstract
  289. Knudsen, V. K., Orozova-Bekkevold, I., Rasmussen, L. B., Mikkelsen, T. B., Michaelsen, K. F., and Olsen, S. F. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr 2004;7(7):843-850. View Abstract
  290. Hilton, J. J. A comparison of folic acid awareness and intake among young women aged 18-24 years. J Am Acad Nurse Pract. 2007;19(10):516-522. View Abstract
  291. Ahluwalia, I. B. and Daniel, K. L. Are women with recent live births aware of the benefits of folic acid? MMWR Recomm.Rep 5-11-2001;50(RR-6):3-14. View Abstract
  292. Unusan, N. Assessment of Turkish women’s knowledge concerning folic acid and prevention of birth defects. Public Health Nutr 2004;7(7):851-855. View Abstract
  293. Frishman, G. N., Spurrell, T. P., and Heber, W. W. Folic acid. Preconception knowledge and use by infertile women. J Reprod.Med 2001;46(12):1025-1030. View Abstract
  294. Sen, S., Manzoor, A., Deviasumathy, M., and Newton, C. Maternal knowledge, attitude and practice regarding folic acid intake during the periconceptional period. Public Health Nutr 2001;4(4):909-912. View Abstract
  295. Pearce HR, Smith NA, Fox EF, and Bingham JS. Periconceptional folic acid: knowledge amongst patients and health care workers in a London teaching hospital. BR J FAM PLANN 1996;22(1):20-21.
  296. Perez-Escamilla, R., Himmelgreen, D., Segura-Millan, S., Gonzalez, A., Mendez, I., and Haldeman, L. Knowledge of folic acid and neural tube defects among inner-city residents: have they heard about it? J Am Diet Assoc 1999;99(1):80-83. View Abstract
  297. Survey shows continued need to educate public about folic acid and birth defects. Am J Health Syst.Pharm 11-1-1997;54(21):2439. View Abstract
  298. Jessa F and Hampshire AJ. Use of folic acid by pregnant British Pakistani women: a qualitative pilot study. HEALTH EDUC J 1999;58(2):139-145.
  299. Kondo, A., Kamihira, O., Shimosuka, Y., Okai, I., Gotoh, M., and Ozawa, H. Awareness of the role of folic acid, dietary folate intake and plasma folate concentration in Japan. J Obstet Gynaecol Res 2005;31(2):172-177. View Abstract
  300. Belanger, M. C. and Gregoire, J. [Periconceptional intake of a folic acid supplement: evaluation of a promotional program]. Can.J Diet Pract.Res 2003;64(4):189-194. View Abstract
  301. Robbins, J. M., Cleves, M. A., Collins, H. B., Andrews, N., Smith, L. N., and Hobbs, C. A. Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women. Am J Obstet Gynecol. 2005;192(4):1126-1132. View Abstract
  302. Mirmohammadali M, Moddares M, Babaei G, and Kamravamanesh M. Effect of education on the knowledge and applying folic acid supplement in women at reproductive ages. HAYAT 2004;10(21):91.
  303. Johnson, P. A., Stadler, D. D., Feldkamp, M., and Webber, B. Impact of an educational seminar on high school students’ knowledge of folic acid supplementation and its role in the prevention of birth defects. J Am Diet Assoc 2002;102(3 Suppl):S78-S81. View Abstract
  304. van, Eijsden M., van der Wal, M. F., and Bonsel, G. J. Folic acid knowledge and use in a multi-ethnic pregnancy cohort: the role of language proficiency. BJOG. 2006;113(12):1446-1451. View Abstract
  305. Evans, L. and Weisman, C. S. Folic acid supplementation in younger and older nonpregnant women of reproductive age: findings from the Central Pennsylvania Women’s Health Study (CePAWHS). Womens Health Issues 2010;20(1):50-57. View Abstract
  306. Koren, G., Goh, Y. I., and Klieger, C. Folic acid: the right dose. Can.Fam.Physician 2008;54(11):1545-1547. View Abstract
  307. Sweeney, M. R., Staines, A., Daly, L., Traynor, A., Daly, S., Bailey, S. W., Alverson, P. B., Ayling, J. E., and Scott, J. M. Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC.Public Health 2009;9:295. View Abstract
  308. Sweeney, M. R., McPartlin, J., Weir, D. G., Daly, S., Pentieva, K., Daly, L., and Scott, J. M. Evidence of unmetabolised folic acid in cord blood of newborn and serum of 4-day-old infants. Br J Nutr 2005;94(5):727-730. View Abstract
  309. Shuaibi, A. M., House, J. D., and Sevenhuysen, G. P. Folate status of young Canadian women after folic acid fortification of grain products. J Am Diet Assoc 2008;108(12):2090-2094. View Abstract
  310. Abdollahi, Z., Elmadfa, I., Djazayeri, A., Sadeghian, S., Freisling, H., Mazandarani, F. S., and Mohamed, K. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran. Ann.Nutr Metab 2008;53(2):143-150. View Abstract
  311. Obeid, R., Kasoha, M., Kirsch, S. H., Munz, W., and Herrmann, W. Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. Am J Clin Nutr 2010;92(6):1416-1422. View Abstract
  312. Davis, B. A., Bailey, L. B., Gregory, J. F., III, Toth, J. P., Dean, J., and Stevenson, R. E. Folic acid absorption in women with a history of pregnancy with neural tube defect. Am J Clin Nutr 1995;62(4):782-784. View Abstract
  313. Acilmis, Y. G., Dikensoy, E., Kutlar, A. I., Balat, O., Cebesoy, F. B., Ozturk, E., Cicek, H., and Pence, S. Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia. J Obstet Gynaecol Res 2011;37(1):45-50. View Abstract
  314. Morrow, J. I., Hunt, S. J., Russell, A. J., Smithson, W. H., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., and Craig, J. J. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol.Neurosurg.Psychiatry 2009;80(5):506-511. View Abstract
  315. Czeizel, A. E. and Vargha, P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol. 2004;191(3):790-794. View Abstract
  316. Signore, C., Mills, J. L., Cox, C., and Trumble, A. C. Effects of folic acid fortification on twin gestation rates. Obstet Gynecol. 2005;105(4):757-762. View Abstract
  317. Li, Z., Gindler, J., Wang, H., Berry, R. J., Li, S., Correa, A., Zheng, J. C., Erickson, J. D., and Wang, Y. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet 2-1-2003;361(9355):380-384. View Abstract
  318. Berry, R. J., Kihlberg, R., and Devine, O. Impact of misclassification of in vitro fertilisation in studies of folic acid and twinning: modelling using population based Swedish vital records. BMJ 4-9-2005;330(7495):815. View Abstract
  319. Kucik, J. and Correa, A. Trends in twinning rates in metropolitan Atlanta before and after folic acid fortification. J Reprod.Med 2004;49(9):707-712. View Abstract
  320. Haggarty, P., Campbell, D. M., Duthie, S., Andrews, K., Hoad, G., Piyathilake, C., Fraser, I., and McNeill, G. Folic acid use in pregnancy and embryo selection. BJOG. 2008;115(7):851-856. View Abstract
  321. Murphy, M. M., Scott, J. M., McPartlin, J. M., and Fernandez-Ballart, J. D. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002;76(3):614-619. View Abstract
  322. Pena-Rosas, J. P. and Viteri, F. E. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane.Database.Syst.Rev 2006;3:CD004736. View Abstract
  323. Bhutta, Z. A., Rizvi, A., Raza, F., Hotwani, S., Zaidi, S., Moazzam, Hossain S., Soofi, S., and Bhutta, S. A comparative evaluation of multiple micronutrient and iron-folic acid supplementation during pregnancy in Pakistan: impact on pregnancy outcomes. Food Nutr Bull 2009;30(4 Suppl):S496-S505. View Abstract
  324. Houghton, L. A., Sherwood, K. L., Pawlosky, R., Ito, S., and O’Connor, D. L. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am J Clin Nutr 2006;83(4):842-850. View Abstract
  325. Houghton, L. A., Yang, J., and O’Connor, D. L. Unmetabolized folic acid and total folate concentrations in breast milk are unaffected by low-dose folate supplements. Am J Clin Nutr 2009;89(1):216-220. View Abstract
  326. Mackey, A. D. and Picciano, M. F. Maternal folate status during extended lactation and the effect of supplemental folic acid. Am.J Clin.Nutr 1999;69(2):285-292. View Abstract
  327. Mandel, H. and Berant, M. Oral contraceptives and breastfeeding: haematological effects on the infant. Arch Dis.Child 1985;60(10):971-972. View Abstract
  328. Connelly, P. J., Prentice, N. P., Cousland, G., and Bonham, J. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer’s disease. Int J Geriatr Psychiatry 2008;23(2):155-160. View Abstract
  329. Van, Dam F. and Van Gool, W. A. Hyperhomocysteinemia and Alzheimer’s disease: A systematic review. Arch.Gerontol.Geriatr. 2009;48(3):425-430. View Abstract
  330. Chen, T. F., Huang, R. F., Lin, S. E., Lu, J. F., Tang, M. C., and Chiu, M. J. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer’s disease transgenic model. J Alzheimers.Dis. 2010;20(2):607-615. View Abstract
  331. Kjaer, D., Horvath-Puho, E., Christensen, J., Vestergaard, M., Czeizel, A. E., Sorensen, H. T., and Olsen, J. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG. 2008;115(1):98-103. View Abstract
  332. Algin DI, Erdinc OO, Alatas O, Toker A, Colak O, and Oner S. Effects of oxcarbazepine on plasma homocysteine, vitamin B12, folic acid levels. ARCH NEUROPSYCHIATRY 2009;46(2):49-51.
  333. Gilbody, S., Lightfoot, T., and Sheldon, T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol.Community Health 2007;61(7):631-637. View Abstract
  334. Ramos, M. I., Allen, L. H., Haan, M. N., Green, R., and Miller, J. W. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr 2004;80(4):1024-1028. View Abstract
  335. Almeida, O. P., McCaul, K., Hankey, G. J., Norman, P., Jamrozik, K., and Flicker, L. Homocysteine and depression in later life. Arch.Gen.Psychiatry 2008;65(11):1286-1294. View Abstract
  336. Ford, A. H., Flicker, L., Thomas, J., Norman, P., Jamrozik, K., and Almeida, O. P. Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin.Psychiatry 2008;69(8):1203-1209. View Abstract
  337. Titaley, C. R., Dibley, M. J., Roberts, C. L., and Agho, K. Combined iron/folic acid supplements and malaria prophylaxis reduce neonatal mortality in 19 sub-Saharan African countries. Am J Clin Nutr 2010;92(1):235-243. View Abstract
  338. Schmiegel, W., Pox, C., and Kroesen, A. [Ulcerative colitis. Cancer prevention]. Z Gastroenterol 2004;42(9):1014-1018. View Abstract
  339. Bertino, J. R. Biomodulation of 5-fluorouracil with antifolates. Semin.Oncol. 1997;24(5 Suppl 18):S18. View Abstract
  340. Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., Carter, R., Tebbutt, N. C., Dervenis, C., Smith, D., Glimelius, B., Charnley, R. M., Lacaine, F., Scarfe, A. G., Middleton, M. R., Anthoney, A., Ghaneh, P., Halloran, C. M., Lerch, M. M., Olah, A., Rawcliffe, C. L., Verbeke, C. S., Campbell, F., and Buchler, M. W. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 7-11-2012;308(2):147-156. View Abstract
  341. Lorgis, V., Chauffert, B., Gentil, J., and Ghiringhelli, F. Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study. Anticancer Res 2012;32(9):4125-4130. View Abstract
  342. Neuzillet, C., Hentic, O., Rousseau, B., Rebours, V., Bengrine-Lefevre, L., Bonnetain, F., Levy, P., Raymond, E., Ruszniewski, P., Louvet, C., and Hammel, P. FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts. World J.Gastroenterol. 9-7-2012;18(33):4533-4541. View Abstract
  343. Bonnetain, F., Bosset, J. F., Gerard, J. P., Calais, G., Conroy, T., Mineur, L., Bouche, O., Maingon, P., Chapet, O., Radosevic-Jelic, L., Methy, N., and Collette, L. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur.J.Cancer 2012;48(12):1781-1790. View Abstract
  344. Giessen, C., Stintzing, S., Laubender, R. P., Ankerst, D. P., Schulz, C., Moosmann, N., Modest, D. P., Schalhorn, A., von Weikersthal, L. F., and Heinemann, V. Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancer. Clin Colorectal Cancer 2011;10(4):317-324. View Abstract
  345. Asseburg, C., Frank, M., Kohne, C. H., Hartmann, J. T., Griebsch, I., Mohr, A., Osowski, U., Schulten, J., and Mittendorf, T. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting. Clin Ther 2011;33(4):482-497. View Abstract
  346. Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., III, Casper, E. S., Cohen, S. J., Czito, B., Ellenhorn, J. D., Hawkins, W. G., Herman, J., Hoffman, J. P., Ko, A., Komanduri, S., Koong, A., Ma, W. W., Malafa, M. P., Merchant, N. B., Mulvihill, S. J., Muscarella, P., Nakakura, E. K., Obando, J., Pitman, M. B., Sasson, A. R., Tally, A., Thayer, S. P., Whiting, S., Wolff, R. A., Wolpin, B. M., Freedman-Cass, D. A., and Shead, D. A. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J.Natl.Compr.Canc.Netw. 6-1-2012;10(6):703-713. View Abstract
  347. Alberts, S. R., Sargent, D. J., Nair, S., Mahoney, M. R., Mooney, M., Thibodeau, S. N., Smyrk, T. C., Sinicrope, F. A., Chan, E., Gill, S., Kahlenberg, M. S., Shields, A. F., Quesenberry, J. T., Webb, T. A., Farr, G. H., Jr., Pockaj, B. A., Grothey, A., and Goldberg, R. M. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA 4-4-2012;307(13):1383-1393. View Abstract
  348. Wald, D. S., Law, M., and Morris, J. K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 11-23-2002;325(7374):1202. View Abstract
  349. McNulty, H., Pentieva, K., Hoey, L., and Ward, M. Homocysteine, B-vitamins and CVD. Proc.Nutr Soc. 2008;67(2):232-237. View Abstract
  350. Hotoleanu, C., Porojan-Iuga, M., Rusu, M. L., and Andercou, A. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis. Rom.J Intern Med 2007;45(2):159-164. View Abstract
  351. Clarke, R., Lewington, S., Sherliker, P., and Armitage, J. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia. Curr Opin.Clin Nutr Metab Care 2007;10(1):32-39. View Abstract
  352. Bailey, L. B. Do low doses of folic acid result in maximum lowering of homocysteine? Am.J Clin.Nutr 2005;82(4):717-718. View Abstract
  353. Kuo, H. K., Sorond, F. A., Chen, J. H., Hashmi, A., Milberg, W. P., and Lipsitz, L. A. The role of homocysteine in multisystem age-related problems: a systematic review. J Gerontol.A Biol.Sci Med Sci 2005;60(9):1190-1201. View Abstract
  354. Boers, G. H. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin.Thromb.Hemost. 2000;26(3):291-295. View Abstract
  355. Weir, D. G. and Scott, J. M. Homocysteine as a risk factor for cardiovascular and related disease: nutritional implications. Nutr Res.Rev 1998;11(2):311-338. View Abstract
  356. Hankey, G. J. and Eikelboom, J. W. Homocysteine and vascular disease. Indian Heart J 2000;52(7 Suppl):S18-S26. View Abstract
  357. Hankey, G. J. and Eikelboom, J. W. Homocysteine and vascular disease. Lancet 7-31-1999;354(9176):407-413. View Abstract
  358. Soliman, E. Z. and Shalash, O. A. Homocysteine, vitamins, and vascular disease prevention: more negative results. Am J Clin Nutr 2008;87(4):1069-1070. View Abstract
  359. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006;151(2):282-287. View Abstract
  360. Virdis, A., Ghiadoni, L., Versari, D., Salvetti, G., Pinto, S., Favilla, S., Taddei, S., and Salvetti, A. Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease? Curr Pharm Des 2005;11(17):2187-2197. View Abstract
  361. Eikelboom, J. W., Lonn, E., Genest, J., Jr., Hankey, G., and Yusuf, S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann.Intern.Med 9-7-1999;131(5):363-375. View Abstract
  362. Wald, N. J. and Law, M. R. A strategy to reduce cardiovascular disease by more than 80%. BMJ 6-28-2003;326(7404):1419. View Abstract
  363. Garner, P. and Brabin, B. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bull World Health Organ 1994;72(1):89-99. View Abstract
  364. Shah, B. K. and Gupta, P. Weekly vs daily iron and folic acid supplementation in adolescent Nepalese girls. Arch Pediatr Adolesc.Med 2002;156(2):131-135. View Abstract
  365. Kanal, K., Busch-Hallen, J., Cavalli-Sforza, T., Crape, B., and Smitasiri, S. Weekly iron-folic acid supplements to prevent anemia among Cambodian women in three settings: process and outcomes of social marketing and community mobilization. Nutr Rev 2005;63(12 Pt 2):S126-S133. View Abstract
  366. Paulino, L. S., Angeles-Agdeppa, I., Etorma, U. M., Ramos, A. C., and Cavalli-Sforza, T. Weekly iron-folic acid supplementation to improve iron status and prevent pregnancy anemia in Filipino women of reproductive age: the Philippine experience through government and private partnership. Nutr Rev 2005;63(12 Pt 2):S109-S115. View Abstract
  367. Pena-Rosas, J. P. and Viteri, F. E. Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database.Syst.Rev 2009;(4):CD004736. View Abstract
  368. Berger, J., Thanh, H. T., Cavalli-Sforza, T., Smitasiri, S., Khan, N. C., Milani, S., Hoa, P. T., Quang, N. D., and Viteri, F. Community mobilization and social marketing to promote weekly iron-folic acid supplementation in women of reproductive age in Vietnam: impact on anemia and iron status. Nutr Rev 2005;63(12 Pt 2):S95-108. View Abstract
  369. Khan, N. C., Thanh, H. T., Berger, J., Hoa, P. T., Quang, N. D., Smitasiri, S., and Cavalli-Sforza, T. Community mobilization and social marketing to promote weekly iron-folic acid supplementation: a new approach toward controlling anemia among women of reproductive age in Vietnam. Nutr Rev 2005;63(12 Pt 2):S87-S94. View Abstract
  370. Katz, J., Khatry, S. K., LeClerq, S. C., Mullany, L. C., Yanik, E. L., Stoltzfus, R. J., Siegel, E. H., and Tielsch, J. M. Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal. J Nutr 2010;140(7):1317-1321. View Abstract
  371. Schumann, K., Longfils, P., Monchy, D., von, Xylander S., Weinheimer, H., and Solomons, N. W. Efficacy and safety of twice-weekly administration of three RDAs of iron and folic acid with and without complement of 14 essential micronutrients at one or two RDAs: a placebo-controlled intervention trial in anemic Cambodian infants 6 to 24 months of age. Eur J Clin Nutr 2009;63(3):355-368. View Abstract
  372. Angeles-Agdeppa, I., Paulino, L. S., Ramos, A. C., Etorma, U. M., Cavalli-Sforza, T., and Milani, S. Government-industry partnership in weekly iron-folic acid supplementation for women of reproductive age in the Philippines: impact on iron status. Nutr Rev 2005;63(12 Pt 2):S116-S125. View Abstract
  373. Sanghvi, T. G., Harvey, P. W., and Wainwright, E. Maternal iron-folic acid supplementation programs: evidence of impact and implementation. Food Nutr Bull. 2010;31(2 Suppl):S100-S107. View Abstract
  374. Crape, B. L., Kenefick, E., Cavalli-Sforza, T., Busch-Hallen, J., Milani, S., and Kanal, K. Positive impact of a weekly iron-folic acid supplement delivered with social marketing to Cambodian women: compliance, participation, and hemoglobin levels increase with higher socioeconomic status. Nutr Rev 2005;63(12 Pt 2):S134-S138. View Abstract
  375. Longfils, P., Heang, U. K., Soeng, H., and Sinuon, M. Weekly iron and folic acid supplementation as a tool to reduce anemia among primary school children in Cambodia. Nutr Rev 2005;63(12 Pt 2):S139-S145. View Abstract
  376. Vir, S. C., Singh, N., Nigam, A. K., and Jain, R. Weekly iron and folic acid supplementation with counseling reduces anemia in adolescent girls: a large-scale effectiveness study in Uttar Pradesh, India. Food Nutr Bull. 2008;29(3):186-194. View Abstract
  377. Zavaleta, N., Caulfield, L. E., and Garcia, T. Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc. Am.J.Clin.Nutr. 2000;71(4):956-961. View Abstract
  378. Ganji, V. and Kafai, M. R. Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in the post-folic acid fortification period than in the pre-folic acid fortification period in US adults. Am J Clin Nutr 2009;89(1):363-371. View Abstract
  379. Thoradeniya, T., Wickremasinghe, R., Ramanayake, R., and Atukorala, S. Low folic acid status and its association with anaemia in urban adolescent girls and women of childbearing age in Sri Lanka. Br J Nutr 2006;95(3):511-516. View Abstract
  380. Titaley, C. R., Dibley, M. J., Roberts, C. L., Hall, J., and Agho, K. Iron and folic acid supplements and reduced early neonatal deaths in Indonesia. Bull.World Health Organ 7-1-2010;88(7):500-508. View Abstract
  381. Pellis, L., Dommels, Y., Venema, D., Polanen, A., Lips, E., Baykus, H., Kok, F., Kampman, E., and Keijer, J. High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells. Br J Nutr 2008;99(4):703-708. View Abstract
  382. Patel, V., Macdonald, J. K., McDonald, J. W., and Chande, N. Methotrexate for maintenance of remission in Crohn’s disease. Cochrane.Database.Syst.Rev 2009;(4):CD006884. View Abstract
  383. Lorenzi, A. R., Johnson, A. H., and Gough, A. Daily folate supplementation is adequate prophylaxis against methotrexate-induced nausea and vomiting and avoids the need for expensive anti-emetic prescription. Rheumatology.(Oxford) 2000;39(7):812-813. View Abstract
  384. Pinarbasi A, Akman A, Yilmaz E, and Basaran E. Is folic acid supplementation necessary for patients treated with methotrexate? TURKISH J DERMATOL 2008;2(2):39-42.
  385. Khanna, D., Park, G. S., Paulus, H. E., Simpson, K. M., Elashoff, D., Cohen, S. B., Emery, P., Dorrier, C., and Furst, D. E. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Arthritis Rheum. 2005;52(10):3030-3038. View Abstract
  386. Alazzam, M., Tidy, J., Hancock, B. W., and Osborne, R. First line chemotherapy in low risk gestational trophoblastic neoplasia. Cochrane.Database.Syst.Rev 2009;(1):CD007102. View Abstract
  387. Foulmann, K., Guastalla, J. P., Caminet, N., Trillet-Lenoir, V., Raudrant, D., Golfier, F., and Schott, A. M. What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence. Gynecol.Oncol. 2006;102(1):103-110. View Abstract
  388. Grem, J. L., King, S. A., Sorensen, J. M., and Christian, M. C. Clinical use of thymidine as a rescue agent from methotrexate toxicity. Invest New Drugs 1991;9(3):281-290. View Abstract
  389. Morgan, S. L., Oster, R. A., Lee, J. Y., Alarcon, G. S., and Baggott, J. E. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3104-3111. View Abstract
  390. Baggott, J. E. and Morgan, S. L. Methotrexate catabolism to 7-hydroxymethotrexate in rheumatoid arthritis alters drug efficacy and retention and is reduced by folic acid supplementation. Arthritis Rheum. 2009;60(8):2257-2261. View Abstract
  391. Zesiewicz, T. A., Wecker, L., Sullivan, K. L., Merlin, L. R., and Hauser, R. A. The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status. Clin Neuropharmacol. 2006;29(3):106-111. View Abstract
  392. DiFabio, J. M., Gori, T., Thomas, G., Jedrzkiewicz, S., and Parker, J. D. Daily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study. Can.J Cardiol 2010;26(9):461-465. View Abstract
  393. de, Bree A., Mennen, L. I., Hercberg, S., and Galan, P. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases. Eur.J Clin.Nutr 2004;58(5):732-744. View Abstract
  394. Klingler, M., Blaschitz, A., Campoy, C., Cano, A., Molloy, A. M., Scott, J. M., Dohr, G., Demmelmair, H., Koletzko, B., and Desoye, G. The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation. Br J Nutr 2006;96(1):182-190. View Abstract
  395. Wilson, S. M., Bivins, B. N., Russell, K. A., and Bailey, L. B. Oral contraceptive use: impact on folate, vitamin B(6), and vitamin B(1)(2) status. Nutr.Rev. 2011;69(10):572-583. View Abstract
  396. Shepherd, F. A. Pemetrexed in the treatment of non-small cell lung cancer. Semin.Oncol. 2002;29(6 Suppl 18):43-48. View Abstract
  397. Ellis, P., Davies, A. M., Evans, W. K., Haynes, A. E., and Lloyd, N. S. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline. J Thorac.Oncol. 2006;1(6):591-601. View Abstract
  398. Dundar, Y., Bagust, A., Dickson, R., Dodd, S., Green, J., Haycox, A., Hill, R., McLeod, C., and Walley, T. Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. Health Technol Assess. 2007;11(1):1-90. View Abstract
  399. Arya, R., Gulati, S., Kabra, M., Sahu, J. K., and Kalra, V. Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children. Neurology 4-12-2011;76(15):1338-1343. View Abstract
  400. Drew, H. J., Vogel, R. I., Molofsky, W., Baker, H., and Frank, O. Effect of folate on phenytoin hyperplasia. J Clin Periodontol. 1987;14(6):350-356. View Abstract
  401. Berg, M. J., Stumbo, P. J., Chenard, C. A., Fincham, R. W., Schneider, P. J., and Schottelius, D. D. Folic acid improves phenytoin pharmacokinetics. J Am Diet Assoc 1995;95(3):352-356. View Abstract
  402. Forna, F., McConnell, M., Kitabire, F. N., Homsy, J., Brooks, J. T., Mermin, J., and Weidle, P. J. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev 2006;8(1):24-36. View Abstract
  403. Erdemir, E. O. and Bergstrom, J. Effect of smoking on folic acid and vitamin B12 after nonsurgical periodontal intervention. J Clin Periodontol. 2007;34(12):1074-1081. View Abstract
  404. Erdemir, E. O. and Bergstrom, J. Relationship between smoking and folic acid, vitamin B12 and some haematological variables in patients with chronic periodontal disease. J Clin Periodontol. 2006;33(12):878-884. View Abstract
  405. Tungtrongchitr, R., Pongpaew, P., Soonthornruengyot, M., Viroonudomphol, D., Vudhivai, N., Tungtrongchitr, A., Phonrat, B., Pooudong, S., and Schelp, F. P. Relationship of tobacco smoking with serum vitamin B12, folic acid and haematological indices in healthy adults. Public Health Nutr 2003;6(7):675-681. View Abstract
  406. Ma, A. G., Schouten, E. G., Zhang, F. Z., Kok, F. J., Yang, F., Jiang, D. C., Sun, Y. Y., and Han, X. X. Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic Acid supplements. J Nutr 2008;138(10):1946-1950. View Abstract
  407. Ahmed, F., Khan, M. R., and Jackson, A. A. Concomitant supplemental vitamin A enhances the response to weekly supplemental iron and folic acid in anemic teenagers in urban Bangladesh. Am.J.Clin.Nutr. 2001;74(1):108-115. View Abstract
  408. Carmel, R. Does high folic acid intake affect unrecognized cobalamin deficiency, and how will we know it if we see it? Am J Clin Nutr 2009;90(6):1449-1450. View Abstract
  409. Morris, M. S., Jacques, P. F., Rosenberg, I. H., and Selhub, J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007;85(1):193-200. View Abstract
  410. Morris, M. S., Jacques, P. F., Rosenberg, I. H., and Selhub, J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr 2010;91(6):1733-1744. View Abstract
  411. Garcia, A., Pulman, K., Zanibbi, K., Day, A., Galaraneau, L., and Freedman, M. Cobalamin reduces homocysteine in older adults on folic acid-fortified diet: a pilot, double-blind, randomized, placebo-controlled trial. J Am Geriatr Soc 2004;52(8):1410-1412. View Abstract
  412. Bronstrup, A., Hages, M., Prinz-Langenohl, R., and Pietrzik, K. Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr 1998;68(5):1104-1110. View Abstract
  413. Katre, P., Bhat, D., Lubree, H., Otiv, S., Joshi, S., Joglekar, C., Rush, E., and Yajnik, C. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status. Asia Pac.J Clin Nutr 2010;19(3):335-343. View Abstract
  414. Eussen, S. J., de Groot, L. C., Joosten, L. W., Bloo, R. J., Clarke, R., Ueland, P. M., Schneede, J., Blom, H. J., Hoefnagels, W. H., and van Staveren, W. A. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am.J Clin.Nutr 2006;84(2):361-370. View Abstract
  415. Armitage, J. M., Bowman, L., Clarke, R. J., Wallendszus, K., Bulbulia, R., Rahimi, K., Haynes, R., Parish, S., Sleight, P., Peto, R., and Collins, R. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 6-23-2010;303(24):2486-2494. View Abstract
  416. Wyckoff, K. F. and Ganji, V. Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period. Am J Clin Nutr 2007;86(4):1187-1192. View Abstract
  417. Mills, J. L., Von, Kohorn, I, Conley, M. R., Zeller, J. A., Cox, C., Williamson, R. E., and Dufour, D. R. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr 2003;77(6):1474-1477. View Abstract
  418. Ray, J. G., Wyatt, P. R., Thompson, M. D., Vermeulen, M. J., Meier, C., Wong, P. Y., Farrell, S. A., and Cole, D. E. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 2007;18(3):362-366. View Abstract
  419. Mason, J. B. and Baron, J. A. Effects of folic acid plus vitamin B12 vs placebo in myocardial infarction survivors. JAMA 10-27-2010;304(16):1783-1784. View Abstract
  420. Muszkat, M., Bialer, O., Blotnick, S., Adar, L., Xie, H. G., Ufer, M., Cascorbi, I., and Caraco, Y. Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults. Clin Ther 2010;32(2):347-356. View Abstract
  421. Stewart, C. P., Christian, P., LeClerq, S. C., West, K. P., Jr., and Khatry, S. K. Antenatal supplementation with folic acid + iron + zinc improves linear growth and reduces peripheral adiposity in school-age children in rural Nepal. Am J Clin Nutr 2009;90(1):132-140. View Abstract
  422. Stang J, Brown J, and Jacobs D. Effects of iron and folic acid supplements on serum zinc levels among a cohort of pregnant women. TOP CLIN NUTR 2002;17(4):15-26.
  423. Tupe, R. S. and Agte, V. V. Role of zinc along with ascorbic acid and folic acid during long-term in vitro albumin glycation. Br J Nutr 2010;103(3):370-377. View Abstract
  424. Hansen, M., Samman, S., Madsen, L. T., Jensen, M., Sorensen, S. S., and Sandstrom, B. Folic acid enrichment of bread does not appear to affect zinc absorption in young women. Am J Clin Nutr 2001;74(1):125-129. View Abstract
  425. Alvares Delfino, V. D., de Andrade Vianna, A. C., Mocelin, A. J., Barbosa, D. S., Mise, R. A., and Matsuo, T. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 2007;23(3):242-247. View Abstract
  426. Title, L. M., Cummings, P. M., Giddens, K., Genest, J. J., Jr., and Nassar, B. A. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000;36(3):758-765. View Abstract
  427. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010;9(9):855-865. View Abstract
  428. Zhang, S. M., Cook, N. R., Albert, C. M., Gaziano, J. M., Buring, J. E., and Manson, J. E. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 11-5-2008;300(17):2012-2021. View Abstract
  429. Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., and Manson, J. E. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 5-7-2008;299(17):2027-2036. View Abstract
  430. Song, Y., Cook, N. R., Albert, C. M., Van, Denburgh M., and Manson, J. E. Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Diabetes 2009;58(8):1921-1928. View Abstract
  431. Ford, A. H., Flicker, L., Alfonso, H., Thomas, J., Clarnette, R., Martins, R., and Almeida, O. P. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology 10-26-2010;75(17):1540-1547. View Abstract
  432. Christen, W. G., Glynn, R. J., Chew, E. Y., Albert, C. M., and Manson, J. E. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women’s Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med 2-23-2009;169(4):335-341. View Abstract
  433. Schnyder, G., Roffi, M., Flammer, Y., Pin, R., and Hess, O. M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 8-28-2002;288(8):973-979. View Abstract
  434. Vermeulen, E. G., Stehouwer, C. D., Twisk, J. W., van den Berg, M., de Jong, S. C., Mackaay, A. J., van Campen, C. M., Visser, F. C., Jakobs, C. A., Bulterjis, E. J., and Rauwerda, J. A. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 2-12-2000;355(9203):517-522. View Abstract
  435. Alemdaroglu, N. C., Dietz, U., Wolffram, S., Spahn-Langguth, H., and Langguth, P. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm.Drug Dispos. 2008;29(6):335-348. View Abstract
  436. Alemdaroglu, N. C., Wolffram, S., Boissel, J. P., Closs, E., Spahn-Langguth, H., and Langguth, P. Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells. Planta Med 2007;73(1):27-32. View Abstract
  437. Abularrage, C. J., Sidawy, A. N., White, P. W., Aidinian, G., Dezee, K. J., Weiswasser, J. M., and Arora, S. Effect of folic acid and vitamins B6 and B12 on microcirculatory vasoreactivity in patients with hyperhomocysteinemia. Vasc.Endovascular.Surg 2007;41(4):339-345. View Abstract
  438. Chang, T. Y., Chou, K. J., Tseng, C. F., Chung, H. M., Fang, H. C., Hung, Y. M., Wu, M. J., Tzeng, H. M., Lind, C. C., and Lu, K. C. Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients. Curr Med Res Opin. 2007;23(8):1879-1886. View Abstract
  439. Lobo, A., Naso, A., Arheart, K., Kruger, W. D., Abou-Ghazala, T., Alsous, F., Nahlawi, M., Gupta, A., Moustapha, A., van, Lente F., Jacobsen, D. W., and Robinson, K. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol 3-15-1999;83(6):821-825. View Abstract
  440. Sun, Y., Lu, C. J., Chien, K. L., Chen, S. T., and Chen, R. C. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer’s disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 2007;29(10):2204-2214. View Abstract
  441. Vyas, S., Collin, S. M., Bertin, E., Davys, G. J., and Mathur, B. Leaf concentrate as an alternative to iron and folic acid supplements for anaemic adolescent girls: a randomised controlled trial in India. Public Health Nutr 2010;13(3):418-423. View Abstract
  442. Shrimpton, R., Huffman, S. L., Zehner, E. R., Darnton-Hill, I., and Dalmiya, N. Multiple micronutrient supplementation during pregnancy in developing-country settings: policy and program implications of the results of a meta-analysis. Food Nutr Bull 2009;30(4 Suppl):S556-S573. View Abstract
  443. Fall, C. H., Fisher, D. J., Osmond, C., and Margetts, B. M. Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on birth size and length of gestation. Food Nutr Bull 2009;30(4 Suppl):S533-S546. View Abstract
  444. Margetts, B. M., Fall, C. H., Ronsmans, C., Allen, L. H., and Fisher, D. J. Multiple micronutrient supplementation during pregnancy in low-income countries: review of methods and characteristics of studies included in the meta-analyses. Food Nutr Bull 2009;30(4 Suppl):S517-S526. View Abstract
  445. Ronsmans, C., Fisher, D. J., Osmond, C., Margetts, B. M., and Fall, C. H. Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on stillbirths and on early and late neonatal mortality. Food Nutr Bull 2009;30(4 Suppl):S547-S555. View Abstract
  446. Allen, L. H. and Peerson, J. M. Impact of multiple micronutrient versus iron-folic acid supplements on maternal anemia and micronutrient status in pregnancy. Food Nutr Bull. 2009;30(4 Suppl):S527-S532. View Abstract
  447. Bhutta, Z., Klemm, R., Shahid, F., Rizvi, A., Rah, J. H., and Christian, P. Treatment response to iron and folic acid alone is the same as with multivitamins and/or anthelminthics in severely anemic 6- to 24-month-old children. J Nutr 2009;139(8):1568-1574. View Abstract
  448. Ahmed, F., Khan, M. R., Akhtaruzzaman, M., Karim, R., Williams, G., Torlesse, H., Darnton-Hill, I., Dalmiya, N., Banu, C. P., and Nahar, B. Long-term intermittent multiple micronutrient supplementation enhances hemoglobin and micronutrient status more than iron + folic acid supplementation in Bangladeshi rural adolescent girls with nutritional anemia. J Nutr 2010;140(10):1879-1886. View Abstract
  449. Eneroth, H., El, Arifeen S., Persson, L. A., Lonnerdal, B., Hossain, M. B., Stephensen, C. B., and Ekstrom, E. C. Maternal multiple micronutrient supplementation has limited impact on micronutrient status of Bangladeshi infants compared with standard iron and folic acid supplementation. J Nutr 2010;140(3):618-624. View Abstract
  450. Strozzi, G. P. and Mogna, L. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol 2008;42 Suppl 3 Pt 2:S179-S184. View Abstract
  451. Bingham, S. The fibre-folate debate in colo-rectal cancer. Proc Nutr Soc 2006;65(1):19-23. View Abstract
  452. Hannon-Fletcher, M. P., Armstrong, N. C., Scott, J. M., Pentieva, K., Bradbury, I., Ward, M., Strain, J. J., Dunn, A. A., Molloy, A. M., Kerr, M. A., and McNulty, H. Determining bioavailability of food folates in a controlled intervention study. Am J Clin Nutr 2004;80(4):911-918. View Abstract
  453. Shikany, J. M., Heimburger, D. C., Piyathilake, C. J., Desmond, R. A., and Greene, P. G. Effect of folic acid fortification of foods on folate intake in female smokers with cervical dysplasia. Nutrition 2004;20(5):409-414. View Abstract
  454. Winkels, R. M., Brouwer, I. A., Clarke, R., Katan, M. B., and Verhoef, P. Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial. Am J Clin Nutr 2008;88(2):348-355. View Abstract
  455. Yeung, L. F., Cogswell, M. E., Carriquiry, A. L., Bailey, L. B., Pfeiffer, C. M., and Berry, R. J. Contributions of enriched cereal-grain products, ready-to-eat cereals, and supplements to folic acid and vitamin B-12 usual intake and folate and vitamin B-12 status in US children: National Health and Nutrition Examination Survey (NHANES), 2003-2006. Am J Clin Nutr 2011;93(1):172-185. View Abstract
  456. Berry, R. J., Bailey, L., Mulinare, J., and Bower, C. Fortification of flour with folic acid. Food Nutr Bull. 2010;31(1 Suppl):S22-S35. View Abstract
  457. Ray, J. G., Vermeulen, M. J., Boss, S. C., and Cole, D. E. Declining rate of folate insufficiency among adults following increased folic acid food fortification in Canada. Can.J Public Health 2002;93(4):249-253. View Abstract
  458. Moynihan, P. J., Rugg-Gunn, A. J., Butler, T. J., and Adamson, A. J. Dietary intake of folate by adolescents and the potential effect of flour fortification with folic acid. Br J Nutr 2001;86(4):529-534. View Abstract
  459. Quinlivan, E. P. and Gregory, J. F., III. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 2003;77(1):221-225. View Abstract
  460. Johansson, M., Witthoft, C. M., Bruce, A., and Jagerstad, M. Study of wheat breakfast rolls fortified with folic acid. The effect on folate status in women during a 3-month intervention. Eur J Nutr 2002;41(6):279-286. View Abstract
  461. Malinow, M. R., Duell, P. B., Hess, D. L., Anderson, P. H., Kruger, W. D., Phillipson, B. E., Gluckman, R. A., Block, P. C., and Upson, B. M. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N.Engl.J Med 4-9-1998;338(15):1009-1015. View Abstract
  462. Roebothan, B. V., Carmichael, J., Barter, V., Aucoin, J., and Murphy, M. Mandatory folic acid fortification in Newfoundland and Labrador. Can.J Diet Pract.Res 2007;68(3):143-145. View Abstract
  463. Hamner, H. C., Mulinare, J., Cogswell, M. E., Flores, A. L., Boyle, C. A., Prue, C. E., Wang, C. Y., Carriquiry, A. L., and Devine, O. Predicted contribution of folic acid fortification of corn masa flour to the usual folic acid intake for the US population: National Health and Nutrition Examination Survey 2001-2004. Am J Clin Nutr 2009;89(1):305-315. View Abstract
  464. Pfeiffer, C. M., Caudill, S. P., Gunter, E. W., Osterloh, J., and Sampson, E. J. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82(2):442-450. View Abstract
  465. Carrero, J. J., Baro, L., Fonolla, J., Gonzalez-Santiago, M., Martinez-Ferez, A., Castillo, R., Jimenez, J., Boza, J. J., and Lopez-Huertas, E. Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia. Nutrition 2004;20(6):521-527. View Abstract
  466. Benito, P., Caballero, J., Moreno, J., Gutierrez-Alcantara, C., Munoz, C., Rojo, G., Garcia, S., and Soriguer, F. C. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin.Nutr. 2006;25(4):581-587. View Abstract
  467. Calomino, F., Di, Paolo N., Nicolai, G., and Miglio, A. Mineral water administration may increase kidney elimination of urea, creatinine and folic acid in a concentration-dependent fashion. Int J Artif.Organs 2010;33(5):317-320. View Abstract
  468. Shirodaria, C., Antoniades, C., Lee, J., Jackson, C. E., Robson, M. D., Francis, J. M., Moat, S. J., Ratnatunga, C., Pillai, R., Refsum, H., Neubauer, S., and Channon, K. M. Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 5-1-2007;115(17):2262-2270. View Abstract
  469. Gamble, M. V., Liu, X., Ahsan, H., Pilsner, J. R., Ilievski, V., Slavkovich, V., Parvez, F., Chen, Y., Levy, D., Factor-Litvak, P., and Graziano, J. H. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 2006;84(5):1093-1101. View Abstract
  470. Gamble, M. V., Liu, X., Slavkovich, V., Pilsner, J. R., Ilievski, V., Factor-Litvak, P., Levy, D., Alam, S., Islam, M., Parvez, F., Ahsan, H., and Graziano, J. H. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr 2007;86(4):1202-1209. View Abstract
  471. Holven, K. B., Haugstad, T. S., Holm, T., Aukrust, P., Ose, L., and Nenseter, M. S. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects. Br J Nutr 2003;89(3):359-363. View Abstract
  472. Melse-Boonstra, A., Holm, P. I., Ueland, P. M., Olthof, M., Clarke, R., and Verhoef, P. Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am J Clin Nutr 2005;81(6):1378-1382. View Abstract
  473. Hernandez-Diaz, S., Werler, M. M., Louik, C., and Mitchell, A. A. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol. 11-1-2002;156(9):806-812. View Abstract
  474. Pathansali, R., Mangoni, A. A., Creagh-Brown, B., Lan, Z. C., Ngow, G. L., Yuan, X. F., Ouldred, E. L., Sherwood, R. A., Swift, C. G., and Jackson, S. H. Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects. Arch Gerontol.Geriatr 2006;43(1):127-137. View Abstract
  475. Williams, C., Kingwell, B. A., Burke, K., McPherson, J., and Dart, A. M. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr 2005;82(1):26-31. View Abstract
  476. Potter, K., Hankey, G. J., Green, D. J., Eikelboom, J., Jamrozik, K., and Arnolda, L. F. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC.Cardiovasc.Disord. 2008;8:24. View Abstract
  477. Moens, A. L., Claeys, M. J., Wuyts, F. L., Goovaerts, I., Van, Hertbruggen E., Wendelen, L. C., Van Hoof, V. O., and Vrints, C. J. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2-15-2007;99(4):476-481. View Abstract
  478. Hoch, A. Z., Lynch, S. L., Jurva, J. W., Schimke, J. E., and Gutterman, D. D. Folic acid supplementation improves vascular function in amenorrheic runners. Clin J Sport Med 2010;20(3):205-210. View Abstract
  479. Pena, A. S., Wiltshire, E., Gent, R., Hirte, C., and Couper, J. Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J Pediatr 2004;144(4):500-504. View Abstract
  480. Pena, A. S., Wiltshire, E., Gent, R., Piotto, L., Hirte, C., and Couper, J. Folic acid does not improve endothelial function in obese children and adolescents. Diabetes Care 2007;30(8):2122-2127. View Abstract
  481. Lamers, Y., Prinz-Langenohl, R., Bramswig, S., and Pietrzik, K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 2006;84(1):156-161. View Abstract
  482. Bakker, D. J., de Jong-van den Berg LT, and Fokkema, M. R. Controlled study on folate status following folic acid supplementation and discontinuation in women of child-bearing age. Ann.Clin Biochem. 2009;46(Pt 3):231-234. View Abstract
  483. Rosenthal, J., Milla, G., Flores, A., Yon, M., Pfeiffer, C., Umana, E., Skerrette, N., and Barahona, F. Effect of different dosage and administration schedules of folic acid on blood folate levels in a population of Honduran women of reproductive age. Public Health Nutr 2008;11(8):822-830. View Abstract
  484. Anderson, C. A., Jee, S. H., Charleston, J., Narrett, M., and Appel, L. J. Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. Am J Epidemiol. 10-15-2010;172(8):932-941. View Abstract
  485. Garcia, A. A., Day, A. G., Zanibbi, K., and Zunzunegui, M. V. Long-term effects of folic acid fortification and B-vitamin supplementation on total folate, homocysteine, methylmalonic acid and cobalamin in older adults. Can.J Public Health 2008;99(5):428-433. View Abstract
  486. Tucker, K. L., Olson, B., Bakun, P., Dallal, G. E., Selhub, J., and Rosenberg, I. H. Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial. Am J Clin Nutr 2004;79(5):805-811. View Abstract
  487. Cuskelly, G. J., McNulty, H., and Scott, J. M. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70(2):234-239. View Abstract
  488. Brouwer, I. A., van, Dusseldorp M., Thomas, C. M., Duran, M., Hautvast, J. G., Eskes, T. K., and Steegers-Theunissen, R. P. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 1999;69(1):99-104. View Abstract
  489. Ashfield-Watt, P. A., Pullin, C. H., Whiting, J. M., Clark, Z. E., Moat, S. J., Newcombe, R. G., Burr, M. L., Lewis, M. J., Powers, H. J., and McDowell, I. F. Methylenetetrahydrofolate reductase 677C–>T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 2002;76(1):180-186. View Abstract
  490. Keizer, S. E., Gibson, R. S., and O’Connor, D. L. Postpartum folic acid supplementation of adolescents: impact on maternal folate and zinc status and milk composition. Am J Clin Nutr 1995;62(2):377-384. View Abstract
  491. Lamers, Y., Prinz-Langenohl, R., Moser, R., and Pietrzik, K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr 2004;79(3):473-478. View Abstract
  492. Hao, L., Yang, Q. H., Li, Z., Bailey, L. B., Zhu, J. H., Hu, D. J., Zhang, B. L., Erickson, J. D., Zhang, L., Gindler, J., Li, S., and Berry, R. J. Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial. Am J Clin Nutr 2008;88(2):448-457. View Abstract
  493. Nguyen, P., Tam, C., O’Connor, D. L., Kapur, B., and Koren, G. Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age. Am J Clin Nutr 2009;89(3):844-852. View Abstract
  494. Akoglu, B., Schrott, M., Bolouri, H., Jaffari, A., Kutschera, E., Caspary, W. F., and Faust, D. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. Eur J Clin Nutr 2008;62(6):796-801. View Abstract
  495. Wolters, M., Strohle, A., and Hahn, A. [Age-associated changes in the metabolism of vitamin B(12) and folic acid: prevalence, aetiopathogenesis and pathophysiological consequences]. Z Gerontol.Geriatr 2004;37(2):109-135. View Abstract
  496. Ossareh, S., Shayan-Moghaddam, H., Salimi, A., Asgari, M., and Farrokhi, F. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial. Iran J Kidney Dis. 2009;3(4):227-233. View Abstract
  497. Wotherspoon, F., Laight, D. W., Turner, C., Meeking, D. R., Allard, S. E., Munday, L. J., Shaw, K. M., and Cummings, M. H. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria. Int J Clin Pract. 2008;62(4):569-574. View Abstract
  498. Hazra, A., Selhub, J., Chao, W. H., Ueland, P. M., Hunter, D. J., and Baron, J. A. Uracil misincorporation into DNA and folic acid supplementation. Am J Clin Nutr 2010;91(1):160-165. View Abstract
  499. Venn, B. J., Green, T. J., Moser, R., and Mann, J. I. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am J Clin Nutr 2003;77(3):658-662. View Abstract
  500. Anderson, J. L., Horne, B. D., Carlquist, J. F., Bair, T. L., Habashi, J., Hart, N. I., Jones, S. K., and Muhlestein, J. B. Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease. Am J Cardiol 9-1-2002;90(5):536-539. View Abstract
  501. van Oort, F. V., Melse-Boonstra, A., Brouwer, I. A., Clarke, R., West, C. E., Katan, M. B., and Verhoef, P. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr 2003;77(5):1318-1323. View Abstract
  502. Dusitanond, P., Eikelboom, J. W., Hankey, G. J., Thom, J., Gilmore, G., Loh, K., Yi, Q., Klijn, C. J., Langton, P., van Bockxmeer, F. M., Baker, R., and Jamrozik, K. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial. Stroke 2005;36(1):144-146. View Abstract
  503. Ganji, V. and Kafai, M. R. Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Am J Clin Nutr 2006;84(5):989-994. View Abstract
  504. Misra, A., Vikram, N. K., Pandey, R. M., Dwivedi, M., Ahmad, F. U., Luthra, K., Jain, K., Khanna, N., Devi, J. R., Sharma, R., and Guleria, R. Hyperhomocysteinemia, and low intakes of folic acid and vitamin B12 in urban North India. Eur J Nutr 2002;41(2):68-77. View Abstract
  505. O’Donnell, E., Goodman, J. M., and Harvey, P. J. Clinical review: Cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women. J.Clin Endocrinol.Metab 2011;96(12):3638-3648. View Abstract
  506. Bayo, M. P., Lopez, M. J., Ortega, A. O., Peinado, C. A., Granados, J. J., de la Serrana, H. L., and Martinez, M. C. [Resistance of hyperhomocysteinemia in renal patients to treatment with supra-physiological doses of parenteral folic acid]. Nutr Hosp. 2008;23(3):268-276. View Abstract
  507. Shojaei, M. H., Djalali, M., Siassi, F., Khatami, M. R., Boroumand, M. A., and Eshragian, M. R. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid. Iran J Kidney Dis. 2009;3(3):141-144. View Abstract
  508. Thambyrajah, J., Landray, M. J., McGlynn, F. J., Jones, H. J., Wheeler, D. C., and Townend, J. N. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 8-22-2000;102(8):871-875. View Abstract
  509. Brouwer, I. A., van, Dusseldorp M., Duran, M., Thomas, C. M., Hautvast, J. G., Eskes, T. K., and Steegers-Theunissen, R. P. Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant women. Br J Nutr 1999;82(2):85-89. View Abstract
  510. Jacques, P. F., Bostom, A. G., Williams, R. R., Ellison, R. C., Eckfeldt, J. H., Rosenberg, I. H., Selhub, J., and Rozen, R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1-1-1996;93(1):7-9. View Abstract
  511. Lim, U. and Song, M. A. Dietary and lifestyle factors of DNA methylation. Methods Mol.Biol 2012;863:359-376. View Abstract
  512. Singh, P. R. and Lele, S. S. Folate gene polymorphisms MTR A2756G, MTRR A66G, and BHMT G742A and risk for coronary artery disease: a meta-analysis. Genet.Test.Mol.Biomarkers 2012;16(6):471-475. View Abstract
  513. Zhou, J. Y., Shi, R., Yu, H. L., Zeng, Y., Zheng, W. L., and Ma, W. L. The association between two polymorphisms in the TS gene and risk of cancer: a systematic review and pooled analysis. Int.J.Cancer 11-1-2012;131(9):2103-2116. View Abstract
  514. Weiner, A. S., Boyarskikh, U. A., Voronina, E. N., Selezneva, I. A., Sinkina, T. V., Lazarev, A. F., Petrova, V. D., and Filipenko, M. L. Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer Epidemiol. 2012;36(2):e95-e100. View Abstract
  515. Varga, E. A., Sturm, A. C., Misita, C. P., and Moll, S. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 5-17-2005;111(19):e289-e293. View Abstract
  516. Clarke, R., Bennett, D. A., Parish, S., Verhoef, P., Dotsch-Klerk, M., Lathrop, M., Xu, P., Nordestgaard, B. G., Holm, H., Hopewell, J. C., Saleheen, D., Tanaka, T., Anand, S. S., Chambers, J. C., Kleber, M. E., Ouwehand, W. H., Yamada, Y., Elbers, C., Peters, B., Stewart, A. F., Reilly, M. M., Thorand, B., Yusuf, S., Engert, J. C., Assimes, T. L., Kooner, J., Danesh, J., Watkins, H., Samani, N. J., Collins, R., and Peto, R. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS.Med. 2012;9(2):e1001177. View Abstract
  517. Malinow, M. R., Nieto, F. J., Kruger, W. D., Duell, P. B., Hess, D. L., Gluckman, R. A., Block, P. C., Holzgang, C. R., Anderson, P. H., Seltzer, D., Upson, B., and Lin, Q. R. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler.Thromb.Vasc.Biol. 1997;17(6):1157-1162. View Abstract
  518. Langevin, S. M., Lin, D., Matsuo, K., Gao, C. M., Takezaki, T., Stolzenberg-Solomon, R. Z., Vasavi, M., Hasan, Q., and Taioli, E. Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol.Lett. 1-30-2009;184(2):73-80. View Abstract
  519. Hou, X. H., Huang, Y. M., and Mi, Y. Y. Methylenetetrahydrofolate reductase gene C677T polymorphism and lung cancer: an updated meta-analysis. Asian Pac.J.Cancer Prev. 2012;13(5):2025-2029. View Abstract
  520. Liu, Y. X., Wang, B., Wan, M. H., Tang, W. F., Huang, F. K., and Li, C. Meta-analysis of the relationship between the Metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac.J.Cancer Prev. 2011;12(1):247-252. View Abstract
  521. Hazra, A., Kraft, P., Lazarus, R., Chen, C., Chanock, S. J., Jacques, P., Selhub, J., and Hunter, D. J. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum.Mol.Genet. 12-1-2009;18(23):4677-4687. View Abstract
  522. Tanaka, T., Scheet, P., Giusti, B., Bandinelli, S., Piras, M. G., Usala, G., Lai, S., Mulas, A., Corsi, A. M., Vestrini, A., Sofi, F., Gori, A. M., Abbate, R., Guralnik, J., Singleton, A., Abecasis, G. R., Schlessinger, D., Uda, M., and Ferrucci, L. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am.J Hum.Genet. 2009;84(4):477-482. View Abstract
  523. Martinez-Frias, M. L., Bermejo, E., Perez, B., Desviat, L. R., Castro, M., Leal, F., Mansilla, E., Martinez-Fernandez, M. L., Rodriguez-Pinilla, E., Rodriguez, L., and Ugarte, M. [Analysis of the frequencies of genotype combinations of 4 polymorphisms of genes acting on the folate cycle in the Spanish population]. Med Clin (Barc.) 6-21-2008;131(3):81-88. View Abstract
  524. Collin, S. M., Metcalfe, C., Zuccolo, L., Lewis, S. J., Chen, L., Cox, A., Davis, M., Lane, J. A., Donovan, J., Smith, G. D., Neal, D. E., Hamdy, F. C., Gudmundsson, J., Sulem, P., Rafnar, T., Benediktsdottir, K. R., Eeles, R. A., Guy, M., Kote-Jarai, Z., Morrison, J., Al Olama, A. A., Stefansson, K., Easton, D. F., and Martin, R. M. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol.Biomarkers Prev. 2009;18(9):2528-2539. View Abstract
  525. Vainer, A. S., Boiarskikh, U. A., Voronina, E. N., Selezneva, I. A., Sinkina, T. V., Lazarev, A. F., Petrova, V. D., and Filipenko, M. L. [Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia]. Mol.Biol.(Mosk) 2010;44(5):816-823. View Abstract
  526. Hu, J., Zhou, G. W., Wang, N., and Wang, Y. J. MTRR A66G polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;124(3):779-784. View Abstract
  527. Boccia, S., Hung, R., Ricciardi, G., Gianfagna, F., Ebert, M. P., Fang, J. Y., Gao, C. M., Gotze, T., Graziano, F., Lacasana-Navarro, M., Lin, D., Lopez-Carrillo, L., Qiao, Y. L., Shen, H., Stolzenberg-Solomon, R., Takezaki, T., Weng, Y. R., Zhang, F. F., van Duijn, C. M., Boffetta, P., and Taioli, E. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol. 3-1-2008;167(5):505-516. View Abstract
  528. Wang, J., Wang, B., Bi, J., and Di, J. The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011;128(1):203-209. View Abstract
  529. Koppen, I. J., Hermans, F. J., and Kaspers, G. J. Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol. 2010;148(1):3-14. View Abstract
  530. Wang, H., Wang, J., Zhao, L., Liu, X., and Mi, W. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC.Med.Genet. 2012;13:77. View Abstract
  531. Fang, Y., Xiao, F., An, Z., and Hao, L. Systematic review on the relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and esophageal squamous cell carcinoma. Asian Pac.J.Cancer Prev. 2011;12(7):1861-1866. View Abstract
  532. Liu, X. M., Liu, F. H., Tang, Y., and Li, Q. MTHFR C677T polymorphism and pancreatic cancer risk: a meta-analysis. Asian Pac.J.Cancer Prev. 2012;13(8):3763-3766. View Abstract
  533. Guo, L. N. Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis. Asian Pac.J.Cancer Prev. 2012;13(5):2193-2197. View Abstract
  534. Zhang, W. B., Zhang, J. H., Pan, Z. Q., Yang, Q. S., and Liu, B. The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls. Asian Pac.J.Cancer Prev. 2012;13(6):2597-2604. View Abstract
  535. Tukova, J., Chladek, J., Hroch, M., Nemcova, D., Hoza, J., and Dolezalova, P. 677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms. J Rheumatol 2010;37(10):2180-2186. View Abstract
  536. Castaldo, P., Magi, S., Nasti, A. A., Arcangeli, S., Lariccia, V., Alesi, N., Tocchini, M., and Amoroso, S. Clinical pharmacogenetics of methotrexate. Curr Drug Metab 2011;12(3):278-286. View Abstract
  537. Gilbody, S., Lewis, S., and Lightfoot, T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 1-1-2007;165(1):1-13. View Abstract
  538. Lewis, S. J., Lawlor, D. A., Davey, Smith G., Araya, R., Timpson, N., Day, I. N., and Ebrahim, S. The thermolabile variant of MTHFR is associated with depression in the British Women’s Heart and Health Study and a meta-analysis. Mol.Psychiatry 2006;11(4):352-360. View Abstract
  539. Kim, S. G., Song, J. Y., Joo, E. J., Jeong, S. H., Kim, S. H., Lee, K. Y., Lee, N. Y., Ahn, Y. M., Kim, Y. S., and Roh, M. S. No association of functional polymorphisms in methlylenetetrahydrofolate reductase and the risk and minor physical anomalies of schizophrenia in Korean population. J.Korean Med.Sci. 2011;26(10):1356-1363. View Abstract
  540. Rai, V. Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell Mol.Biol (Noisy.-le-grand) 2011;57 Suppl:OL1558-OL1566. View Abstract
  541. Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Dalla, Bernardina B., and Bonassi, S. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic.Biol.Med. 5-15-2012;52(10):2128-2141. View Abstract
  542. Gupta, N., Gupta, S., Dama, M., David, A., Khanna, G., Khanna, A., and Rajender, S. Strong association of 677 C>T substitution in the MTHFR gene with male infertility–a study on an indian population and a meta-analysis. PLoS.One. 2011;6(7):e22277. View Abstract
  543. Lewis, S. J., Ebrahim, S., and Davey, Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 11-5-2005;331(7524):1053. View Abstract
  544. Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., and Schouten, E. G. MTHFR 677C–>T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 10-23-2002;288(16):2023-2031. View Abstract
  545. Kluijtmans, L. A. and Whitehead, A. S. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J 2001;22(4):294-299. View Abstract
  546. Fohr, I. P., Prinz-Langenohl, R., Bronstrup, A., Bohlmann, A. M., Nau, H., Berthold, H. K., and Pietrzik, K. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 2002;75(2):275-282. View Abstract
  547. Liu, C. S., Chiang, H. C., and Chen, H. W. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease. Nutrition 2004;20(11-12):974-978. View Abstract
  548. Sharp, L., Miedzybrodzka, Z., Cardy, A. H., Inglis, J., Madrigal, L., Barker, S., Chesney, D., Clark, C., and Maffulli, N. The C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR), maternal use of folic acid supplements, and risk of isolated clubfoot: A case-parent-triad analysis. Am J Epidemiol. 11-1-2006;164(9):852-861. View Abstract
  549. Pan, Y., Zhang, W., Ma, J., Du, Y., Li, D., Cai, Q., Jiang, H., Wang, M., Zhang, Z., and Wang, L. Infants’ MTHFR polymorphisms and nonsyndromic orofacial clefts susceptibility: a meta-analysis based on 17 case-control studies. Am.J.Med.Genet.A 2012;158A(9):2162-2169. View Abstract
  550. Yin, M., Dong, L., Zheng, J., Zhang, H., Liu, J., and Xu, Z. Meta analysis of the association between MTHFR C677T polymorphism and the risk of congenital heart defects. Ann.Hum.Genet. 2012;76(1):9-16. View Abstract
  551. Nie, Y., Gu, H., Gong, J., Wang, J., Gong, D., Cong, X., Chen, X., and Hu, S. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis. Clin Chem.Lab Med. 2011;49(12):2101-2108. View Abstract
  552. Finnell, R. H., Shaw, G. M., Lammer, E. J., and Volcik, K. A. Does prenatal screening for 5,10-methylenetetrahydrofolate reductase (MTHFR) mutations in high-risk neural tube defect pregnancies make sense? Genet Test. 2002;6(1):47-52. View Abstract
  553. de, Franchis R., Buoninconti, A., Mandato, C., Pepe, A., Sperandeo, M. P., Del, Gado R., Capra, V., Salvaggio, E., Andria, G., and Mastroiacovo, P. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet. 1998;35(12):1009-1013. View Abstract
  554. Yan, L., Zhao, L., Long, Y., Zou, P., Ji, G., Gu, A., and Zhao, P. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PLoS.One. 2012;7(10):e41689. View Abstract
  555. Holmes, M. V., Newcombe, P., Hubacek, J. A., Sofat, R., Ricketts, S. L., Cooper, J., Breteler, M. M., Bautista, L. E., Sharma, P., Whittaker, J. C., Smeeth, L., Fowkes, F. G., Algra, A., Shmeleva, V., Szolnoki, Z., Roest, M., Linnebank, M., Zacho, J., Nalls, M. A., Singleton, A. B., Ferrucci, L., Hardy, J., Worrall, B. B., Rich, S. S., Matarin, M., Norman, P. E., Flicker, L., Almeida, O. P., van Bockxmeer, F. M., Shimokata, H., Khaw, K. T., Wareham, N. J., Bobak, M., Sterne, J. A., Smith, G. D., Talmud, P. J., van, Duijn C., Humphries, S. E., Price, J. F., Ebrahim, S., Lawlor, D. A., Hankey, G. J., Meschia, J. F., Sandhu, M. S., Hingorani, A. D., and Casas, J. P. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 8-13-2011;378(9791):584-594. View Abstract
  556. van Beynum, I. M., den, Heijer M., Blom, H. J., and Kapusta, L. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM. 2007;100(12):743-753. View Abstract
  557. Oussalah, A., Gueant, J. L., and Peyrin-Biroulet, L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment.Pharmacol.Ther 2011;34(10):1173-1184. View Abstract
  558. Wang, H. G., Wang, J. L., Zhang, J., Zhao, L. X., Zhai, G. X., Xiang, Y. Z., and Chang, P. Reduced folate carrier A80G polymorphism and susceptibility to neural tube defects: a meta-analysis. Gene 12-1-2012;510(2):180-184. View Abstract
  559. Winkels, R. M., Brouwer, I. A., Verhoef, P., van Oort, F. V., Durga, J., and Katan, M. B. Gender and body size affect the response of erythrocyte folate to folic acid treatment. J Nutr 2008;138(8):1456-1461. View Abstract
  560. Piyathilake, C. J., Celedonio, J. E., Macaluso, M., Bell, W. C., Azrad, M., and Grizzle, W. E. Mandatory fortification with folic acid in the United States is associated with increased expression of DNA methyltransferase-1 in the cervix. Nutrition 2008;24(1):94-99. View Abstract
  561. Karelin, A. A., Korotkina, R. N., Matskevich, G. N., Borisov, V. V., Vishnevskii, A. A., Polikarpova, L. V., and Kunitsyn, A. G. In vitro effects of folic acid on gamma-glutamyltransferase and glutathione reductase activities in malignant lung and thymus tumors. Bull.Exp.Biol Med. 2000;130(10):973-975. View Abstract
  562. Ubbink, J. B., Becker, P. J., and Vermaak, W. J. Will an increased dietary folate intake reduce the incidence of cardiovascular disease? Nutr Rev 1996;54(7):213-216. View Abstract
  563. Liu, Z., Luo, H., Zhang, L., Huang, Y., Liu, B., Ma, K., Feng, J., Xie, J., Zheng, J., Hu, J., Zhan, S., Zhu, Y., Xu, Q., Kong, W., and Wang, X. Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice. Circ.Res 10-26-2012;111(10):1261-1273. View Abstract
  564. Luhmann, D., Schramm, S., and Raspe, H. The role of Homocysteine as a predictor for coronary heart disease. GMS.Health Technol Assess. 2007;3:Doc11. View Abstract
  565. Carlsson, C. M. Lowering homocysteine for stroke prevention. Lancet 6-2-2007;369(9576):1841-1842. View Abstract
  566. Mahid, S. S., Minor, K. S., and Galandiuk, S. Folic acid supplementation and cardiovascular diseases. JAMA 4-11-2007;297(14):1549. View Abstract
  567. Nguyen, P., Grajeda, R., Melgar, P., Marcinkevage, J., Flores, R., and Martorell, R. Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women. J Nutr 2008;138(8):1491-1498. View Abstract
  568. Wald, D. S., Law, M., and Morris, J. K. The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening. Eur J Cardiovasc.Prev.Rehabil 2004;11(3):250-253. View Abstract
  569. Wald, D. S., Law, M., Morris, J., and Wald, N. J. Folate and risk of cardiovascular disease. Study results were misinterpreted. BMJ 5-10-2003;326(7397):1035. View Abstract
  570. Bellisarii, F. I., Gallina, S., Zimarino, M., and De, Caterina R. Mechanisms of nitrate tolerance: potential roles of folate. Eur J Clin Invest 2003;33(11):933-940. View Abstract
  571. Mignini, L. E., Latthe, P. M., Villar, J., Kilby, M. D., Carroli, G., and Khan, K. S. Mapping the theories of preeclampsia: the role of homocysteine. Obstet.Gynecol. 2005;105(2):411-425. View Abstract
  572. Wald, N. J., Law, M. R., Morris, J. K., and Wald, D. S. Quantifying the effect of folic acid. Lancet 12-15-2001;358(9298):2069-2073. View Abstract
  573. Busby, A., Abramsky, L., Dolk, H., Armstrong, B., Addor, M. C., Anneren, G., Armstrong, N., Baguette, A., Barisic, I., Berghold, A., Bianca, S., Braz, P., Calzolari, E., Christiansen, M., Cocchi, G., Daltveit, A. K., De, Walle H., Edwards, G., Gatt, M., Gener, B., Gillerot, Y., Gjergja, R., Goujard, J., Haeusler, M., Latos-Bielenska, A., McDonnell, R., Neville, A., Olars, B., Portillo, I., Ritvanen, A., Robert-Gnansia, E., Rosch, C., Scarano, G., and Steinbicker, V. Preventing neural tube defects in Europe: a missed opportunity. Reprod.Toxicol. 2005;20(3):393-402. View Abstract
  574. Joelson, D. W., Fiebig, E. W., and Wu, A. H. Diminished need for folate measurements among indigent populations in the post folic acid supplementation era. Arch Pathol.Lab Med 2007;131(3):477-480. View Abstract
  575. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morb.Mortal.Wkly.Rep 8-13-2010;59(31):980-984. View Abstract
  576. Robbins, J. M., Tilford, J. M., Bird, T. M., Cleves, M. A., Reading, J. A., and Hobbs, C. A. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid. Pediatrics 2006;118(3):906-915. View Abstract
  577. Heseker, H. B., Mason, J. B., Selhub, J., Rosenberg, I. H., and Jacques, P. F. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr 2009;102(2):173-180. View Abstract
  578. Lin, K. W. and Birmingham, E. Folic Acid for the prevention of neural tube defects. Am Fam.Physician 12-15-2010;82(12):1533. View Abstract
  579. Wolff, T., Witkop, C. T., Miller, T., and Syed, S. B. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann.Intern Med 5-5-2009;150(9):632-639. View Abstract
  580. Lantz, A. G., Edmundson, J. G., Kisely, S. R., and MacLellan, D. L. Sources of information for the use of periconceptual folic acid. Public Health 2010;124(4):238-240. View Abstract
  581. Koren, G., Klinger, G., and Ohlsson, A. Fetal pharmacotherapy. Drugs 2002;62(5):757-773. View Abstract
  582. McKillop, D. J., McNulty, H., Scott, J. M., McPartlin, J. M., Strain, J. J., Bradbury, I., Girvan, J., Hoey, L., McCreedy, R., Alexander, J., Patterson, B. K., Hannon-Fletcher, M., and Pentieva, K. The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation. Am J Clin Nutr 2006;84(1):167-173. View Abstract
  583. Wright, A. J., Finglas, P. M., Dainty, J. R., Hart, D. J., Wolfe, C. A., Southon, S., and Gregory, J. F. Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies. Br J Nutr 2003;90(2):363-371. View Abstract
  584. Verwei, M., van den Berg, H., Havenaar, R., and Groten, J. P. Effect of folate-binding protein on intestinal transport of folic acid and 5-methyltetrahydrofolate across Caco-2 cells. Eur J Nutr 2005;44(4):242-249. View Abstract
  585. Kalmbach, R. D., Choumenkovitch, S. F., Troen, A. P., Jacques, P. F., D’Agostino, R., and Selhub, J. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J Nutr 2008;138(12):2323-2327. View Abstract
  586. Winkels, R. M., Brouwer, I. A., Siebelink, E., Katan, M. B., and Verhoef, P. Bioavailability of food folates is 80% of that of folic acid. Am J Clin Nutr 2007;85(2):465-473. View Abstract
  587. Hartman-Craven, B., Christofides, A., O’Connor, D. L., and Zlotkin, S. Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women. BMC.Pregnancy Childbirth. 2009;9:33. View Abstract
  588. Melse-Boonstra, A., Verhoef, P., West, C. E., van Rhijn, J. A., van Breemen, R. B., Lasaroms, J. J., Garbis, S. D., Katan, M. B., and Kok, F. J. A dual-isotope-labeling method of studying the bioavailability of hexaglutamyl folic acid relative to that of monoglutamyl folic acid in humans by using multiple orally administered low doses. Am J Clin Nutr 2006;84(5):1128-1133. View Abstract
  589. Melse-Boonstra, A., Lievers, K. J., Blom, H. J., and Verhoef, P. Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. Am J Clin Nutr 2004;80(3):700-704. View Abstract
  590. Melse-Boonstra, A., West, C. E., Katan, M. B., Kok, F. J., and Verhoef, P. Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults. Am J Clin Nutr 2004;79(3):424-429. View Abstract
  591. Wright, A. J., King, M. J., Wolfe, C. A., Powers, H. J., and Finglas, P. M. Comparison of (6 S)-5-methyltetrahydrofolic acid v. folic acid as the reference folate in longer-term human dietary intervention studies assessing the relative bioavailability of natural food folates: comparative changes in folate status following a 16-week placebo-controlled study in healthy adults. Br J Nutr 2010;103(5):724-729. View Abstract
  592. Kalmbach, R. D., Choumenkovitch, S. F., Troen, A. M., D’Agostino, R., Jacques, P. F., and Selhub, J. Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr 2008;88(3):763-768. View Abstract
  593. Stites, T. E., Bailey, L. B., Scott, K. C., Toth, J. P., Fisher, W. P., and Gregory, J. F., III. Kinetic modeling of folate metabolism through use of chronic administration of deuterium-labeled folic acid in men. Am J Clin Nutr 1997;65(1):53-60. View Abstract
  594. Leblanc, M., Pichette, V., Geadah, D., and Ouimet, D. Folic acid and pyridoxal-5′-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation. J Ren Nutr 2000;10(4):196-201. View Abstract
  595. Shaw, G. M., Carmichael, S. L., Nelson, V., Selvin, S., and Schaffer, D. M. Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid. Public Health Rep 2004;119(2):170-173. View Abstract
  596. Mosley, B. S., Cleves, M. A., Siega-Riz, A. M., Shaw, G. M., Canfield, M. A., Waller, D. K., Werler, M. M., and Hobbs, C. A. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol. 1-1-2009;169(1):9-17. View Abstract
  597. Persad, V. L., Van den Hof, M. C., Dube, J. M., and Zimmer, P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ. 8-6-2002;167(3):241-245. View Abstract
  598. De, Wals P., Tairou, F., Van Allen, M. I., Uh, S. H., Lowry, R. B., Sibbald, B., Evans, J. A., Van den Hof, M. C., Zimmer, P., Crowley, M., Fernandez, B., Lee, N. S., and Niyonsenga, T. Reduction in neural-tube defects after folic acid fortification in Canada. N.Engl.J Med 7-12-2007;357(2):135-142. View Abstract
  599. Martinez de Villarreal, L. E., Arredondo, P., Hernandez, R., and Villarreal, J. Z. Weekly administration of folic acid and epidemiology of neural tube defects. Matern.Child Health J 2006;10(5):397-401. View Abstract
  600. Botto, L. D., Lisi, A., Robert-Gnansia, E., Erickson, J. D., Vollset, S. E., Mastroiacovo, P., Botting, B., Cocchi, G., de, Vigan C., De, Walle H., Feijoo, M., Irgens, L. M., McDonnell, B., Merlob, P., Ritvanen, A., Scarano, G., Siffel, C., Metneki, J., Stoll, C., Smithells, R., and Goujard, J. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 3-12-2005;330(7491):571. View Abstract
  601. Abeywardana, S., Bower, C., Halliday, J., Chan, A., and Sullivan, E. A. Prevalence of neural tube defects in Australia prior to mandatory fortification of bread-making flour with folic acid. Aust.N.Z J Public Health 2010;34(4):351-355. View Abstract
  602. Bentley, T. G., Willett, W. C., Weinstein, M. C., and Kuntz, K. M. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health 2006;96(11):2040-2047. View Abstract
  603. Quinlivan, E. P. and Gregory, J. F., III. Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 2007;86(6):1773-1779. View Abstract
  604. Bailey, R. L., Dodd, K. W., Gahche, J. J., Dwyer, J. T., McDowell, M. A., Yetley, E. A., Sempos, C. A., Burt, V. L., Radimer, K. L., and Picciano, M. F. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr 2010;91(1):231-237. View Abstract
  605. Trends in folic acid supplement intake among women of reproductive age–California, 2002-2006. MMWR Morb.Mortal.Wkly.Rep 10-26-2007;56(42):1106-1109. View Abstract
  606. Bower, C., Blum, L., O’Daly, K., Higgins, C., Loutsky, F., and Kosky, C. Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Aust.N.Z J Public Health 1997;21(7):716-721. View Abstract
  607. Trends in wheat-flour fortification with folic acid and iron–worldwide, 2004 and 2007. MMWR Morb.Mortal.Wkly.Rep 1-11-2008;57(1):8-10. View Abstract
  608. Alozie Arole, C. N., Puder, K. S., Reznar, M., Eby, E., and Zhu, B. P. Folic acid awareness in Michigan, 1996-1999. Obstet Gynecol. 2003;102(5 Pt 1):1046-1050. View Abstract
  609. Lawrence MA, Rutishauser IHE, and Lewis JL. Knowledge about folate and the contribution of nutrient supplements to the intake of folic acid and vitamin B12 in Australian adults in 1995 and 1996. AUST J NUTR DIET 2001;58(1):12-8.
  610. Mckeown S, Roberts C, and Tudor-Smith C. The folic acid campaign in Wales: changes in women’s knowledge from 1995 to 1997. HEALTH EDUC J 1998;57(4):374-384.
  611. de Jong-van den Berg LT, Hernandez-Diaz, S., Werler, M. M., Louik, C., and Mitchell, A. A. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol. 2005;192(1):121-128. View Abstract
  612. Relton C, Jackson A, and Burn J. Folic acid — changes in women’s knowledge. BR J MIDWIFERY 2003;11(7):438-441.
  613. Kadir, R. A., Sabin, C., Whitlow, B., Brockbank, E., and Economides, D. Neural tube defects and periconceptional folic acid in England and Wales: retrospective study. BMJ 7-10-1999;319(7202):92-93. View Abstract
  614. Green, R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am.J.Clin Nutr. 2011;94(2):666S-672S. View Abstract
  615. Halsted, C. H., Villanueva, J. A., Devlin, A. M., and Chandler, C. J. Metabolic interactions of alcohol and folate. J Nutr 2002;132(8 Suppl):2367S-2372S. View Abstract
  616. Esfahani, A., Wong, J. M., Truan, J., Villa, C. R., Mirrahimi, A., Srichaikul, K., and Kendall, C. W. Health effects of mixed fruit and vegetable concentrates: a systematic review of the clinical interventions. J.Am.Coll.Nutr. 2011;30(5):285-294. View Abstract
  617. Ganji, V. and Kafai, M. R. Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J Nutr 2009;139(2):345-352. View Abstract
  618. Ubbink, J. B., van der Merwe, A., Vermaak, W. J., and Delport, R. Hyperhomocysteinemia and the response to vitamin supplementation. Clin.Investig. 1993;71(12):993-998. View Abstract
  619. Ubbink, J. B., Vermaak, W. J., van der Merwe, A., Becker, P. J., Delport, R., and Potgieter, H. C. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124(10):1927-1933. View Abstract
  620. Dierkes J. Vitamin requirements for the reduction of homocysteine blood levels in healthy young women [dissertation]. Bonn: University of Bonn. 1995;
  621. Saltzman E, Mason JB, and Jacques PF. B-vitamin supplementation lowers homocysteine levels in heart disease. Clin Res 1994;42:172A.
  622. Landgren, F., Israelsson, B., Lindgren, A., Hultberg, B., Andersson, A., and Brattstrom, L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995;237(4):381-388. View Abstract
  623. Naurath, H. J., Joosten, E., Riezler, R., Stabler, S. P., Allen, R. H., and Lindenbaum, J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 7-8-1995;346(8967):85-89. View Abstract
  624. Cuskelly G, McNulty W, McPartlin J, Strain JJ, and Scott JM. Plasma homocysteine response to folate intervention in young women. Ir JMedSci 1995;164:3.
  625. Woodside, J. V., Yarnell, J. W., McMaster, D., Young, I. S., Harmon, D. L., McCrum, E. E., Patterson, C. C., Gey, K. F., Whitehead, A. S., and Evans, A. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. Am.J Clin.Nutr 1998;67(5):858-866. View Abstract
  626. den, Heijer M., Brouwer, I. A., Bos, G. M., Blom, H. J., van der Put, N. M., Spaans, A. P., Rosendaal, F. R., Thomas, C. M., Haak, H. L., Wijermans, P. W., and Gerrits, W. B. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler.Thromb.Vasc.Biol. 1998;18(3):356-361. View Abstract
  627. Schorah, C. J., Devitt, H., Lucock, M., and Dowell, A. C. The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur.J Clin.Nutr 1998;52(6):407-411. View Abstract
  628. Bronstrup A. Effects of single and combined B-vitamin supplementation on homocysteine concentrations in different population groups. Doctoral dissertation. University of Bonn, Bonn, Germany. 1998;
  629. Dierkes, J., Kroesen, M., and Pietrzik, K. Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women. Int J Vitam.Nutr Res. 1998;68(2):98-103. View Abstract
  630. MacMahon, M., Kirkpatrick, C., Cummings, C. E., Clayton, A., Robinson, P. J., Tomiak, R. H., Liu, M., Kush, D., and Tobert, J. A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH). Nutr Metab Cardiovasc.Dis. 2000;10(4):195-203. View Abstract
  631. Wald, D. S., Bishop, L., Wald, N. J., Law, M., Hennessy, E., Weir, D., McPartlin, J., and Scott, J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 3-12-2001;161(5):695-700. View Abstract
  632. Thambyrajah, J., Landray, M. J., Jones, H. J., McGlynn, F. J., Wheeler, D. C., and Townend, J. N. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J Am Coll Cardiol 6-1-2001;37(7):1858-1863. View Abstract
  633. Woodside JV, Yarnell JWG, Young IS, McCrum EE, Patterson CC, and Gey F. The effects of oral vitamin supplementation on cardiovascular risk factors. Roc Nutr Soc 1997;56:149.
  634. Brattstrom, L. E., Hardebo, J. E., and Hultberg, B. L. Moderate homocysteinemia–a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984;15(6):1012-1016. View Abstract
  635. Boers, G. H., Smals, A. G., Trijbels, F. J., Fowler, B., Bakkeren, J. A., Schoonderwaldt, H. C., Kleijer, W. J., and Kloppenborg, P. W. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N.Engl.J Med 9-19-1985;313(12):709-715. View Abstract
  636. Araki, A., Sako, Y., Fukushima, Y., Matsumoto, M., Asada, T., and Kita, T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989;79(2-3):139-146. View Abstract
  637. Brattstrom, L., Israelsson, B., Norrving, B., Bergqvist, D., Thorne, J., Hultberg, B., and Hamfelt, A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990;81(1):51-60. View Abstract
  638. Coull, B. M., Malinow, M. R., Beamer, N., Sexton, G., Nordt, F., and de, Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21(4):572-576. View Abstract
  639. Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., and Graham, I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N.Engl.J Med 4-25-1991;324(17):1149-1155. View Abstract
  640. Brattstrom, L., Lindgren, A., Israelsson, B., Malinow, M. R., Norrving, B., Upson, B., and Hamfelt, A. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992;22(3):214-221. View Abstract
  641. Dudman, N. P., Wilcken, D. E., Wang, J., Lynch, J. F., Macey, D., and Lundberg, P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler.Thromb. 1993;13(9):1253-1260. View Abstract
  642. Graham I. Interactions between homocysteinaemia and conventional risk factors in vascular disease. Eur Heart J 1994;15(suppl):530.
  643. Daly L and Graham I. Hyperhomocysteinaemia: a powerful risk factor for vascular disease. Presented at the Annual Scientific Meeting Working Group/ Epidemiology and Prevention of the European Society of Cardiology; Venice, Italy. 4-25-1994;
  644. Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkaniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., and Ehnholm, C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994;106(1):9-19. View Abstract
  645. Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., and Stampfer, M. J. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994;25(10):1924-1930. View Abstract
  646. Guttormsen, A. B., Ueland, P. M., Nesthus, I., Nygard, O., Schneede, J., Vollset, S. E., and Refsum, H. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin.Invest 11-1-1996;98(9):2174-2183. View Abstract
  647. Ward, M., McNulty, H., McPartlin, J., Strain, J. J., Weir, D. G., and Scott, J. M. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM. 1997;90(8):519-524. View Abstract
  648. Jacob, R. A., Wu, M. M., Henning, S. M., and Swendseid, M. E. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr 1994;124(7):1072-1080. View Abstract
  649. Franken, D. G., Boers, G. H., Blom, H. J., and Trijbels, J. M. Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinaemia in vascular patients. J Inherit.Metab Dis. 1994;17(1):159-162. View Abstract
  650. Franken, D. G., Boers, G. H., Blom, H. J., Trijbels, F. J., and Kloppenborg, P. W. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler.Thromb. 1994;14(3):465-470. View Abstract
  651. van den Berg, M., Franken, D. G., Boers, G. H., Blom, H. J., Jakobs, C., Stehouwer, C. D., and Rauwerda, J. A. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc.Surg. 1994;20(6):933-940. View Abstract
  652. Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W., and Rosenberg, I. H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N.Engl.J Med 5-13-1999;340(19):1449-1454. View Abstract
  653. Rimm, E. B., Willett, W. C., Hu, F. B., Sampson, L., Colditz, G. A., Manson, J. E., Hennekens, C., and Stampfer, M. J. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 2-4-1998;279(5):359-364. View Abstract
  654. Peterson, J. C. and Spence, J. D. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Lancet 1-24-1998;351(9098):263. View Abstract
  655. Wilcken, D. E. and Wilcken, B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit.Metab Dis. 1997;20(2):295-300. View Abstract
  656. Booth, G. L. and Wang, E. E. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ. 7-11-2000;163(1):21-29. View Abstract
  657. Ebbing, M., Bonaa, K. H., Arnesen, E., Ueland, P. M., Nordrehaug, J. E., Rasmussen, K., Njolstad, I., Nilsen, D. W., Refsum, H., Tverdal, A., Vollset, S. E., Schirmer, H., Bleie, O., Steigen, T., Midttun, O., Fredriksen, A., Pedersen, E. R., and Nygard, O. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern.Med 2010;268(4):367-382. View Abstract
  658. Bonaa, K. H., Njolstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., and Rasmussen, K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N.Engl.J Med 4-13-2006;354(15):1578-1588. View Abstract
  659. Ebbing, M., Bleie, O., Ueland, P. M., Nordrehaug, J. E., Nilsen, D. W., Vollset, S. E., Refsum, H., Pedersen, E. K., and Nygard, O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 8-20-2008;300(7):795-804. View Abstract
  660. Fishman, S. M., Christian, P., and West, K. P. The role of vitamins in the prevention and control of anaemia. Public Health Nutr 2000;3(2):125-150. View Abstract
  661. Burland, W. L., Simpson, K., and Lord, J. Response of low birthweight infant to treatment with folic acid. Arch.Dis.Child 1971;46(246):189-194. View Abstract
  662. Batu, A. T., Toe, T., Pe, H., and Nyunt, K. K. A prophylactic trial of iron and folic acid supplements in pregnant Burmese women. Isr.J.Med.Sci. 1976;12(12):1410-1417. View Abstract
  663. Srisupandit, S., Pootrakul, P., Areekul, S., Neungton, S., Mokkaves, J., Kiriwat, O., and Kanokpongsukdi, S. A prophylactic supplementation of iron and folate in pregnancy. Southeast Asian J Trop Med Public Health 1983;14(3):317-323. View Abstract
  664. Charoenlarp, P., Dhanamitta, S., Kaewvichit, R., Silprasert, A., Suwanaradd, C., Na-Nakorn, S., Prawatmuang, P., Vatanavicharn, S., Nutcharas, U., Pootrakul, P., and . A WHO collaborative study on iron supplementation in Burma and in Thailand. Am.J.Clin.Nutr. 1988;47(2):280-297. View Abstract
  665. Basu, R. N., Sood, S. K., Ramachandran, K., Mathur, M., and Ramalingaswami, V. Etiopathogenesis of nutritional anemia in pregnancy: a therapeutic approach. Am.J Clin.Nutr 1973;26(6):591-594. View Abstract
  666. Sood, S. K., Ramachandran, K., Mathur, M., Gupta, K., Ramalingaswamy, V., Swarnabai, C., Ponniah, J., Mathan, V. I., and Baker, S. J. W.H.O. sponsored collaborative studies on nutritional anaemia in India. 1. The effects of supplemental oral iron administration to pregnant women. Q.J.Med. 1975;44(174):241-258. View Abstract
  667. Iyengar, L. and Rajalakshmi, K. Effect of folic acid supplement on birth weights of infants. Am.J Obstet.Gynecol. 6-1-1975;122(3):332-336. View Abstract
  668. Iyengar, L. and Apte, S. V. Prophylaxis of anemia in pregnancy. Am.J Clin.Nutr 1970;23(6):725-730. View Abstract
  669. Osifo, B. O. The effect of folic acid and iron in the prevention of nutritional anaemias in pregnancy in Nigeria. Br J Nutr 1970;24(3):689-694. View Abstract
  670. Jackson, R. T. and Latham, M. C. Anemia of pregnancy in Liberia, West Africa: a therapeutic trial. Am.J Clin.Nutr 1982;35(4):710-714. View Abstract
  671. Fleming, A. F., Martin, J. D., Hahnel, R., and Westlake, A. J. Effects of iron and folic acid antenatal supplements on maternal haematology and fetal wellbeing. Med.J.Aust. 9-21-1974;2(12):429-436. View Abstract
  672. Colman, N., Larsen, J. V., Barker, M., Barker, E. A., Green, R., and Metz, J. Prevention of folate deficiency by food fortification. III. Effect in pregnant subjects of varying amounts of added folic acid. Am.J Clin.Nutr 1975;28(5):465-470. View Abstract
  673. Fleming, A. F., Ghatoura, G. B., Harrison, K. A., Briggs, N. D., and Dunn, D. T. The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria. Ann Trop Med Parasitol. 1986;80(2):211-233. View Abstract
  674. Tee, E. S., Kandiah, M., Awin, N., Chong, S. M., Satgunasingam, N., Kamarudin, L., Milani, S., Dugdale, A. E., and Viteri, F. E. School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls. Am.J.Clin.Nutr. 1999;69(6):1249-1256. View Abstract
  675. Areekul, S., Subcharoen, A., Cheeramakara, C., Srisukawat, K., and Limsuwan, S. Studies on the effect of folic acid supplement on folate and vitamin B12 status in children. Southeast Asian J Trop.Med Public Health 1980;11(1):81-86. View Abstract
  676. Kendall, A. C., Jones, E. E., Wilson, C. I., Shinton, N. K., and Elwood, P. C. Folic acid in low birthweight infants. Arch.Dis.Child 1974;49(9):736-738. View Abstract
  677. Roberts, P. M., Arrowsmith, D. E., Lloyd, A. V., and Monk-Jones, M. E. Effect of folic acid treatment on premature infants. Arch.Dis.Child 1972;47(254):631-634. View Abstract
  678. Stevens, D., Burman, D., Strelling, M. K., and Morris, A. Folic acid supplementation in low birth weight infants. Pediatrics 1979;64(3):333-335. View Abstract
  679. Worthington-White, D. A., Behnke, M., and Gross, S. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity. Am.J Clin.Nutr 1994;60(6):930-935. View Abstract
  680. Wald, N. J., Hackshaw, A. D., Stone, R., and Sourial, N. A. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol 1996;103(4):319-324. View Abstract
  681. Oakley, G. P., Jr. Folic acid-preventable spina bifida: a good start but much to be done. Am J Prev.Med 2010;38(5):569-570. View Abstract
  682. Oakley, G. P., Jr. The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle from epidemiology. Ann.Epidemiol. 2009;19(4):226-230. View Abstract
  683. Toriello, H. V. Policy statement on folic acid and neural tube defects. Genet.Med. 2011;13(6):593-596. View Abstract
  684. Lumley, J., Watson, L., Watson, M., and Bower, C. Modelling the potential impact of population-wide periconceptional folate/multivitamin supplementation on multiple births. BJOG. 2001;108(9):937-942. View Abstract
  685. Wang, Z. P., Shang, X. X., and Zhao, Z. T. Low maternal vitamin B(12) is a risk factor for neural tube defects: a meta-analysis. J.Matern.Fetal Neonatal Med. 2012;25(4):389-394. View Abstract
  686. Fruzzetti, F. Beyaz(R): an oral contraceptive fortified with folate. Womens Health (Lond Engl.) 2012;8(1):13-19. View Abstract
  687. Charles, D. H., Ness, A. R., Campbell, D., Smith, G. D., Whitley, E., and Hall, M. H. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr.Perinat.Epidemiol. 2005;19(2):112-124. View Abstract
  688. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 7-20-1991;338(8760):131-137. View Abstract
  689. Czeizel, A. E., Dudas, I., and Metneki, J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol.Obstet 1994;255(3):131-139. View Abstract
  690. Kirke, P. N., Daly, L. E., and Elwood, J. H. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis.Child 1992;67(12):1442-1446. View Abstract
  691. Laurence, K. M., James, N., Miller, M. H., Tennant, G. B., and Campbell, H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 5-9-1981;282(6275):1509-1511. View Abstract
  692. Czeizel, A. E., Dobo, M., and Vargha, P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol.Teratol. 2004;70(11):853-861. View Abstract
  693. Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., Mulinare, J., Zhao, P., Wong, L. Y., Gindler, J., Hong, S. X., and Correa, A. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N.Engl.J.Med. 11-11-1999;341(20):1485-1490. View Abstract
  694. Milunsky, A., Jick, H., Jick, S. S., Bruell, C. L., MacLaughlin, D. S., Rothman, K. J., and Willett, W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 11-24-1989;262(20):2847-2852. View Abstract
  695. Bower, C., D’Antoine, H., and Stanley, F. J. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Defects Res A Clin Mol.Teratol. 2009;85(4):269-273. View Abstract
  696. Calvo, E. B. and Biglieri, A. [Impact of folic acid fortification on women’s nutritional status and on the prevalence of neural tube defects]. Arch.Argent Pediatr. 2008;106(6):492-498. View Abstract
  697. Chen, B. H., Carmichael, S. L., Selvin, S., Abrams, B., and Shaw, G. M. NTD prevalences in central California before and after folic acid fortification. Birth Defects Res A Clin Mol.Teratol. 2008;82(8):547-552. View Abstract
  698. De, Wals P., Rusen, I. D., Lee, N. S., Morin, P., and Niyonsenga, T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol.Teratol. 2003;67(11):919-923. View Abstract
  699. Liu, S., West, R., Randell, E., Longerich, L., O’connor, K. S., Scott, H., Crowley, M., Lam, A., Prabhakaran, V., and McCourt, C. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC.Pregnancy.Childbirth. 9-27-2004;4(1):20. View Abstract
  700. Lopez-Camelo, J. S., Orioli, I. M., da Graca, Dutra M., Nazer-Herrera, J., Rivera, N., Ojeda, M. E., Canessa, A., Wettig, E., Fontannaz, A. M., Mellado, C., and Castilla, E. E. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am.J.Med.Genet.A 6-1-2005;135(2):120-125. View Abstract
  701. Sayed, A. R., Bourne, D., Pattinson, R., Nixon, J., and Henderson, B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol.Teratol. 2008;82(4):211-216. View Abstract
  702. Lumley, J., Watson, L., Watson, M., and Bower, C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane.Database.Syst.Rev 2001;(3):CD001056. View Abstract
  703. Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian J Med Res 2000;112:206-211. View Abstract
  704. Smithells, R. W., Sheppard, S., Schorah, C. J., Seller, M. J., Nevin, N. C., Harris, R., Read, A. P., and Fielding, D. W. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 2-16-1980;1(8164):339-340. View Abstract
  705. Smithells, R. W., Sheppard, S., Schorah, C. J., Seller, M. J., Nevin, N. C., Harris, R., Read, A. P., and Fielding, D. W. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch.Dis.Child 1981;56(12):911-918. View Abstract
  706. Smithells, R. W., Nevin, N. C., Seller, M. J., Sheppard, S., Harris, R., Read, A. P., Fielding, D. W., Walker, S., Schorah, C. J., and Wild, J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 5-7-1983;1(8332):1027-1031. View Abstract
  707. Holmes-Siedle M, Lindenbaum RH, and Galliard A. Vitamin supplementation and neural tube defects. Lancet 1982;1:275-276.
  708. Vergel, R. G., Sanchez, L. R., Heredero, B. L., Rodriguez, P. L., and Martinez, A. J. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat.Diagn. 1990;10(3):149-152. View Abstract
  709. Seller, M. J. and Nevin, N. C. Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet. 1984;21(5):325-330. View Abstract
  710. Czeizel, A. E. and Dudas, I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl.J Med 12-24-1992;327(26):1832-1835. View Abstract
  711. Jian, M., Wang, J., and Sun, H. [Meta-analysis of effect of intervention with folic acid on neural tube defects]. Wei Sheng Yan.Jiu. 2009;38(6):682-684. View Abstract
  712. Grosse, S. D. and Collins, J. S. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol.Teratol. 2007;79(11):737-742. View Abstract
  713. Smithells, R. W. Can vitamins prevent neural tube defects? Can.Med Assoc J 8-15-1984;131(4):273-4, 276. View Abstract
  714. Dean JH, Collins JS, and Clary NJ. Preventing the recurrence of neural tube defects in South Carolina. Proc Greenwood Genet Center 2007;26:40-44.
  715. Morse, N. L. Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation. Nutrients. 2012;4(7):799-840. View Abstract
  716. Chen, G., Song, X., Ji, Y., Zhang, L., Pei, L., Chen, J., Liu, J., Li, C., and Zheng, X. Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China. Birth Defects Res A Clin Mol.Teratol. 2008;82(8):592-596. View Abstract
  717. Goh, Y. I., Bollano, E., Einarson, T. R., and Koren, G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can. 2006;28(8):680-689. View Abstract
  718. Shaw, G. M., Schaffer, D., Velie, E. M., Morland, K., and Harris, J. A. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6(3):219-226. View Abstract
  719. Thompson, S. J., Torres, M. E., Stevenson, R. E., Dean, J. H., and Best, R. G. Periconceptional multivitamin folic acid use, dietary folate, total folate and risk of neural tube defects in South Carolina. Ann.Epidemiol. 2003;13(6):412-418. View Abstract
  720. Wilson, R. D., Davies, G., Desilets, V., Reid, G. J., Summers, A., Wyatt, P., and Young, D. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet.Gynaecol.Can. 2003;25(11):959-973. View Abstract
  721. Morgan, S. L., Baggott, J. E., Vaughn, W. H., Young, P. K., Austin, J. V., Krumdieck, C. L., and Alarcon, G. S. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 1990;33(1):9-18. View Abstract
  722. Weinblatt, M. E., Maier, A. L., and Coblyn, J. S. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 1993;20(6):950-952. View Abstract
  723. Shiroky, J. B., Neville, C., Esdaile, J. M., Choquette, D., Zummer, M., Hazeltine, M., Bykerk, V., Kanji, M., St-Pierre, A., Robidoux, L., and . Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 1993;36(6):795-803. View Abstract
  724. Salim, A., Tan, E., Ilchyshyn, A., and Berth-Jones, J. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 2006;154(6):1169-1174. View Abstract
  725. van Ede, A. E., Laan, R. F., Rood, M. J., Huizinga, T. W., van de Laar, M. A., van Denderen, C. J., Westgeest, T. A., Romme, T. C., de Rooij, D. J., Jacobs, M. J., de Boo, T. M., van der Wilt, G. J., Severens, J. L., Hartman, M., Krabbe, P. F., Dijkmans, B. A., Breedveld, F. C., and van de Putte, L. B. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2001;44(7):1515-1524. View Abstract
  726. Griffith, S. M., Fisher, J., Clarke, S., Montgomery, B., Jones, P. W., Saklatvala, J., Dawes, P. T., Shadforth, M. F., Hothersall, T. E., Hassell, A. B., and Hay, E. M. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology.(Oxford) 2000;39(10):1102-1109. View Abstract
  727. Morgan, S. L., Baggott, J. E., Vaughn, W. H., Austin, J. S., Veitch, T. A., Lee, J. Y., Koopman, W. J., Krumdieck, C. L., and Alarcon, G. S. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann.Intern Med 12-1-1994;121(11):833-841. View Abstract
  728. Joyce, D. A., Will, R. K., Hoffman, D. M., Laing, B., and Blackbourn, S. J. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann.Rheum.Dis. 1991;50(12):913-914. View Abstract
  729. Buckley, L. M., Vacek, P. M., and Cooper, S. M. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. J Rheumatol 1990;17(9):1158-1161. View Abstract
  730. Hanrahan, P. S. and Russell, A. S. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol 1988;15(7):1078-1080. View Abstract
  731. Dockerty, J. D., Herbison, P., Skegg, D. C., and Elwood, M. Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study. BMC.Public Health 2007;7:136. View Abstract
  732. Yakoob, M. Y. and Bhutta, Z. A. Effect of routine iron supplementation with or without folic acid on anemia during pregnancy. BMC Public Health 2011;11 Suppl 3:S21. View Abstract
  733. Bhutta, Z. A., Imdad, A., Ramakrishnan, U., and Martorell, R. Is it time to replace iron folate supplements in pregnancy with multiple micronutrients? Paediatr.Perinat.Epidemiol. 2012;26 Suppl 1:27-35. View Abstract
  734. Ramakrishnan, U., Goldenberg, T., and Allen, L. H. Do multiple micronutrient interventions improve child health, growth, and development? J.Nutr. 2011;141(11):2066-2075. View Abstract
  735. Kile, M. L. and Ronnenberg, A. G. Can folate intake reduce arsenic toxicity? Nutr Rev 2008;66(6):349-353. View Abstract
  736. Sachdev, P. S., Parslow, R. A., Lux, O., Salonikas, C., Wen, W., Naidoo, D., Christensen, H., and Jorm, A. F. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol.Med 2005;35(4):529-538. View Abstract
  737. Coppen, A., Chaudhry, S., and Swade, C. Folic acid enhances lithium prophylaxis. J.Affect.Disord. 1986;10(1):9-13. View Abstract
  738. Behzadi, A. H., Omrani, Z., Chalian, M., Asadi, S., and Ghadiri, M. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr.Scand. 2009;120(6):441-445. View Abstract
  739. Mayne, S. T., Ferrucci, L. M., and Cartmel, B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annu.Rev.Nutr. 8-21-2012;32:369-390. View Abstract
  740. Lazzeroni, M., Gandini, S., Puntoni, M., Bonanni, B., Gennari, A., and Decensi, A. The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. Breast 2011;20 Suppl 3:S36-S41. View Abstract
  741. Heimburger, D. C., Alexander, C. B., Birch, R., Butterworth, C. E., Jr., Bailey, W. C., and Krumdieck, C. L. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 3-11-1988;259(10):1525-1530. View Abstract
  742. Shen, H., Wei, Q., Pillow, P. C., Amos, C. I., Hong, W. K., and Spitz, M. R. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol.Biomarkers Prev. 2003;12(10):980-986. View Abstract
  743. Baker F, Picton D, and Blackwood S. Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial. Circulation 2002;(106):741S.
  744. Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C. H., and Stampfer, M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2-4-2004;291(5):565-575. View Abstract
  745. Jamison, R. L., Hartigan, P., Kaufman, J. S., Goldfarb, D. S., Warren, S. R., Guarino, P. D., and Gaziano, J. M. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 9-12-2007;298(10):1163-1170. View Abstract
  746. Chen, J., Gammon, M. D., Chan, W., Palomeque, C., Wetmur, J. G., Kabat, G. C., Teitelbaum, S. L., Britton, J. A., Terry, M. B., Neugut, A. I., and Santella, R. M. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2-15-2005;65(4):1606-1614. View Abstract
  747. Ma, E., Iwasaki, M., Junko, I., Hamada, G. S., Nishimoto, I. N., Carvalho, S. M., Motola, J., Jr., Laginha, F. M., and Tsugane, S. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC.Cancer 2009;9:122. View Abstract
  748. Ma, E., Iwasaki, M., Kobayashi, M., Kasuga, Y., Yokoyama, S., Onuma, H., Nishimura, H., Kusama, R., and Tsugane, S. Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer 2009;61(4):447-456. View Abstract
  749. Sharp, L., Little, J., Schofield, A. C., Pavlidou, E., Cotton, S. C., Miedzybrodzka, Z., Baird, J. O., Haites, N. E., Heys, S. D., and Grubb, D. A. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett. 7-8-2002;181(1):65-71. View Abstract
  750. Chou, Y. C., Wu, M. H., Yu, J. C., Lee, M. S., Yang, T., Shih, H. L., Wu, T. Y., and Sun, C. A. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 2006;27(11):2295-2300. View Abstract
  751. Suzuki, T., Matsuo, K., Hirose, K., Hiraki, A., Kawase, T., Watanabe, M., Yamashita, T., Iwata, H., and Tajima, K. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008;29(2):356-362. View Abstract
  752. Levi, F., Pasche, C., Lucchini, F., and La Vecchia, C. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 2001;91(2):260-263.
  753. Shrubsole, M. J., Jin, F., Dai, Q., Shu, X. O., Potter, J. D., Hebert, J. R., Gao, Y. T., and Zheng, W. Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res 10-1-2001;61(19):7136-7141. View Abstract
  754. Lajous, M., Lazcano-Ponce, E., Hernandez-Avila, M., Willett, W., and Romieu, I. Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women. Cancer Epidemiol.Biomarkers Prev. 2006;15(3):443-448. View Abstract
  755. Beilby, J., Ingram, D., Hahnel, R., and Rossi, E. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur.J.Cancer 2004;40(8):1250-1254. View Abstract
  756. Shrubsole, M. J., Gao, Y. T., Cai, Q., Shu, X. O., Dai, Q., Hebert, J. R., Jin, F., and Zheng, W. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol.Biomarkers Prev. 2004;13(2):190-196. View Abstract
  757. Shrubsole, M. J., Gao, Y. T., Cai, Q., Shu, X. O., Dai, Q., Jin, F., and Zheng, W. MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol.Biomarkers Prev. 2006;15(3):586-588. View Abstract
  758. Zhu, K., Davidson, N. E., Hunter, S., Yang, X., Payne-Wilks, K., Roland, C. L., Phillips, D., Bentley, C., Dai, M., and Williams, S. M. Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes. Cancer Causes Control 2003;14(9):827-836. View Abstract
  759. Adzersen, K. H., Jess, P., Freivogel, K. W., Gerhard, I., and Bastert, G. Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany. Nutr.Cancer 2003;46(2):131-137. View Abstract
  760. Rohan, T. E., Jain, M. G., Howe, G. R., and Miller, A. B. Dietary folate consumption and breast cancer risk. J Natl.Cancer Inst. 2-2-2000;92(3):266-269. View Abstract
  761. Tjonneland, A., Christensen, J., Olsen, A., Stripp, C., Nissen, S. B., Overvad, K., and Thomsen, B. L. Folate intake, alcohol and risk of breast cancer among postmenopausal women in Denmark. Eur.J.Clin Nutr. 2006;60(2):280-286. View Abstract
  762. Zhang, S. M., Willett, W. C., Selhub, J., Hunter, D. J., Giovannucci, E. L., Holmes, M. D., Colditz, G. A., and Hankinson, S. E. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J.Natl.Cancer Inst. 3-5-2003;95(5):373-380. View Abstract
  763. Lin, J., Lee, I. M., Song, Y., Cook, N. R., Selhub, J., Manson, J. E., Buring, J. E., and Zhang, S. M. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res 3-15-2010;70(6):2397-2405. View Abstract
  764. Ericson, U., Sonestedt, E., Ivarsson, M. I., Gullberg, B., Carlson, J., Olsson, H., and Wirfalt, E. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol.Biomarkers Prev. 2009;18(4):1101-1110. View Abstract
  765. Ericson, U. C., Ivarsson, M. I., Sonestedt, E., Gullberg, B., Carlson, J., Olsson, H., and Wirfalt, E. Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am.J.Clin Nutr. 2009;90(5):1380-1389. View Abstract
  766. Ericson, U., Borgquist, S., Ivarsson, M. I., Sonestedt, E., Gullberg, B., Carlson, J., Olsson, H., Jirstrom, K., and Wirfalt, E. Plasma folate concentrations are positively associated with risk of estrogen receptor beta negative breast cancer in a Swedish nested case control study. J.Nutr. 2010;140(9):1661-1668. View Abstract
  767. Maruti, S. S., Ulrich, C. M., and White, E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am.J.Clin Nutr. 2009;89(2):624-633. View Abstract
  768. Sellers, T. A., Alberts, S. R., Vierkant, R. A., Grabrick, D. M., Cerhan, J. R., Vachon, C. M., Olson, J. E., Kushi, L. H., and Potter, J. D. High-folate diets and breast cancer survival in a prospective cohort study. Nutr.Cancer 2002;44(2):139-144. View Abstract
  769. Sellers, T. A., Kushi, L. H., Cerhan, J. R., Vierkant, R. A., Gapstur, S. M., Vachon, C. M., Olson, J. E., Therneau, T. M., and Folsom, A. R. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001;12(4):420-428. View Abstract
  770. Cho, E., Spiegelman, D., Hunter, D. J., Chen, W. Y., Zhang, S. M., Colditz, G. A., and Willett, W. C. Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epidemiol.Biomarkers Prev. 2003;12(8):713-720. View Abstract
  771. Feigelson, H. S., Jonas, C. R., Robertson, A. S., McCullough, M. L., Thun, M. J., and Calle, E. E. Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol.Biomarkers Prev. 2003;12(2):161-164. View Abstract
  772. Stolzenberg-Solomon, R. Z., Chang, S. C., Leitzmann, M. F., Johnson, K. A., Johnson, C., Buys, S. S., Hoover, R. N., and Ziegler, R. G. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am.J.Clin Nutr. 2006;83(4):895-904. View Abstract
  773. Kabat, G. C., Miller, A. B., Jain, M., and Rohan, T. E. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br.J.Cancer 9-2-2008;99(5):816-821. View Abstract
  774. Duffy, C. M., Assaf, A., Cyr, M., Burkholder, G., Coccio, E., Rohan, T., McTiernan, A., Paskett, E., Lane, D., and Chetty, V. K. Alcohol and folate intake and breast cancer risk in the WHI Observational Study. Breast Cancer Res Treat. 2009;116(3):551-562. View Abstract
  775. Larsson, S. C., Bergkvist, L., and Wolk, A. Folate intake and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Epidemiol.Biomarkers Prev. 2008;17(12):3444-3449. View Abstract
  776. Roswall, N., Olsen, A., Christensen, J., Dragsted, L. O., Overvad, K., and Tjonneland, A. Micronutrient intake and breast cancer characteristics among postmenopausal women. Eur.J.Cancer Prev. 2010;19(5):360-365. View Abstract
  777. Ericson, U., Sonestedt, E., Gullberg, B., Olsson, H., and Wirfalt, E. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am.J.Clin Nutr. 2007;86(2):434-443. View Abstract
  778. Rossi, E., Hung, J., Beilby, J. P., Knuiman, M. W., Divitini, M. L., and Bartholomew, H. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann.Epidemiol. 2006;16(3):206-212. View Abstract
  779. Stevens, V. L., McCullough, M. L., Sun, J., and Gapstur, S. M. Folate and other one-carbon metabolism-related nutrients and risk of postmenopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort. Am.J.Clin Nutr. 2010;91(6):1708-1715. View Abstract
  780. Lajous, M., Romieu, I., Sabia, S., Boutron-Ruault, M. C., and Clavel-Chapelon, F. Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women. Cancer Causes Control 2006;17(9):1209-1213. View Abstract
  781. Baglietto, L., English, D. R., Gertig, D. M., Hopper, J. L., and Giles, G. G. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. BMJ 10-8-2005;331(7520):807. View Abstract
  782. Bao, Y., Michaud, D. S., Spiegelman, D., Albanes, D., Anderson, K. E., Bernstein, L., van den Brandt, P. A., English, D. R., Freudenheim, J. L., Fuchs, C. S., Giles, G. G., Giovannucci, E., Goldbohm, R. A., Hakansson, N., Horn-Ross, P. L., Jacobs, E. J., Kitahara, C. M., Marshall, J. R., Miller, A. B., Robien, K., Rohan, T. E., Schatzkin, A., Stevens, V. L., Stolzenberg-Solomon, R. Z., Virtamo, J., Wolk, A., Ziegler, R. G., and Smith-Warner, S. A. Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies. J.Natl.Cancer Inst. 12-21-2011;103(24):1840-1850. View Abstract
  783. Clarke, R., Lewington, S., and Landray, M. Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int Suppl 2003;(84):S131-S133. View Abstract
  784. Connor, S. L., Ojeda, L. S., Sexton, G., Weidner, G., and Connor, W. E. Diets lower in folic acid and carotenoids are associated with the coronary disease epidemic in Central and Eastern Europe. J Am Diet Assoc 2004;104(12):1793-1799. View Abstract
  785. Wang, Z. M., Zhou, B., Nie, Z. L., Gao, W., Wang, Y. S., Zhao, H., Zhu, J., Yan, J. J., Yang, Z. J., and Wang, L. S. Folate and risk of coronary heart disease: a meta-analysis of prospective studies. Nutr.Metab Cardiovasc.Dis. 2012;22(10):890-899. View Abstract
  786. Debreceni, B. and Debreceni, L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc.Ther. 2012;30(4):227-233. View Abstract
  787. Austen, S. K., Fassett, R. G., Geraghty, D. P., and Coombes, J. S. Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients. Clin Nephrol. 2006;66(5):373-379. View Abstract
  788. Zoungas, S., McGrath, B. P., Branley, P., Kerr, P. G., Muske, C., Wolfe, R., Atkins, R. C., Nicholls, K., Fraenkel, M., Hutchison, B. G., Walker, R., and McNeil, J. J. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol 3-21-2006;47(6):1108-1116. View Abstract
  789. Vianna, A. C., Mocelin, A. J., Matsuo, T., Morais-Filho, D., Largura, A., Delfino, V. A., Soares, A. E., and Matni, A. M. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Hemodial.Int 2007;11(2):210-216. View Abstract
  790. Fernandez-Miranda, C., Yebra, M., Aranda, J. L., Gomez, P., Martinez, J., Nunez, V., and Gomez, de la Camara. Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease. Int J Cardiol 6-12-2007;118(3):345-349. View Abstract
  791. Nafar, M., Khatami, F., Kardavani, B., Farjad, R., Pour-Reza-Gholi, F., Firouzan, A., Kalantar, A., Farhangi, S., and Einollahi, B. Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial. Exp.Clin Transplant. 2009;7(1):33-39. View Abstract
  792. Ntaios, G., Savopoulos, C., Karamitsos, D., Economou, I., Destanis, E., Chryssogonidis, I., Pidonia, I., Zebekakis, P., Polatides, C., Sion, M., Grekas, D., and Hatzitolios, A. The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial. Int.J.Cardiol. 8-6-2010;143(1):16-19. View Abstract
  793. Durga, J., Bots, M. L., Schouten, E. G., Grobbee, D. E., Kok, F. J., and Verhoef, P. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am.J.Clin Nutr. 2011;93(5):941-949. View Abstract
  794. Marcucci, R., Zanazzi, M., Bertoni, E., Rosati, A., Fedi, S., Lenti, M., Prisco, D., Castellani, S., Abbate, R., and Salvadori, M. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients. Transplantation 5-15-2003;75(9):1551-1555. View Abstract
  795. Till, U., Rohl, P., Jentsch, A., Till, H., Muller, A., Bellstedt, K., Plonne, D., Fink, H. S., Vollandt, R., Sliwka, U., Herrmann, F. H., Petermann, H., and Riezler, R. Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12. Atherosclerosis 2005;181(1):131-135. View Abstract
  796. Hodis, H. N., Mack, W. J., Dustin, L., Mahrer, P. R., Azen, S. P., Detrano, R., Selhub, J., Alaupovic, P., Liu, C. R., Liu, C. H., Hwang, J., Wilcox, A. G., and Selzer, R. H. High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke 2009;40(3):730-736. View Abstract
  797. Mark, S. D., Wang, W., Fraumeni, J. F., Jr., Li, J. Y., Taylor, P. R., Wang, G. Q., Guo, W., Dawsey, S. M., Li, B., and Blot, W. J. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial. Am.J.Epidemiol. 4-1-1996;143(7):658-664. View Abstract
  798. Righetti, M., Ferrario, G. M., Milani, S., Serbelloni, P., La, Rosa L., Uccellini, M., and Sessa, A. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients. Med Sci Monit. 2003;9(4):I19-I24. View Abstract
  799. Righetti, M., Serbelloni, P., Milani, S., and Ferrario, G. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Blood Purif. 2006;24(4):379-386. View Abstract
  800. Lange, H., Suryapranata, H., De, Luca G., Borner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., and Dambrink, J. H. Folate therapy and in-stent restenosis after coronary stenting. N.Engl.J Med 6-24-2004;350(26):2673-2681. View Abstract
  801. Liem, A. H., van Boven, A. J., Veeger, N. J., Withagen, A. J., Robles de Medina, R. M., Tijssen, J. G., and van Veldhuisen, D. J. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol 2004;93(2-3):175-179. View Abstract
  802. Liem, A., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., and van Veldhuisen, D. J. Secondary prevention with folic acid: results of the Goes extension study. Heart 2005;91(9):1213-1214. View Abstract
  803. Wrone, E. M., Hornberger, J. M., Zehnder, J. L., McCann, L. M., Coplon, N. S., and Fortmann, S. P. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J.Am.Soc.Nephrol. 2004;15(2):420-426. View Abstract
  804. Potena, L., Grigioni, F., Masetti, M., Magnani, G., Coccolo, F., Fallani, F., Russo, A., Pizzuti, M., Scalone, A., Bianchi, I. G., and Branzi, A. Long-term effect of folic acid therapy in heart transplant recipients: follow-up analysis of a randomized study. Transplantation 4-27-2008;85(8):1146-1150. View Abstract
  805. Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., and Hercberg, S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010;341:c6273. View Abstract
  806. Bostom, A. G., Carpenter, M. A., Kusek, J. W., Levey, A. S., Hunsicker, L., Pfeffer, M. A., Selhub, J., Jacques, P. F., Cole, E., Gravens-Mueller, L., House, A. A., Kew, C., McKenney, J. L., Pacheco-Silva, A., Pesavento, T., Pirsch, J., Smith, S., Solomon, S., and Weir, M. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation 4-26-2011;123(16):1763-1770. View Abstract
  807. Imasa, M. S., Gomez, N. T., and Nevado, J. B., Jr. Folic acid-based intervention in non-ST elevation acute coronary syndromes. Asian Cardiovasc.Thorac.Ann. 2009;17(1):13-21. View Abstract
  808. House, A. A., Eliasziw, M., Cattran, D. C., Churchill, D. N., Oliver, M. J., Fine, A., Dresser, G. K., and Spence, J. D. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 4-28-2010;303(16):1603-1609. View Abstract
  809. Heinz, J., Kropf, S., Domrose, U., Westphal, S., Borucki, K., Luley, C., Neumann, K. H., and Dierkes, J. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation 3-30-2010;121(12):1432-1438. View Abstract
  810. Wald, D. S., Morris, J. K., and Wald, N. J. Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PLoS.One. 2011;6(2):e16473. View Abstract
  811. Mei, W., Rong, Y., Jinming, L., Yongjun, L., and Hui, Z. Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials. Int J Clin Pract. 2010;64(2):208-215. View Abstract
  812. den, Heijer M., Willems, H. P., Blom, H. J., Gerrits, W. B., Cattaneo, M., Eichinger, S., Rosendaal, F. R., and Bos, G. M. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood 1-1-2007;109(1):139-144. View Abstract
  813. Bowman, L., Armitage, J., Bulbulia, R., Parish, S., and Collins, R. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors. Am Heart J 2007;154(5):815-23, 823. View Abstract
  814. Mann, J. F., Sheridan, P., McQueen, M. J., Held, C., Arnold, J. M., Fodor, G., Yusuf, S., and Lonn, E. M. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease–results of the renal Hope-2 study. Nephrol.Dial.Transplant. 2008;23(2):645-653. View Abstract
  815. Marta E, øyvind B, and Per MU. Mortality and cardiovascular events in patients treated with homocysteine-liowering B vitamins after coronary angiography. JAMA 2008;300:795-804.
  816. Miller, E. R., III, Juraschek, S., Pastor-Barriuso, R., Bazzano, L. A., Appel, L. J., and Guallar, E. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol 8-15-2010;106(4):517-527. View Abstract
  817. Collins R. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): randomized comparison of folic acid 2 mg plus vitamin B12 1mg daily versus placebo for 7 years in 12,064 myocardial infarction survivors. Presented at a meeting of the American Heart Association, late breaking trials; New Orleans. 11-9-2008;
  818. Marti-Carvajal, A. J., Sola, I., Lathyris, D., and Salanti, G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane.Database.Syst.Rev 2009;(4):CD006612. View Abstract
  819. Liem, A., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., and van Veldhuisen, D. J. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 6-18-2003;41(12):2105-2113. View Abstract
  820. Woo, K. S., Chook, P., Lolin, Y. I., Sanderson, J. E., Metreweli, C., and Celermajer, D. S. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999;34(7):2002-2006. View Abstract
  821. Chambers, J. C., Ueland, P. M., Obeid, O. A., Wrigley, J., Refsum, H., and Kooner, J. S. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 11-14-2000;102(20):2479-2483. View Abstract
  822. Title, L. M., Ur, E., Giddens, K., McQueen, M. J., and Nassar, B. A. Folic acid improves endothelial dysfunction in type 2 diabetes–an effect independent of homocysteine-lowering. Vasc.Med 2006;11(2):101-109. View Abstract
  823. Lekakis, J. P., Papamichael, C. M., Papaioannou, T. G., Dagre, A. G., Stamatelopoulos, K. S., Tryfonopoulos, D., Protogerou, A. D., Stamatelopoulos, S. F., and Mavrikakis, M. Oral folic acid enhances endothelial function in patients with hypercholesterolaemia receiving statins. Eur J Cardiovasc.Prev.Rehabil 2004;11(5):416-420. View Abstract
  824. Dinckal, M. H., Aksoy, N., Aksoy, M., Davutoglu, V., Soydinc, S., Kirilmaz, A., Dinckal, N., and Akdemir, I. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia. Acta Cardiol 2003;58(5):389-396. View Abstract
  825. Sydow, K., Schwedhelm, E., Arakawa, N., Bode-Boger, S. M., Tsikas, D., Hornig, B., Frolich, J. C., and Boger, R. H. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc.Res 2003;57(1):244-252. View Abstract
  826. Bennett-Richards, K., Kattenhorn, M., Donald, A., Oakley, G., Varghese, Z., Rees, L., and Deanfield, J. E. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 4-16-2002;105(15):1810-1815. View Abstract
  827. Olthof, M. R., Bots, M. L., Katan, M. B., and Verhoef, P. Effect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteers. PLoS.Clin Trials 2006;1(2):e10. View Abstract
  828. Hirsch, S., Pia, De la Maza, Yanez, P., Glasinovic, A., Petermann, M., Barrera, G., Gattas, V., Escobar, E., and Bunout, D. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation. Clin Cardiol 2002;25(11):495-501. View Abstract
  829. Woodman, R. J., Celermajer, D. E., Thompson, P. L., and Hung, J. Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects. Clin Sci (Lond) 2004;106(4):353-358. View Abstract
  830. MacKenzie, K. E., Wiltshire, E. J., Gent, R., Hirte, C., Piotto, L., and Couper, J. J. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006;118(1):242-253. View Abstract
  831. Carlsson, C. M., Pharo, L. M., Aeschlimann, S. E., Mitchell, C., Underbakke, G., and Stein, J. H. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults. Am Heart J 2004;148(3):E11. View Abstract
  832. van Dijk, R. A., Rauwerda, J. A., Steyn, M., Twisk, J. W., and Stehouwer, C. D. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler.Thromb.Vasc.Biol. 2001;21(12):2072-2079. View Abstract
  833. de, Bree A., van Mierlo, L. A., and Draijer, R. Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2007;86(3):610-617. View Abstract
  834. Bellamy, M. F., McDowell, I. F., Ramsey, M. W., Brownlee, M., Newcombe, R. G., and Lewis, M. J. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest 1999;29(8):659-662. View Abstract
  835. Pullin, C. H., Ashfield-Watt, P. A., Burr, M. L., Clark, Z. E., Lewis, M. J., Moat, S. J., Newcombe, R. G., Powers, H. J., Whiting, J. M., and McDowell, I. F. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 2001;38(7):1799-1805. View Abstract
  836. Doshi, S. N., McDowell, I. F., Moat, S. J., Lang, D., Newcombe, R. G., Kredan, M. B., Lewis, M. J., and Goodfellow, J. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler.Thromb.Vasc.Biol. 2001;21(7):1196-1202. View Abstract
  837. Doshi, S. N., McDowell, I. F., Moat, S. J., Payne, N., Durrant, H. J., Lewis, M. J., and Goodfellow, J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 1-1-2002;105(1):22-26. View Abstract
  838. Bazzano, L. A., Reynolds, K., Holder, K. N., and He, J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 12-13-2006;296(22):2720-2726. View Abstract
  839. Bleys, J., Miller, E. R., III, Pastor-Barriuso, R., Appel, L. J., and Guallar, E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am.J Clin.Nutr 2006;84(4):880-887. View Abstract
  840. Spence, J. D., Blake, C., Landry, A., and Fenster, A. Measurement of carotid plaque and effect of vitamin therapy for total homocysteine. Clin.Chem.Lab Med 2003;41(11):1498-1504. View Abstract
  841. Potena, L., Grigioni, F., Magnani, G., Ortolani, P., Coccolo, F., Sassi, S., Kessels, K., Marrozzini, C., Marzocchi, A., Carigi, S., Musuraca, A. C., Russo, A., Magelli, C., and Branzi, A. Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. Am.J Transplant. 2005;5(9):2258-2264. View Abstract
  842. Khandanpour, N., Loke, Y. K., Meyer, F. J., Jennings, B., and Armon, M. P. Homocysteine and peripheral arterial disease: systematic review and meta-analysis. Eur J Vasc.Endovasc.Surg 2009;38(3):316-322. View Abstract
  843. Mayer, O., Filipovsky, J., Hromadka, M., Svobodova, V., Racek, J., Mayer, O., Jr., Stehlik, P., Trefil, L., and Zarybnicka, M. Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markers. J Cardiovasc.Pharmacol. 2002;39(6):851-857. View Abstract
  844. Carrero, J. J., Lopez-Huertas, E., Salmeron, L. M., Baro, L., and Ros, E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J.Nutr. 2005;135(6):1393-1399. View Abstract
  845. Ziegler, S., Mittermayer, F., Plank, C., Minar, E., Wolzt, M., and Schernthaner, G. H. Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease. J Clin Endocrinol.Metab 2005;90(4):2175-2178. View Abstract
  846. Schernthaner, G. H., Plank, C., Minar, E., Bieglmayer, C., Koppensteiner, R., and Schernthaner, G. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 2006;36(5):333-339. View Abstract
  847. Jacobson, W., Saich, T., Borysiewicz, L. K., Behan, W. M., Behan, P. O., and Wreghitt, T. G. Serum folate and chronic fatigue syndrome. Neurology 1993;43(12):2645-2647. View Abstract
  848. Kaslow, J. E., Rucker, L., and Onishi, R. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 1989;149(11):2501-2503. View Abstract
  849. Ellinson, M., Thomas, J., and Patterson, A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 2004;17(4):371-383. View Abstract
  850. Raman, G., Tatsioni, A., Chung, M., Rosenberg, I. H., Lau, J., Lichtenstein, A. H., and Balk, E. M. Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr 2007;137(7):1789-1794. View Abstract
  851. Mooijaart, S. P., Gussekloo, J., Frolich, M., Jolles, J., Stott, D. J., Westendorp, R. G., and de Craen, A. J. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr 2005;82(4):866-871. View Abstract
  852. Morris, M. C. Nutritional determinants of cognitive aging and dementia. Proc.Nutr.Soc. 2012;71(1):1-13. View Abstract
  853. Skorka, A., Gieruszczak-Bialek, D., Piescik, M., and Szajewska, H. Effects of prenatal and/or postnatal (maternal and/or child) folic acid supplementation on the mental performance of children. Crit Rev.Food Sci.Nutr. 2012;52(11):959-964. View Abstract
  854. Fioravanti, M., Ferrario, E., Massaia, M., Cappa, G., Rivolta, G., Grossi, E., and Buckley, A. E. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch.Gerontol.Geriatr. 1998;26(1):1-13. View Abstract
  855. Bryan, J., Calvaresi, E., and Hughes, D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 2002;132(6):1345-1356. View Abstract
  856. Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., and Verhoef, P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 1-20-2007;369(9557):208-216. View Abstract
  857. Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., van Dyck, C. H., Weiner, M. F., Bottiglieri, T., Jin, S., Stokes, K. T., Thomas, R. G., and Thal, L. J. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 10-15-2008;300(15):1774-1783. View Abstract
  858. Clarke, R., Harrison, G., and Richards, S. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern.Med 2003;254(1):67-75. View Abstract
  859. de Jager, C. A., Oulhaj, A., Jacoby, R., Refsum, H., and Smith, A. D. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int.J.Geriatr.Psychiatry 2012;27(6):592-600. View Abstract
  860. Kwok, T., Lee, J., Law, C. B., Pan, P. C., Yung, C. Y., Choi, K. C., and Lam, L. C. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr. 2011;30(3):297-302. View Abstract
  861. Kang, J. H., Cook, N., Manson, J., Buring, J. E., Albert, C. M., and Grodstein, F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am.J.Clin.Nutr. 2008;88(6):1602-1610. View Abstract
  862. Lewerin, C., Matousek, M., Steen, G., Johansson, B., Steen, B., and Nilsson-Ehle, H. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am.J Clin.Nutr 2005;81(5):1155-1162. View Abstract
  863. McMahon, J. A., Green, T. J., Skeaff, C. M., Knight, R. G., Mann, J. I., and Williams, S. M. A controlled trial of homocysteine lowering and cognitive performance. N.Engl.J Med 6-29-2006;354(26):2764-2772. View Abstract
  864. Stott, D. J., MacIntosh, G., Lowe, G. D., Rumley, A., McMahon, A. D., Langhorne, P., Tait, R. C., O’Reilly, D. S., Spilg, E. G., MacDonald, J. B., MacFarlane, P. W., and Westendorp, R. G. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am.J Clin.Nutr 2005;82(6):1320-1326. View Abstract
  865. Wald, D. S., Kasturiratne, A., and Simmonds, M. Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med 2010;123(6):522-527. View Abstract
  866. McNeill, G., Avenell, A., Campbell, M. K., Cook, J. A., Hannaford, P. C., Kilonzo, M. M., Milne, A. C., Ramsay, C. R., Seymour, D. G., Stephen, A. I., and Vale, L. D. Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial. Nutr J 2007;6:10. View Abstract
  867. Malouf, R. and Grimley, Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane.Database.Syst.Rev 2008;(4):CD004514. View Abstract
  868. Sommer, B. R., Hoff, A. L., and Costa, M. Folic acid supplementation in dementia: a preliminary report. J Geriatr.Psychiatry Neurol. 2003;16(3):156-159. View Abstract
  869. Malouf, M., Grimley, E. J., and Areosa, S. A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane.Database.Syst.Rev 2003;(4):CD004514. View Abstract
  870. Balk, E. M., Raman, G., Tatsioni, A., Chung, M., Lau, J., and Rosenberg, I. H. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch.Intern.Med 1-8-2007;167(1):21-30. View Abstract
  871. Shaw, D. M., Macsweeney, D. A., Johnson, A. L., O’Keeffe, R., Naidoo, D., Macleod, D. M., Jog, S., Preece, J. M., and Crowley, J. M. Folate and amine metabolites in senile dementia: a combined trial and biochemical study. Psychol.Med 1971;1(2):166-171. View Abstract
  872. Hvas, A. M., Juul, S., Lauritzen, L., Nexo, E., and Ellegaard, J. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect.Disord. 2004;81(3):269-273. View Abstract
  873. Seal, E. C., Metz, J., Flicker, L., and Melny, J. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am.Geriatr.Soc. 2002;50(1):146-151. View Abstract
  874. Kwok, T., Tang, C., Woo, J., Lai, W. K., Law, L. K., and Pang, C. P. Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriatr.Psychiatry 1998;13(9):611-616. View Abstract
  875. Kral, V. A., Solyom, L., Enesco, H., and Ledwidge, B. Relationship of vitamin B12 and folic acid to memory function. Biol.Psychiatry 1970;2(1):19-26. View Abstract
  876. Deijen, J. B., van der Beek, E. J., Orlebeke, J. F., and van den Berg, H. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology (Berl) 1992;109(4):489-496. View Abstract
  877. Perez, L., Heim, L., Sherzai, A., Jaceldo-Siegl, K., and Sherzai, A. Nutrition and vascular dementia. J.Nutr.Health Aging 2012;16(4):319-324. View Abstract
  878. Ho, R. C., Cheung, M. W., Fu, E., Win, H. H., Zaw, M. H., Ng, A., and Mak, A. Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am.J.Geriatr.Psychiatry 2011;19(7):607-617. View Abstract
  879. Wald, D. S., Kasturiratne, A., and Simmonds, M. Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers.Dement. 2011;7(4):412-417. View Abstract
  880. Clarke, R. B-vitamins and prevention of dementia. Proc Nutr Soc 2008;67(1):75-81. View Abstract
  881. Annerbo, S., Wahlund, L. O., and Lokk, J. The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer’s disease in mild cognitive impairment: a 6-year follow-up study. Am J Alzheimers.Dis.Other Demen. 2006;21(3):182-188. View Abstract
  882. Corrada, M. M., Kawas, C. H., Hallfrisch, J., Muller, D., and Brookmeyer, R. Reduced risk of Alzheimer’s disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers.Dement. 2005;1(1):11-18. View Abstract
  883. Haan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., Allen, L. H., and Green, R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007;85(2):511-517. View Abstract
  884. Luchsinger, J. A., Tang, M. X., Shea, S., Miller, J., Green, R., and Mayeux, R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 6-8-2004;62(11):1972-1976. View Abstract
  885. Luchsinger, J. A., Tang, M. X., Miller, J., Green, R., and Mayeux, R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007;64(1):86-92. View Abstract
  886. Maxwell, C. J., Hogan, D. B., and Ebly, E. M. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement.Geriatr Cogn Disord 2002;13(4):225-234. View Abstract
  887. Morris, M. C., Evans, D. A., Schneider, J. A., Tangney, C. C., Bienias, J. L., and Aggarwal, N. T. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer’s disease. J Alzheimers.Dis. 2006;9(4):435-443. View Abstract
  888. Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., and Licastro, F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82(3):636-643. View Abstract
  889. Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Pantieri, G., and Mariani, E. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement.Geriatr Cogn Disord. 2006;21(1):51-58. View Abstract
  890. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D’Agostino, R. B., Wilson, P. W., and Wolf, P. A. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N.Engl.J Med 2-14-2002;346(7):476-483. View Abstract
  891. Wang, H. X., Wahlin, A., Basun, H., Fastbom, J., Winblad, B., and Fratiglioni, L. Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology 5-8-2001;56(9):1188-1194. View Abstract
  892. Solfrizzi, V., Colacicco, A. M., D’Introno, A., Capurso, C., Del, Parigi A., Capurso, S. A., Argentieri, G., Capurso, A., and Panza, F. Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp.Gerontol. 2006;41(6):619-627. View Abstract
  893. Laurin, D., Verreault, R., Lindsay, J., Dewailly, E., and Holub, B. J. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers.Dis. 2003;5(4):315-322. View Abstract
  894. Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., Van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M. Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology 12-24-2002;59(12):1915-1921. View Abstract
  895. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., and Schneider, J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60(7):940-946. View Abstract
  896. Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W., and Wolf, P. A. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63(11):1545-1550. View Abstract
  897. Barberger-Gateau, P., Letenneur, L., Deschamps, V., Peres, K., Dartigues, J. F., and Renaud, S. Fish, meat, and risk of dementia: cohort study. BMJ 10-26-2002;325(7370):932-933. View Abstract
  898. Huang, T. L., Zandi, P. P., Tucker, K. L., Fitzpatrick, A. L., Kuller, L. H., Fried, L. P., Burke, G. L., and Carlson, M. C. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 11-8-2005;65(9):1409-1414. View Abstract
  899. Laitinen, M. H., Ngandu, T., Rovio, S., Helkala, E. L., Uusitalo, U., Viitanen, M., Nissinen, A., Tuomilehto, J., Soininen, H., and Kivipelto, M. Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study. Dement.Geriatr Cogn Disord. 2006;22(1):99-107. View Abstract
  900. Obeid R, FinkGeisel U, Eckert R, and Herrmann W. Effect of the Bvitamins on cognitive function in elderly people with mild cognitive dysfunction. Clin Chem Lab Med 2005;43:A28.
  901. Freund-Levi, Y., Eriksdotter-Jonhagen, M., Cederholm, T., Basun, H., Faxen-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L. O., and Palmblad, J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63(10):1402-1408. View Abstract
  902. Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., and Hirayama, T. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 1999;34 Suppl:S345-S346. View Abstract
  903. Jorissen, B. L., Brouns, F., van Boxtel, M. P., Ponds, R. W., Verhey, F. R., Jolles, J., and Riedel, W. J. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci 2001;4(2):121-134. View Abstract
  904. Yehuda, S., Rabinovtz, S., Carasso, R. L., and Mostofsky, D. I. Essential fatty acids preparation (SR-3) improves Alzheimer’s patients quality of life. Int J Neurosci. 1996;87(3-4):141-149. View Abstract
  905. Dangour, A. D., Whitehouse, P. J., Rafferty, K., Mitchell, S. A., Smith, L., Hawkesworth, S., and Vellas, B. B-vitamins and fatty acids in the prevention and treatment of Alzheimer’s disease and dementia: a systematic review. J Alzheimers.Dis. 2010;22(1):205-224. View Abstract
  906. Daviglus, M. L., Plassman, B. L., Pirzada, A., Bell, C. C., Bowen, P. E., Burke, J. R., Connolly, E. S., Jr., Dunbar-Jacob, J. M., Granieri, E. C., McGarry, K., Patel, D., Trevisan, M., and Williams, J. W., Jr. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch.Neurol. 2011;68(9):1185-1190. View Abstract
  907. Lazarou, C. and Kapsou, M. The role of folic acid in prevention and treatment of depression: an overview of existing evidence and implications for practice. Complement Ther Clin Pract. 2010;16(3):161-166. View Abstract
  908. Papakostas, G. I., Cassiello, C. F., and Iovieno, N. Folates and S-adenosylmethionine for major depressive disorder. Can.J.Psychiatry 2012;57(7):406-413. View Abstract
  909. Coppen, A. and Bailey, J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect.Disord. 2000;60(2):121-130. View Abstract
  910. Godfrey, P. S., Toone, B. K., Carney, M. W., Flynn, T. G., Bottiglieri, T., Laundy, M., Chanarin, I., and Reynolds, E. H. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 8-18-1990;336(8712):392-395. View Abstract
  911. Passeri, M., Cucinotta, D., Abate, G., Senin, U., Ventura, A., Stramba, Badiale M., Diana, R., La, Greca P., and Le, Grazie C. Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano.) 1993;5(1):63-71. View Abstract
  912. Bartlett, H. E. and Eperjesi, F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008;28(6):503-523. View Abstract
  913. Mangoni, A. A., Sherwood, R. A., Asonganyi, B., Swift, C. G., Thomas, S., and Jackson, S. H. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens. 2005;18(2 Pt 1):220-226. View Abstract
  914. Spoelstra-de, M. A., Brouwer, C. B., Terheggen, F., Bollen, J. M., Stehouwer, C. D., and Smulders, Y. M. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia. Neth.J Med 2004;62(7):246-253. View Abstract
  915. Gargari, B. P., Aghamohammadi, V., and Aliasgharzadeh, A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract. 2011;94(1):33-38. View Abstract
  916. Aghamohammadi, V., Gargari, B. P., and Aliasgharzadeh, A. Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J.Am.Coll.Nutr. 2011;30(3):210-215. View Abstract
  917. Meijer, W. M., Werler, M. M., Louik, C., Hernandez-Diaz, S., de Jong-van den Berg LT, and Mitchell, A. A. Can folic acid protect against congenital heart defects in Down syndrome? Birth Defects Res A Clin Mol.Teratol. 2006;76(10):714-717. View Abstract
  918. Zintzaras, E. Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J Hum Genet. 2007;52(11):943-953. View Abstract
  919. Ranganathan, L. N. and Ramaratnam, S. Vitamins for epilepsy. Cochrane.Database.Syst.Rev 2005;(2):CD004304. View Abstract
  920. Botez, M. I., Botez, T., Ross-Chouinard, A., and Lalonde, R. Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale. Epilepsy Res 1993;16(2):157-163. View Abstract
  921. Bowe, J. C., Cornish, E. J., and Dawson, M. Evaluation of folic acid supplements in children taking phenytoin. Dev.Med Child Neurol. 1971;13(3):343-354. View Abstract
  922. Backman, N., Holm, A. K., Hanstrom, L., Blomquist, H. K., Heijbel, J., and Safstrom, G. Folate treatment of diphenylhydantoin-induced gingival hyperplasia. Scand J Dent Res 1989;97(3):222-232. View Abstract
  923. Brown, R. S., Di Stanislao, P. T., Beaver, W. T., and Bottomley, W. K. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol. 1991;71(5):565-568. View Abstract
  924. Christiansen, C., Rodbro, P., and Lund, M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J 12-22-1973;4(5894):695-701. View Abstract
  925. Christiansen, C., Rodbro, P., and Nielsen, C. T. Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial. Acta Paediatr.Scand 1975;64(2):219-224. View Abstract
  926. Gibberd, F. B., Nicholls, A., and Wright, M. G. The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol. 1981;19(1):57-60. View Abstract
  927. Grant, R. H. and Stores, O. P. Folic acid in folate-deficient patients with epilepsy. Br Med J 12-12-1970;4(5736):644-648. View Abstract
  928. Horwitz, S. J., Klipstein, F. A., and Lovelace, R. E. Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet 3-16-1968;1(7542):563-565. View Abstract
  929. Jensen, O. N. and Olesen, O. V. Subnormal serum folate due to anticonvulsive therapy. A double-blind study of the effect of folic acid treatment in patients with drug-induced subnormal serum folates. Arch Neurol. 1970;22(2):181-182. View Abstract
  930. Mattson, R. H., Gallagher, B. B., Reynolds, E. H., and Glass, D. Folate therapy in epilepsy. A controlled study. Arch Neurol. 1973;29(2):78-81. View Abstract
  931. Ogunmekan, A. O. and Hwang, P. A. A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 1989;30(1):84-89. View Abstract
  932. Poppell, T. D., Keeling, S. D., Collins, J. F., and Hassell, T. M. Effect of folic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy. J Clin Periodontol. 1991;18(2):134-139. View Abstract
  933. Ralston, A. J., Snaith, R. P., and Hinley, J. B. Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants. Lancet 4-25-1970;1(7652):867-868. View Abstract
  934. Asfour, R., Wahbeh, N., Waslien, C. I., Guindi, S., and Darby, W. J. Folacin requirement of children. III. Normal infants. Am.J.Clin Nutr. 1977;30(7):1098-1105. View Abstract
  935. Hadler, M. C., Sigulem, D. M., Alves, Mde F., and Torres, V. M. Treatment and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiania, Goias State, Brazil: a randomized controlled trial. Cad.Saude Publica 2008;24 Suppl 2:S259-S271. View Abstract
  936. Matoth, Y., Zehavi, I., Topper, E., and Klein, T. Folate nutrition and growth in infancy. Arch.Dis.Child 1979;54(9):699-702. View Abstract
  937. Beca, J. P. and Saieh, C. [Folic acid suplement. Prevention of anemia in premature infants?]. Rev.Chil.Pediatr. 1975;46(4):347-350. View Abstract
  938. Blehaut, H., Mircher, C., Ravel, A., Conte, M., de, Portzamparc, V, Poret, G., de Kermadec, F. H., Rethore, M. O., and Sturtz, F. G. Effect of leucovorin (folinic acid) on the developmental quotient of children with Down’s syndrome (trisomy 21) and influence of thyroid status. PLoS.One. 2010;5(1):e8394. View Abstract
  939. Ek, J., Behncke, L., Halvorsen, K. S., and Magnus, E. Plasma and red cell folate values and folate requirements in formula-fed premature infants. Eur.J.Pediatr. 1984;142(2):78-82. View Abstract
  940. Ellis, J. M., Tan, H. K., Gilbert, R. E., Muller, D. P., Henley, W., Moy, R., Pumphrey, R., Ani, C., Davies, S., Edwards, V., Green, H., Salt, A., and Logan, S. Supplementation with antioxidants and folinic acid for children with Down’s syndrome: randomised controlled trial. BMJ 3-15-2008;336(7644):594-597. View Abstract
  941. Foged, N., Lillquist, K., Rolschau, J., and Blaabjerg, O. Effect of folic acid supplementation on small-for-gestational-age infants born at term. Eur.J.Pediatr. 1989;149(1):65-67. View Abstract
  942. Fuller, N. J., Bates, C. J., Hayes, R. J., Bradley, A. K., Greenwood, A. M., Tulloch, S., and Greenwood, B. M. The effects of antimalarials and folate supplements on haematological indices and red cell folate levels in Gambian children. Ann.Trop.Paediatr. 1988;8(2):61-67. View Abstract
  943. Gandy, G. and Jacobson, W. Influence of folic acid on birthweight and growth of the erythroblastotic infant. III. Effect of folic acid supplementation. Arch.Dis.Child 1977;52(1):16-21. View Abstract
  944. Hogeveen, M., den, Heijer M., Schonbeck, Y., Ijland, M., van, Oppenraaij D., Gunnewiek, J. K., and Blom, H. J. The effect of folinic acid supplementation on homocysteine concentrations in newborns. Eur.J.Clin Nutr. 2010;64(11):1266-1271. View Abstract
  945. Huemer, M., Ausserer, B., Graninger, G., Hubmann, M., Huemer, C., Schlachter, K., Tscharre, A., Ulmer, H., and Simma, B. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia 2005;46(10):1677-1683. View Abstract
  946. Ratanachu-Ek, S. Effects of multivitamin and folic acid supplementation in malnourished children. J.Med.Assoc.Thai. 2003;86 Suppl 3:S537-S542. View Abstract
  947. Rosado, J. L., Gonzalez, K. E., Caamano, Mdel C., Garcia, O. P., Preciado, R., and Odio, M. Efficacy of different strategies to treat anemia in children: a randomized clinical trial. Nutr.J. 2010;9:40. View Abstract
  948. Samuel, P. D., Burland, W. L., and Simpson, K. Response to oral administration of pteroylmonoglutamic acid or pteroylpolyglutamate in newborn infants of low birth weight. Br.J.Nutr. 1973;30(2):165-169. View Abstract
  949. Wu, K., Platz, E. A., Willett, W. C., Fuchs, C. S., Selhub, J., Rosner, B. A., Hunter, D. J., and Giovannucci, E. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 2009;90(6):1623-1631. View Abstract
  950. Xu, F., Zhang, L., and Li, M. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR and risk of pseudoexfoliation glaucoma: a meta-analysis. Graefes Arch.Clin Exp.Ophthalmol. 2012;250(7):1067-1074. View Abstract
  951. Xu, F., Zhao, X., Zeng, S. M., Li, L., Zhong, H. B., and Li, M. Homocysteine, B vitamins, methylenetetrahydrofolate reductase gene, and risk of primary open-angle glaucoma: a meta-analysis. Ophthalmology 2012;119(12):2493-2499. View Abstract
  952. Singh, J. A., Reddy, S. G., and Kundukulam, J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin.Rheumatol. 2011;23(2):192-202. View Abstract
  953. Allen, L. H., Peerson, J. M., and Olney, D. K. Provision of multiple rather than two or fewer micronutrients more effectively improves growth and other outcomes in micronutrient-deficient children and adults. J Nutr 2009;139(5):1022-1030. View Abstract
  954. Durga, J., Verhoef, P., Anteunis, L. J., Schouten, E., and Kok, F. J. Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial. Ann.Intern Med 1-2-2007;146(1):1-9. View Abstract
  955. Lin, R. J., Krall, R., Westerberg, B. D., Chadha, N. K., and Chau, J. K. Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoscope 2012;122(3):624-635. View Abstract
  956. Lahner, E., Persechino, S., and Annibale, B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17(1):1-15. View Abstract
  957. Kaisar, M., Isbel, N., and Johnson, D. W. Cardiovascular disease in patients with chronic kidney disease. A clinical review. Minerva Urol.Nefrol. 2007;59(3):281-297. View Abstract
  958. Nanayakkara, P. W., van, Guldener C., ter Wee, P. M., Scheffer, P. G., van Ittersum, F. J., Twisk, J. W., Teerlink, T., van, Dorp W., and Stehouwer, C. D. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch.Intern.Med. 6-25-2007;167(12):1262-1270. View Abstract
  959. Qin, X., Huo, Y., Langman, C. B., Hou, F., Chen, Y., Matossian, D., Xu, X., and Wang, X. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2011;6(3):482-488. View Abstract
  960. Heinz, J., Kropf, S., Luley, C., and Dierkes, J. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J Kidney Dis. 2009;54(3):478-489. View Abstract
  961. Dierkes, J., Domrose, U., Bosselmann, K. P., Neumann, K. H., and Luley, C. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease. J.Ren Nutr. 2001;11(2):67-72. View Abstract
  962. Sunder-Plassmann, G., Fodinger, M., Buchmayer, H., Papagiannopoulos, M., Wojcik, J., Kletzmayr, J., Enzenberger, B., Janata, O., Winkelmayer, W. C., Paul, G., Auinger, M., Barnas, U., and Horl, W. H. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J.Am.Soc.Nephrol. 2000;11(6):1106-1116. View Abstract
  963. Sombolos, K., Papaioannou, A., Christidou, F., Natse, T., Bamichas, G., Gionanlis, L., Katsaris, G., and Progia, E. The effect of two different doses comprising the simultaneous administration of intravenous B-complex vitamins and oral folic acid on serum homocysteine levels in hemodialysis patients. Int.Urol.Nephrol. 2006;38(3-4):725-730. View Abstract
  964. Disorders of homocysteine metabolism: from rare genetic defects to common risk factors. Proceedings of an international symposium. Fulda, Germany, 20-22 November 1996. Eur.J.Pediatr. 1998;157 Suppl 2:S39-142. View Abstract
  965. Bostom, A. G., Shemin, D., Lapane, K. L., Hume, A. L., Yoburn, D., Nadeau, M. R., Bendich, A., Selhub, J., and Rosenberg, I. H. High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996;49(1):147-152. View Abstract
  966. Azadibakhsh, N., Hosseini, R. S., Atabak, S., Nateghiyan, N., Golestan, B., and Rad, A. H. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients. Saudi.J.Kidney Dis.Transpl. 2009;20(5):779-788. View Abstract
  967. Pastore, A., De, Angelis S., Casciani, S., Ruggia, R., Di, Giovamberardino G., Noce, A., Splendiani, G., Cortese, C., Federici, G., and Dessi’, M. Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes. Clin Chem. 2006;52(1):145-148. View Abstract
  968. Kendrick, J. and Chonchol, M. B. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat.Clin Pract.Nephrol. 2008;4(12):672-681. View Abstract
  969. Shrubsole, M. J., Shu, X. O., Li, H. L., Cai, H., Yang, G., Gao, Y. T., Gao, J., and Zheng, W. Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am.J.Epidemiol. 5-15-2011;173(10):1171-1182. View Abstract
  970. Wolpin, B. M., Wei, E. K., Ng, K., Meyerhardt, J. A., Chan, J. A., Selhub, J., Giovannucci, E. L., and Fuchs, C. S. Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J.Clin Oncol. 7-1-2008;26(19):3222-3228. View Abstract
  971. Figueiredo, J. C., Grau, M. V., Haile, R. W., Sandler, R. S., Summers, R. W., Bresalier, R. S., Burke, C. A., McKeown-Eyssen, G. E., and Baron, J. A. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J.Natl.Cancer Inst. 3-18-2009;101(6):432-435. View Abstract
  972. Kaisar, M. O., Isbel, N. M., and Johnson, D. W. Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. Rev Recent Clin Trials 2008;3(2):79-88. View Abstract
  973. Worthington, H. V., Clarkson, J. E., and Eden, O. B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane.Database.Syst.Rev. 2007;(4):CD000978. View Abstract
  974. Erlichman, C., Fine, S., Wong, A., and Elhakim, T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol. 1988;6(3):469-475. View Abstract
  975. Zhu, Y., He, Z. Y., and Liu, H. N. Meta-analysis of the relationship between homocysteine, vitamin B(1)(2), folate, and multiple sclerosis. J.Clin Neurosci. 2011;18(7):933-938. View Abstract
  976. Thomson, M. E. and Pack, A. R. Effects of extended systemic and topical folate supplementation on gingivitis of pregnancy. J Clin Periodontol. 1982;9(3):275-280. View Abstract
  977. Pack, A. R. and Thomson, M. E. Effects of topical and systemic folic acid supplementation on gingivitis in pregnancy. J Clin Periodontol. 1980;7(5):402-414. View Abstract
  978. Yakoob, M. Y., Menezes, E. V., Soomro, T., Haws, R. A., Darmstadt, G. L., and Bhutta, Z. A. Reducing stillbirths: behavioural and nutritional interventions before and during pregnancy. BMC.Pregnancy Childbirth. 2009;9 Suppl 1:S3. View Abstract
  979. Christian, P. Micronutrients, birth weight, and survival. Annu.Rev Nutr 8-21-2010;30:83-104. View Abstract
  980. Ray, J. G. and Laskin, C. A. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 1999;20(7):519-529. View Abstract
  981. Badovinac, R. L., Werler, M. M., Williams, P. L., Kelsey, K. T., and Hayes, C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol.Teratol. 2007;79(1):8-15. View Abstract
  982. Johnson, C. Y. and Little, J. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol. 2008;37(5):1041-1058. View Abstract
  983. Ray, J. G., Meier, C., Vermeulen, M. J., Wyatt, P. R., and Cole, D. E. Association between folic acid food fortification and congenital orofacial clefts. J Pediatr 2003;143(6):805-807. View Abstract
  984. Ionescu-Ittu, R., Marelli, A. J., Mackie, A. S., and Pilote, L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 2009;338:b1673. View Abstract
  985. Czeizel, A. E. Periconceptional folic acid-containing multivitamin supplementation for the prevention of neural tube defects and cardiovascular malformations. Ann.Nutr.Metab 2011;59(1):38-40. View Abstract
  986. Baumslag, N., Edelstein, T., and Metz, J. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br.Med.J. 1-3-1970;1(5687):16-17. View Abstract
  987. Iyengar, L. Folic acid requirements of Indian pregnant women. Am.J.Obstet.Gynecol. 1971;111(1):13-16. View Abstract
  988. Lira, P., Barrena, N., Foradori, A., Gormaz, G., and Grebe, G. [Deficiency of folates in pregnancy: effect of supplementary folic acid]. Sangre (Barc.) 1989;34(1):24-27. View Abstract
  989. Nogueira, N. D., Macedo, A. D., Parente, J. V., and Cozzolino, S. Nutritional profile of newborns of adolescent mothers supplemented with iron, in different concentrations, zinc and pholic acid. Brazilian Journal of Nutrition 2002;15(2):193-200.
  990. Rolschau, J., Date, J., and Kristoffersen, K. Folic acid supplement and intrauterine growth. Acta Obstet.Gynecol.Scand. 1979;58(4):343-346. View Abstract
  991. Tchernia, G., Blot, I., Rey, A., Kaltwasser, J. P., Zittoun, J., and Papiernik, E. Maternal folate status, birthweight and gestational age. Dev.Pharmacol.Ther 1982;4 Suppl:58-65. View Abstract
  992. Chiaffarino, F., Ascone, G. B., Bortolus, R., Mastroia-Covo, P., Ricci, E., Cipriani, S., and Parazzini, F. [Effects of folic acid supplementation on pregnancy outcomes: a review of randomized clinical trials]. Minerva Ginecol. 2010;62(4):293-301. View Abstract
  993. Mahomed, K. Folate supplementation in pregnancy. Cochrane.Database.Syst.Rev 2000;(2):CD000183. View Abstract
  994. Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., Clemens, J. D., and Cutler, J. A. Trial of calcium to prevent preeclampsia. N.Engl J Med 7-10-1997;337(2):69-76. View Abstract
  995. The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity. J Obstet.Gynaecol.Br Emp. 1946;53(6):498-509. View Abstract
  996. Herrera, J. A., Arevalo-Herrera, M., and Herrera, S. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstet.Gynecol. 1998;91(4):585-590. View Abstract
  997. Harrison, K. A. Child-bearing, health and social priorities: a survey of 22 774 consecutive hospital births in Zaria, Northern Nigeria. Br J Obstet.Gynaecol. 1985;92 Suppl 5:1-119. View Abstract
  998. Hemminki, E. and Rimpela, U. A randomized comparison of routine versus selective iron supplementation during pregnancy. J.Am.Coll.Nutr. 1991;10(1):3-10. View Abstract
  999. Spatling, L. and Spatling, G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet.Gynaecol. 1988;95(2):120-125. View Abstract
  1000. Mahomed, K., James, D. K., Golding, J., and McCabe, R. Zinc supplementation during pregnancy: a double blind randomised controlled trial. BMJ 9-30-1989;299(6703):826-830. View Abstract
  1001. Jonsson, B., Hauge, B., Larsen, M. F., and Hald, F. Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet.Gynecol.Scand 1996;75(8):725-729. View Abstract
  1002. Lopez-Jaramillo, P., Delgado, F., Jacome, P., Teran, E., Ruano, C., and Rivera, J. Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet.Gynecol. 1997;90(2):162-167. View Abstract
  1003. Purwar, M., Kulkarni, H., Motghare, V., and Dhole, S. Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet.Gynaecol.Res 1996;22(5):425-430. View Abstract
  1004. Fleming, A. F., Hendrickse, J. P., and Allan, N. C. The prevention of megaloblastic anaemia in pregnancy in Nigeria. J Obstet.Gynaecol.Br Commonw. 1968;75(4):425-432. View Abstract
  1005. Fletcher, J., Gurr, A., Fellingham, F. R., Prankerd, T. A., Brant, H. A., and Menzies, D. N. The value of folic acid supplements in pregnancy. J Obstet.Gynaecol.Br Commonw. 1971;78(9):781-785. View Abstract
  1006. Hall, M. H. Folic acid deficiency and abruptio placentae. J Obstet.Gynaecol.Br Commonw. 1972;79(3):222-225. View Abstract
  1007. Blot, I., Papiernik, E., Kaltwasser, J. P., Werner, E., and Tchernia, G. Influence of routine administration of folic acid and iron during pregnancy. Gynecol.Obstet.Invest 1981;12(6):294-304. View Abstract
  1008. Simmer, K., Lort-Phillips, L., James, C., and Thompson, R. P. A double-blind trial of zinc supplementation in pregnancy. Eur J Clin Nutr 1991;45(3):139-144. View Abstract
  1009. Hunt, I. F., Murphy, N. J., Cleaver, A. E., Faraji, B., Swendseid, M. E., Coulson, A. H., Clark, V. A., Laine, N., Davis, C. A., and Smith, J. C., Jr. Zinc supplementation during pregnancy: zinc concentration of serum and hair from low-income women of Mexican descent. Am J Clin Nutr 1983;37(4):572-582. View Abstract
  1010. Sibai, B. M., Villar, M. A., and Bray, E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet.Gynecol. 1989;161(1):115-119. View Abstract
  1011. D’Almeida, A., Carter, J. P., Anatol, A., and Prost, C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19(2-3):117-131. View Abstract
  1012. Belizan, J. M., Villar, J., Bergel, E., del, Pino A., Di, Fulvio S., Galliano, S. V., and Kattan, C. Long-term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ 8-2-1997;315(7103):281-285. View Abstract
  1013. Sanchez-Ramos, L., Briones, D. K., Kaunitz, A. M., Delvalle, G. O., Gaudier, F. L., and Walker, C. D. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet.Gynecol. 1994;84(3):349-353. View Abstract
  1014. Lopez-Jaramillo, P., Narvaez, M., Weigel, R. M., and Yepez, R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet.Gynaecol. 1989;96(6):648-655. View Abstract
  1015. Lopez-Jaramillo, P., Narvaez, M., Felix, C., and Lopez, A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 2-3-1990;335(8684):293. View Abstract
  1016. Villar, J. and Repke, J. T. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet.Gynecol. 1990;163(4 Pt 1):1124-1131. View Abstract
  1017. Villar, J., Repke, J., Belizan, J. M., and Pareja, G. Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstet.Gynecol. 1987;70(3 Pt 1):317-322. View Abstract
  1018. Olsen, S. F., Sorensen, J. D., Secher, N. J., Hedegaard, M., Henriksen, T. B., Hansen, H. S., and Grant, A. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 4-25-1992;339(8800):1003-1007. View Abstract
  1019. Moodley, J. and Norman, R. J. Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia. Prostaglandins Leukot.Essent.Fatty Acids 1989;37(3):145-147. View Abstract
  1020. Rush, D., Stein, Z., and Susser, M. A randomized controlled trial of prenatal nutritional supplementation in New York City. Pediatrics 1980;65(4):683-697. View Abstract
  1021. Mardones-Santander, F., Rosso, P., Stekel, A., Ahumada, E., Llaguno, S., Pizarro, F., Salinas, J., Vial, I., and Walter, T. Effect of a milk-based food supplement on maternal nutritional status and fetal growth in underweight Chilean women. Am J Clin Nutr 1988;47(3):413-419. View Abstract
  1022. Arikan G, Panzitt T, Gaucer F, Boritsch J, Trojovski A, and Haeusler MCH. Oral magnesium supplementation and the prevention of preterm labor. Am J Obstet Gynecol 1997;76:S45.
  1023. Mora JO, de Navarro L, Clement J, Wagner M, de Paredes B, and Herrera MG. The effect of nutritional supplementation on calorie and protein intake of pregnant women. Nutr Rep Intl 1978;17:217-228.
  1024. Kulier, R., de, Onis M., Gulmezoglu, A. M., and Villar, J. Nutritional interventions for the prevention of maternal morbidity. Int J Gynaecol.Obstet. 1998;63(3):231-246. View Abstract
  1025. Goh, Y. I., Bollano, E., Einarson, T. R., and Koren, G. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol.Ther 2007;81(5):685-691. View Abstract
  1026. Haider, B. A. and Bhutta, Z. A. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database.Syst.Rev 2006;(4):CD004905. View Abstract
  1027. Haider, B. A., Yakoob, M. Y., and Bhutta, Z. A. Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes. BMC.Public Health 2011;11 Suppl 3:S19. View Abstract
  1028. Haider, B. A. and Bhutta, Z. A. Multiple-micronutrient supplementation for women during pregnancy. Cochrane.Database.Syst.Rev. 2012;11:CD004905. View Abstract
  1029. Kawai, K., Spiegelman, D., Shankar, A. H., and Fawzi, W. W. Maternal multiple micronutrient supplementation and pregnancy outcomes in developing countries: meta-analysis and meta-regression. Bull.World Health Organ 6-1-2011;89(6):402-411B. View Abstract
  1030. Pena-Rosas, J. P., De-Regil, L. M., Dowswell, T., and Viteri, F. E. Daily oral iron supplementation during pregnancy. Cochrane.Database.Syst.Rev. 2012;12:CD004736. View Abstract
  1031. Ramakrishnan, U., Grant, F. K., Goldenberg, T., Bui, V., Imdad, A., and Bhutta, Z. A. Effect of multiple micronutrient supplementation on pregnancy and infant outcomes: a systematic review. Paediatr.Perinat.Epidemiol. 2012;26 Suppl 1:153-167. View Abstract
  1032. Ray, J. G., O’Brien, T. E., and Chan, W. S. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM. 2001;94(8):435-444. View Abstract
  1033. Shah, P. S. and Ohlsson, A. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. CMAJ. 6-9-2009;180(12):E99-108. View Abstract
  1034. Mendez-Gonzalez, J., Rodriguez-Millan, E., Julve, J., and Blanco-Vaca, F. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]. Rev Neurol. 2-16-2010;50(4):235-244. View Abstract
  1035. Cronin, S., Furie, K. L., and Kelly, P. J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005;36(7):1581-1587. View Abstract
  1036. Herrmann, W. Significance of hyperhomocysteinemia. Clin Lab 2006;52(7-8):367-374. View Abstract
  1037. Schwammenthal, Y. and Tanne, D. Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol. 2004;3(8):493-495. View Abstract
  1038. Lee, M., Hong, K. S., Chang, S. C., and Saver, J. L. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke 2010;41(6):1205-1212. View Abstract
  1039. Saposnik, G. Meta analysis suggests that folic acid supplementation does not reduce risk of stroke, but there may be some benefit when given in combination with vitamins B6 and B12 and in primary prevention. Evid.Based Med 2010;15(6):168-170. View Abstract
  1040. Barrios, M. and Alliot, C. Venous thrombosis associated with pernicious anaemia. A report of two cases and review. Hematology. 2006;11(2):135-138. View Abstract
  1041. Deol, P. S., Barnes, T. A., Dampier, K., John, Pasi K., Oppenheimer, C., and Pavord, S. R. The effects of folic acid supplements on coagulation status in pregnancy. Br.J.Haematol. 2004;127(2):204-208. View Abstract
  1042. Ray, J. G., Kearon, C., Yi, Q., Sheridan, P., and Lonn, E. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Ann.Intern.Med. 6-5-2007;146(11):761-767. View Abstract
  1043. Rueda, J. R., Ballesteros, J., and Tejada, M. I. Systematic review of pharmacological treatments in fragile X syndrome. BMC.Neurol. 2009;9:53. View Abstract
  1044. Brown, W. T., Cohen, I. L., Fisch, G. S., Wolf-Schein, E. G., Jenkins, V. A., Malik, M. N., and Jenkins, E. C. High dose folic acid treatment of fragile (X) males. Am J Med Genet. 1986;23(1-2):263-271. View Abstract
  1045. Fisch, G. S., Cohen, I. L., Gross, A. C., Jenkins, V., Jenkins, E. C., and Brown, W. T. Folic acid treatment of fragile X males: a further study. Am J Med Genet. 1988;30(1-2):393-399. View Abstract
  1046. Froster-Iskenius, U., Bodeker, K., Oepen, T., Matthes, R., Piper, U., and Schwinger, E. Folic acid treatment in males and females with fragile-(X)-syndrome. Am J Med Genet. 1986;23(1-2):273-289. View Abstract
  1047. Hagerman, R. J., Jackson, A. W., Levitas, A., Braden, M., McBogg, P., Kemper, M., McGavran, L., Berry, R., Matus, I., and Hagerman, P. J. Oral folic acid versus placebo in the treatment of males with the fragile X syndrome. Am J Med Genet. 1986;23(1-2):241-262. View Abstract
  1048. Strom, C. M., Brusca, R. M., and Pizzi, W. J. Double-blind, placebo-controlled crossover study of folinic acid (Leucovorin for the treatment of fragile X syndrome. Am J Med Genet. 11-15-1992;44(5):676-682. View Abstract
  1049. Hagerman, R. J., Murphy, M. A., and Wittenberger, M. D. A controlled trial of stimulant medication in children with the fragile X syndrome. Am J Med Genet. 1988;30(1-2):377-392. View Abstract
  1050. Torrioli, M. G., Vernacotola, S., Peruzzi, L., Tabolacci, E., Mila, M., Militerni, R., Musumeci, S., Ramos, F. J., Frontera, M., Sorge, G., Marzullo, E., Romeo, G., Vallee, L., Veneselli, E., Cocchi, E., Garbarino, E., Moscato, U., Chiurazzi, P., D’Iddio, S., Calvani, M., and Neri, G. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am.J Med.Genet.A 4-1-2008;146(7):803-812. View Abstract
  1051. Berry-Kravis, E., Krause, S. E., Block, S. S., Guter, S., Wuu, J., Leurgans, S., Decle, P., Potanos, K., Cook, E., Salt, J., Maino, D., Weinberg, D., Lara, R., Jardini, T., Cogswell, J., Johnson, S. A., and Hagerman, R. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc.Psychopharmacol 2006;16(5):525-540. View Abstract
  1052. Torrioli, M. G., Vernacotola, S., Mariotti, P., Bianchi, E., Calvani, M., De Gaetano, A., Chiurazzi, P., and Neri, G. Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome. Am.J Med Genet. 12-3-1999;87(4):366-368. View Abstract
  1053. Brown, W. T., Jenkins, E. C., Friedman, E., Brooks, J., Cohen, I. L., Duncan, C., Hill, A. L., Malik, M. N., Morris, V., Wolf, E., and . Folic acid therapy in the fragile X syndrome. Am J Med Genet. 1984;17(1):289-297. View Abstract
  1054. Carpenter NJ, Barber DH, Jones M, Lindley W, and Carr C. Controlled six-month study of oral folic acid therapy in boys with fragile X-linked mental retardation. Am J Med Genet 1983;35(243):82A.
  1055. Madison, L. S., Wells, T. E., Fristo, T. E., and Benesch, C. G. A controlled study of folic acid treatment in three fragile X syndrome males. J Dev.Behav.Pediatr 1986;7(4):253-256. View Abstract
  1056. Rosenblatt, D. S., Duschenes, E. A., Hellstrom, F. V., Golick, M. S., Vekemans, M. J., Zeesman, S. F., and Andermann, E. Folic acid blinded trial in identical twins with fragile X syndrome. Am J Hum Genet. 1985;37(3):543-552. View Abstract
  1057. Gillberg, C., Wahlstrom, J., Johansson, R., Tornblom, M., and Albertsson-Wikland, K. Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX). Dev.Med Child Neurol. 1986;28(5):624-627. View Abstract
  1058. Zhao, Z., Pelletier, E., Barber, B., Bhosle, M., Wang, S., Gao, S., and Klingman, D. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe. Curr Med.Res Opin. 2012;28(2):221-229. View Abstract
  1059. Vieitez, J. M., Garcia-Carbonero, R., Aparicio, J., Feliu, J., Gonzalez-Flores, E., Grande, E., Perez-Hoyos, T., Salud, A., Torres, E., Valero, M., Valladares-Ayerbes, M., and Diaz-Rubio, E. Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain. Clin Transl.Oncol. 2011;13(11):798-804. View Abstract
  1060. Van, Loon K. and Venook, A. P. Adjuvant treatment of colon cancer: what is next? Curr Opin.Oncol. 2011;23(4):403-409. View Abstract
  1061. Ling, W., Fan, J., Ma, Y., Ma, Y., and Wang, H. Capecitabine-based chemotherapy for metastatic colorectal cancer. J.Cancer Res Clin Oncol. 2011;137(6):927-938. View Abstract
  1062. Montagnani, F., Chiriatti, A., Turrisi, G., Francini, G., and Fiorentini, G. A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity. Colorectal Dis. 2011;13(8):846-852. View Abstract
  1063. Lam, V. W., Spiro, C., Laurence, J. M., Johnston, E., Hollands, M. J., Pleass, H. C., and Richardson, A. J. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann.Surg.Oncol. 2012;19(4):1292-1301. View Abstract
  1064. Chuang, V. T. and Suno, M. Levoleucovorin as replacement for leucovorin in cancer treatment. Ann.Pharmacother. 2012;46(10):1349-1357. View Abstract
  1065. Vargas, A. J. and Thompson, P. A. Diet and nutrient factors in colorectal cancer risk. Nutr.Clin Pract. 2012;27(5):613-623. View Abstract
  1066. Solimando, R., Bazzoli, F., and Ricciardiello, L. Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? Best.Pract.Res Clin Gastroenterol. 2011;25(4-5):555-568. View Abstract
  1067. Carroll, C., Cooper, K., Papaioannou, D., Hind, D., Tappenden, P., Pilgrim, H., and Booth, A. Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer. Aliment.Pharmacol.Ther 2010;31(7):708-718. View Abstract
  1068. Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., Snover, D. C., Church, T. R., Allen, J. I., Beach, M., Beck, G. J., Bond, J. H., Byers, T., Greenberg, E. R., Mandel, J. S., Marcon, N., Mott, L. A., Pearson, L., Saibil, F., and van Stolk, R. U. A randomized trial of aspirin to prevent colorectal adenomas. N.Engl.J Med 3-6-2003;348(10):891-899. View Abstract
  1069. Zhu S, Mason J, and Yaol S. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J 2003;116:15-19.
  1070. Cole B, Baron J, and Sandler R. A randomized trial of folic acid to prevent colorectal adenomas. Proc Am Assoc Cancer Res Annu Meet 2005;46:4399.
  1071. Zhu S, Mason J, and Shi Y. The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers – Clinical trial and follow- up for seven years. Chinese Journal of Gastroenterology 2002;7:73-78.
  1072. Jaszewski, R., Misra, S., Tobi, M., Ullah, N., Naumoff, J. A., Kucuk, O., Levi, E., Axelrod, B. N., Patel, B. B., and Majumdar, A. P. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol 7-28-2008;14(28):4492-4498. View Abstract
  1073. Lonn, E., Held, C., Arnold, J. M., Probstfield, J., McQueen, M., Micks, M., Pogue, J., Sheridan, P., Bosch, J., Genest, J., and Yusuf, S. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can.J Cardiol 2006;22(1):47-53. View Abstract
  1074. Figueiredo, J. C., Mott, L. A., Giovannucci, E., Wu, K., Cole, B., Grainge, M. J., Logan, R. F., and Baron, J. A. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer 7-1-2011;129(1):192-203. View Abstract
  1075. Ibrahim, E. M. and Zekri, J. M. Folic acid supplementation for the prevention of recurrence of colorectal adenomas: metaanalysis of interventional trials. Med Oncol. 2010;27(3):915-918. View Abstract
  1076. Paspatis, G. A. and Karamanolis, D. G. Folate supplementation and adenomatous colonic polyps. Dis.Colon Rectum 1994;37(12):1340-1341. View Abstract
  1077. Kim, Y. I., Baik, H. W., Fawaz, K., Knox, T., Lee, Y. M., Norton, R., Libby, E., and Mason, J. B. Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol 2001;96(1):184-195. View Abstract
  1078. Figueiredo, J. C., Levine, A. J., Grau, M. V., Barry, E. L., Ueland, P. M., Ahnen, D. J., Byers, T., Bresalier, R. S., Summers, R. W., Bond, J., McKeown-Eyssen, G. E., Sandler, R. S., Haile, R. W., and Baron, J. A. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol.Biomarkers Prev. 2008;17(10):2625-2631. View Abstract
  1079. Hubner, R. A., Muir, K. R., Liu, J. F., Sellick, G. S., Logan, R. F., Grainge, M., Armitage, N., Chau, I., and Houlston, R. S. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence. Cancer Epidemiol.Biomarkers Prev. 2006;15(9):1607-1613. View Abstract
  1080. Levine, A. J., Wallace, K., Tsang, S., Haile, R. W., Saibil, F., Ahnen, D., Cole, B. F., Barry, E. L., Munroe, D. J., Ali, I. U., Ueland, P., and Baron, J. A. MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial. Cancer Epidemiol.Biomarkers Prev. 2008;17(9):2409-2415. View Abstract
  1081. Burn, J., Bishop, D. T., Mecklin, J. P., Macrae, F., Moslein, G., Olschwang, S., Bisgaard, M. L., Ramesar, R., Eccles, D., Maher, E. R., Bertario, L., Jarvinen, H. J., Lindblom, A., Evans, D. G., Lubinski, J., Morrison, P. J., Ho, J. W., Vasen, H. F., Side, L., Thomas, H. J., Scott, R. J., Dunlop, M., Barker, G., Elliott, F., Jass, J. R., Fodde, R., Lynch, H. T., and Mathers, J. C. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N.Engl.J Med 12-11-2008;359(24):2567-2578. View Abstract
  1082. Burn J, Chapman PD, Bishop DT, Dixon R, Turner F, and Coaker J. Results of the CAPP1 Study: aspirin and resistant starch are beneficial in familial adenomatous polyposis. Am J Hum Genet 2003;73
  1083. Benamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., and Chaussade, S. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 2003;125(2):328-336. View Abstract
  1084. Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., Steinbach, G., and Schilsky, R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N.Engl.J Med 3-6-2003;348(10):883-890. View Abstract
  1085. Cook, N. R., Lee, I. M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., and Buring, J. E. Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial. JAMA 7-6-2005;294(1):47-55. View Abstract
  1086. Gann, P. H., Manson, J. E., Glynn, R. J., Buring, J. E., and Hennekens, C. H. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 8-4-1993;85(15):1220-1224. View Abstract
  1087. Farrell, B., Godwin, J., Richards, S., and Warlow, C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol.Neurosurg.Psychiatry 1991;54(12):1044-1054. View Abstract
  1088. Peto, R., Gray, R., Collins, R., Wheatley, K., Hennekens, C., Jamrozik, K., Warlow, C., Hafner, B., Thompson, E., Norton, S., and . Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1-30-1988;296(6618):313-316. View Abstract
  1089. Giardiello, F. M., Yang, V. W., Hylind, L. M., Krush, A. J., Petersen, G. M., Trimbath, J. D., Piantadosi, S., Garrett, E., Geiman, D. E., Hubbard, W., Offerhaus, G. J., and Hamilton, S. R. Primary chemoprevention of familial adenomatous polyposis with sulindac. N.Engl.J Med 4-4-2002;346(14):1054-1059. View Abstract
  1090. Iwama, T., Akasu, T., Utsunomiya, J., and Muto, T. Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial. Int J Clin Oncol. 2006;11(2):133-139. View Abstract
  1091. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N.Engl.J Med 6-29-2000;342(26):1946-1952. View Abstract
  1092. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N.Engl.J Med 5-6-1993;328(18):1313-1316. View Abstract
  1093. Nugent, K. P., Farmer, K. C., Spigelman, A. D., Williams, C. B., and Phillips, R. K. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80(12):1618-1619. View Abstract
  1094. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M., and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101(3):635-639. View Abstract
  1095. Arber, N., Eagle, C. J., Spicak, J., Racz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., Rosenstein, R. B., Macdonald, K., Bhadra, P., Fowler, R., Wittes, J., Zauber, A. G., Solomon, S. D., and Levin, B. Celecoxib for the prevention of colorectal adenomatous polyps. N.Engl.J Med 8-31-2006;355(9):885-895. View Abstract
  1096. Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., Hess, T. M., Woloj, G. M., Boisserie, F., Anderson, W. F., Viner, J. L., Bagheri, D., Burn, J., Chung, D. C., Dewar, T., Foley, T. R., Hoffman, N., Macrae, F., Pruitt, R. E., Saltzman, J. R., Salzberg, B., Sylwestrowicz, T., Gordon, G. B., and Hawk, E. T. Celecoxib for the prevention of sporadic colorectal adenomas. N.Engl.J Med 8-31-2006;355(9):873-884. View Abstract
  1097. Ladenheim, J., Garcia, G., Titzer, D., Herzenberg, H., Lavori, P., Edson, R., and Omary, M. B. Effect of sulindac on sporadic colonic polyps. Gastroenterology 1995;108(4):1083-1087. View Abstract
  1098. Zhu, S., Mason, J., Shi, Y., Hu, Y., Li, R., Wahg, M., Zhou, Y., Jin, G., Xie, Y., Wu, G., Xia, D., Qian, Z., Sohg, H., Zhang, L., Russell, R., and Xiao, S. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med.J.(Engl.) 2003;116(1):15-19. View Abstract
  1099. Thomas, M. G., Thomson, J. P., and Williamson, R. C. Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. Br.J Surg. 1993;80(4):499-501. View Abstract
  1100. Bonithon-Kopp, C., Kronborg, O., Giacosa, A., Rath, U., and Faivre, J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 10-14-2000;356(9238):1300-1306. View Abstract
  1101. Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., Bond, J. H., and Greenberg, E. R. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N.Engl.J Med. 1-14-1999;340(2):101-107. View Abstract
  1102. Hofstad, B., Almendingen, K., Vatn, M., Andersen, S. N., Owen, R. W., Larsen, S., and Osnes, M. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998;59(2):148-156. View Abstract
  1103. Lappe, J. M., Travers-Gustafson, D., Davies, K. M., Recker, R. R., and Heaney, R. P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85(6):1586-1591. View Abstract
  1104. Wactawski-Wende, J., Kotchen, J. M., Anderson, G. L., Assaf, A. R., Brunner, R. L., O’Sullivan, M. J., Margolis, K. L., Ockene, J. K., Phillips, L., Pottern, L., Prentice, R. L., Robbins, J., Rohan, T. E., Sarto, G. E., Sharma, S., Stefanick, M. L., Van, Horn L., Wallace, R. B., Whitlock, E., Bassford, T., Beresford, S. A., Black, H. R., Bonds, D. E., Brzyski, R. G., Caan, B., Chlebowski, R. T., Cochrane, B., Garland, C., Gass, M., Hays, J., Heiss, G., Hendrix, S. L., Howard, B. V., Hsia, J., Hubbell, F. A., Jackson, R. D., Johnson, K. C., Judd, H., Kooperberg, C. L., Kuller, L. H., LaCroix, A. Z., Lane, D. S., Langer, R. D., Lasser, N. L., Lewis, C. E., Limacher, M. C., and Manson, J. E. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N.Engl.J Med. 2-16-2006;354(7):684-696. View Abstract
  1105. Baron, J. A., Cole, B. F., Mott, L., Haile, R., Grau, M., Church, T. R., Beck, G. J., and Greenberg, E. R. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J.Natl.Cancer Inst. 5-21-2003;95(10):717-722. View Abstract
  1106. Palmieri Y. Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. Brussels: Se-Te Press. 1998;
  1107. Ponz de, Leon M. and Roncucci, L. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scand J Gastroenterol Suppl 1997;222:72-75. View Abstract
  1108. Roncucci, L., Di, Donato P., Carati, L., Ferrari, A., Perini, M., Bertoni, G., Bedogni, G., Paris, B., Svanoni, F., Girola, M., and . Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. Dis.Colon Rectum 1993;36(3):227-234. View Abstract
  1109. MacLennan, R., Macrae, F., Bain, C., Battistutta, D., Chapuis, P., Gratten, H., Lambert, J., Newland, R. C., Ngu, M., Russell, A., and . Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J.Natl.Cancer Inst. 12-6-1995;87(23):1760-1766. View Abstract
  1110. McKeown-Eyssen, G., Holloway, C., Jazmaji, V., Bright-See, E., Dion, P., and Bruce, W. R. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 8-15-1988;48(16):4701-4705. View Abstract
  1111. Gaziano, J. M., Glynn, R. J., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Sesso, H. D., and Buring, J. E. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA 1-7-2009;301(1):52-62. View Abstract
  1112. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., Parnes, H. L., Minasian, L. M., Gaziano, J. M., Hartline, J. A., Parsons, J. K., Bearden, J. D., III, Crawford, E. D., Goodman, G. E., Claudio, J., Winquist, E., Cook, E. D., Karp, D. D., Walther, P., Lieber, M. M., Kristal, A. R., Darke, A. K., Arnold, K. B., Ganz, P. A., Santella, R. M., Albanes, D., Taylor, P. R., Probstfield, J. L., Jagpal, T. J., Crowley, J. J., Meyskens, F. L., Jr., Baker, L. H., and Coltman, C. A., Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 1-7-2009;301(1):39-51. View Abstract
  1113. Lin, J., Cook, N. R., Albert, C., Zaharris, E., Gaziano, J. M., Van, Denburgh M., Buring, J. E., and Manson, J. E. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J.Natl.Cancer Inst. 1-7-2009;101(1):14-23. View Abstract
  1114. Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Meyskens, F. L., Jr., Omenn, G. S., Valanis, B., and Williams, J. H., Jr. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J.Natl.Cancer Inst. 12-1-2004;96(23):1743-1750. View Abstract
  1115. Hercberg, S., Galan, P., Preziosi, P., Bertrais, S., Mennen, L., Malvy, D., Roussel, A. M., Favier, A., and Briancon, S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern.Med 11-22-2004;164(21):2335-2342. View Abstract
  1116. Virtamo, J., Pietinen, P., Huttunen, J. K., Korhonen, P., Malila, N., Virtanen, M. J., Albanes, D., Taylor, P. R., and Albert, P. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 7-23-2003;290(4):476-485. View Abstract
  1117. Duffield-Lillico, A. J., Reid, M. E., Turnbull, B. W., Combs, G. F., Jr., Slate, E. H., Fischbach, L. A., Marshall, J. R., and Clark, L. C. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol.Biomarkers Prev. 2002;11(7):630-639. View Abstract
  1118. No author. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 7-6-2002;360(9326):23-33. View Abstract
  1119. Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., Willett, W., and Peto, R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N.Engl.J.Med. 5-2-1996;334(18):1145-1149. View Abstract
  1120. Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. F., Maguire, C., Hind, D., and Tappenden, P. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol.Assess. 2010;14(32):1-206. View Abstract

Natural Standard Research Collaboration (www.naturalstandard. com) provides access to the most comprehensive database of high-quality, evidence-based systematic reviews on dietary supplements and CAM therapies. This database is a clinical decision support tool that is designed to advise clinicians and researchers on the safety and efficacy of herbs, supplements, vitamins, diets, nutrition, exercise and complementary practices and modalities. Using a comprehensive methodology, reproducible grading scales and the collective expertise of a multi-disciplinary Editorial Board, Natural Standard’s mission is to provide organizations with access to the highest-quality evidence-based intelligence to make more informed and safer therapeutic decisions. Questions about the database can be directed to (617) 591-3348.